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ABSTRACT
Effects of pesticide exposure on the humoral immune response following
Streptococcus pneumoniae vaccination

Keith Douglas Salazar
As pesticide use rises in the US annually, the need for extensive characterization of the
risks associated with these substances also increases. Herbicides represent the most
frequently used type of pesticides. 3,4-dichloropropionanilide (propanil) and 2,4dicholorophenoxyacetic acid (2,4-D) are two of the most commonly used herbicides.
These experiments evaluated the effects of propanil and 2,4-D on the humoral immune
response in C57BL/6 mice following heat-killed Streptococcus pneumoniae (HKSP)
immunization. Intraperitoneal exposure of 150 mg/kg propanil on the same day as HKSP
immunization enhances the splenic T-independent type 2 antibody response to
phosphorylcholine (PC) antigen 4-6-fold. Maximal PC enhancement occurs 7 days postexposure. Propanil exposure 9 days following HKSP immunization enhances the Tdependent antibody response to the pneumococcal surface protein A (PspA). 2,4-D
exposure decreases the PC-specific antibody response in the bone marrow and the
antibody serum titers 10 days post-exposure. Mixture exposure to the herbicides did not
produce any synergistic effects. In addition, aspiration of the mixture of herbicides did
not affect the antibody response. Ovariectomy and inhibition of ovarian steroid synthesis
abrogates the PC-specific antibody enhancement in propanil-treated mice. Several
studies examined the direct and indirect estrogenic activity of propanil. Interestingly,
propanil enhances the PC-specific splenic antibody response independent of an estrogenic
mechanism. Although male mice also had enhanced antibody responses following
propanil exposure, orchiectomy did not affect the enhancement. Finally, propanil
exposure did not enhance survival following a suboptimal immunization to a virulent
strain of S. pneumoniae. Altogether, these results provide a number of findings that
contribute to our understanding of the regulation of the humoral response to HKSP.
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CHAPTER 1: GENERAL INTRODUCTION
PROPANIL
Background and General Toxicity
The pesticide 3,4-dichloropropionanilide (propanil) is an herbicide that is
predominantly used for the control of weeds on commercial rice crops. Numerous
studies have investigated the toxicological potential of propanil. It has been established
in the literature that propanil has a number of immunotoxic effects. This report will
provide a brief background of the general toxic effects of propanil exposure and primarily
focus on the immunotoxicity studies that have been performed in both in vivo and in vitro
models. In addition, epidemiological reports examining the immunotoxic effects of
propanil on professional applicators and people living in areas of propanil use will be
summarized.
Propanil is in the acetanilide chemical family (U.S. EPA OFFICE OF
PESTICIDE PROGRAMS, 2003). Approximately 99% of the propanil used in the
United States is for the control of weeds on rice crops (U.S. EPA OFFICE OF
PESTICIDE PROGRAMS, 2003). Roughly 50-70% of all rice grown in the U.S. is
treated with propanil (U.S. EPA OFFICE OF PESTICIDE PROGRAMS, 2003). A 2001
estimate by the Environmental Protection Agency (EPA) ranks propanil as the 17th most
used pesticide in the U.S. The range of propanil application extends throughout the lower
southern states along the Mississippi River and in some areas of California. Propanil is
restricted exclusively to commercial use and it is readily degraded in the soil and water.
The half-life in the soil is 1-3 days and 2-3 days in the water (Wauchope et al., 1992).
Given the lack of residential use of propanil and the short half-life, exposure of the
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chemical is primarily restricted to applicators and residents who live near the treated
farms. The preferred method of application is via groundboom sprayers and aerial
methods (U.S. EPA OFFICE OF PESTICIDE PROGRAMS, 2003).
The most common routes of propanil exposure include inhalational, dermal,
orbital, and to a lesser extent, oral. Upon entry into the organism, propanil is rapidly
metabolized in the liver by the enzyme acylamidase into the major metabolite 3,4dichloroaniline (DCA) (Williams et al., 1966). Other metabolites of propanil include 2’hydroxypropanil and 6’-hydroxypropanil (McMillan et al., 1990a). DCA is subsequently
metabolized to 6-hydroxy-3, 4-dichloroaniline and N-hydroxy-3, 4-dichloroaniline. Due
to the rapid metabolism of the parent compound, propanil remains at detectable
concentrations in the blood of rats for approximately 48 hours following exposure
(Izmerov, 1984).
Following exposure to propanil, a number of toxic side effects are induced
including hemolytic anemia, methemoglobinemia, and myelotoxicity. In vivo studies in
Sprague-Dawley rats have shown that inhibition of the acylamidase activity with
triorthotolyl phosphate decreased the amount of methemoglobinemia formed following a
400 mg/kg intraperitoneal (i.p.) exposure to propanil (Singleton et al., 1973). In addition,
i.p. injections of the metabolite N-hydroxy-3, 4-dichloroaniline into rats was found to
induce the same amount of hemolytic anemia as the parent compound (McMillan et al.,
1991). In vitro studies analyzing the ability of propanil metabolites to oxidize
hemoglobin in erythrocyte suspensions confirmed that N-hydroxy-3, 4-dichloroaniline
was the most potent oxidizing metabolite (McMillan et al., 1990a). Altogether, theses
studies indicate that metabolism of the parent compound is necessary for anemia.
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Duration of the anemic effects differ according to the exposure concentration of
propanil (McMillan et al., 1990b). Analysis of blood samples from acutely exposed
Sprague-Dawley rats treated with 300 mg/kg of propanil showed that
methemoglobinemia effects peak at 4.5 hours post-exposure and these effects can be
detected for as long as 24 hours (McMillan et al., 1990b). However, 100 mg/kg of
propanil induced a peak in methemoglobin levels at 1.5 hours and could be detected for
12 hours (McMillan et al., 1990b). These data indicate that the anemic effects induced
by propanil are brief and these effects do not persist following the clearance of propanil
from the blood.
More recently, myelotoxic effects have also been established following propanil
exposure (Malerba et al., 2002; Blyler et al., 1994). Ex vivo colony-forming assays from
the bone marrow of acutely exposed C57Bl/6 mice demonstrated that the early stem cell
progenitors, myeloid stem cells (CFU-S) and erythroid burst-forming units (BFU-E), are
decreased in number following 200 mg/kg propanil exposure (Blyler et al., 1994).
However, the more differentiated cell types such as erythroid colony-forming units
(CFU-E), granulocyte/macrophage progenitor cells (GM-CFU), macrophages (CFU-M),
and neutrophils (CFU-G) are not reduced in number following propanil treatment (Blyler
et al., 1994). Similar effects on the early erythroid stem cells are seen with human cord
progenitor cells following propanil treatment (Malerba et al., 2002). In vitro exposure to
cord blood demonstrated that the CFU-E and BFU-E progenitors had 50% of their growth
inhibited (IC50) by 234 and 441 µM of propanil, respectively (Malerba et al., 2002). The
more differentiated CFU-GM progenitors had an IC50 of greater than 500 µM, indicating
similar susceptibility to the effects of propanil on the more immature progenitors in both
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humans and mice (Malerba et al., 2002). However, unlike mice, DCA is far less toxic to
human CFU/BFU-E progenitors than its parent compound (Malerba et al., 2002).
Initial chronic and acute exposure studies found that secondary immune organs
are also affected after exposure to propanil (Barnett et al., 1989; Ambrose et al., 1972).
Female and male rats exposed for 2 years to 400 ppm of propanil mixed in their feed
have increased spleen weights, but the heart, kidney, liver and testes weights are
unaffected (Ambrose et al., 1972). In a subchronic study, female and male rats treated
for 3 months with 1000 and 3300 ppm of propanil, respectively, did not have altered
organ weights except increased spleen sizes (Ambrose et al., 1972). Additionally,
acutely exposed C57Bl/6 mice treated i.p. with 200 mg/kg of propanil had decreased
thymus weights and increased spleen weights (Barnett and Gandy, 1989). These studies
suggest that propanil may be more toxic to secondary immune organs than other
nonimmune organs. The relevance of these immunotoxic effects will be discussed in
more detail in later sections.
Other studies using common toxic endpoints such as mutagenicity, reproductive
toxicity, and carcinogenicity have yielded negative results. Propanil has not been found
to be mutagenic as determined in Salmonella reversion assays (McMillan et al., 1988).
The EPA has determined that propanil is not a carcinogen in humans (U.S. EPA OFFICE
OF PESTICIDE PROGRAMS, 2003). Reproductive studies in rats have shown that
chronic oral propanil exposure does not cause any abnormalities in the fertility of the
parents nor does it affect the health of the offspring (Ambrose et al., 1972). Propanil is
classified in the “slightly toxic” toxicity class III for oral exposures and toxicity class IV
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for inhalation and dermal exposures (U.S. EPA OFFICE OF PESTICIDE PROGRAMS,
2003).
Assessment of the effects of propanil on humans demonstrates that the greatest
risk of toxic exposure is most hazardous with applicators and manufacturing workers.
Examination of immune changes in farm-families exposed to propanil observed decreases
in IL-2+ cells and natural killer (NK) cell counts (McClure et al., 2001). However, these
lower counts were associated with the preseason measurements and the cell counts
rebounded during the spray season (McClure et al., 2001). This could be due to the low
particulate concentration of propanil in family homes lying adjacent to the spray fields
(Richards et al., 2001). Non-applicator personnel working in adjacent propanil-treated
fields were also exposed to very low concentrations of propanil (Barnes et al., 1987).
These personnel were exposed to concentrations that were several orders of magnitude
lower than the concentrations shown to be toxic (Barnes et al., 1987). However, 61% of
production workers exposed to propanil had chloracne indicating the higher risk of
toxicity (Morse et al., 1979).
Innate immune studies
The innate immune system is responsible for not only rapidly eliminating
pathogens, but also initiating adaptive immune responses. Immunotoxic effects on cells
of this system may also compromise the ability of an organism to control initial infections
until an adaptive immune response can be generated. Two important effector cells of the
innate immune system are macrophages and NK cells.
Propanil has been demonstrated to inhibit macrophage function. LPS-stimulated
peritoneal macrophages harvested from mice 7 days following i.p. propanil exposure
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(200 mg/kg) have reduced production of IL-6 (32% of control) and TNF-α (55 % of
control) (Xie et al., 1997b). In addition, oral exposure to propanil (400 mg/kg) also
reduced the production of IL-6 (40% of control) (Xie et al., 1997b). However,
macrophage TNF-α production is more sensitive to the effects of an oral exposure to
propanil. Forty mg/kg of propanil reduced the levels of TNF-α approximately the same
amount as an i.p. exposure of 200 mg/kg of propanil (Xie et al., 1997b). This data
suggests that different routes of exposure can affect the extent of immunotoxicity on
macrophages. However, the sensitivity of macrophages to the effects of propanil varies
depending on the endpoint studied and the route of exposure.
Both Ca2+ release and NF-κB regulate the production of IL-6 and TNF-α in
macrophages. Ca2+, in combination with diacylgylcerol (DAG), stimulates protein kinase
C (PKC). At the cytoplasmic membrane, PKC enhances the phosphorylation of some
transcription factors for cytokine transcription, such as NF-κB. Macrophages treated in
vitro with propanil have a significant reduction in intracellular Ca2+ release (Xie et al.,
1997a). In addition, NF-κB p65 subunit is decreased in the nucleus of propanil-treated
macrophages (Frost et al., 2001). The binding of NF-κB to the TNF-α promoter is
reduced in propanil-treated cells after 18 hours of in vitro exposure (Frost et al., 2001).
These data suggest the mechanism regulating the reduction in inflammatory cytokine
production in propanil-treated macrophages is an effect on NF-κB and Ca2+.
NK cell function is also inhibited following propanil exposure. Mice treated i.p.
with propanil and DCA have reduced NK cell cytotoxicity. NK cells harvested from the
spleens of mice treated i.p. with 50 mg/kg of propanil have an approximate 20%
reduction in their ability to lyse a target cell (Barnett et al., 1992). The metabolite, DCA,
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also inhibits the cytolytic ability of NK cells similar to the parent compound (Barnett et
al., 1992). The data suggests that propanil may reduce the capacity of cells of the innate
immune system to fight new infections.
T cell toxicity
One of the first studied immunotoxic effects induced by propanil was observed on
T cells (Barnett and Gandy, 1989). T cells are essential in facilitating a potent adaptive
immune response. Briefly, CD4+ T cells are responsible for activating and coordinating
the humoral immune response as well as cell-mediated immune responses. CD8+ T cells
function primarily in executing cell-mediated immune responses. The thymus is the
organ responsible for T cell development and maturation.
As mentioned previously, propanil induces thymic atrophy. Thymic atrophy is
seen in acutely exposed mice approximately 2-4 days post-exposure (Cuff et al., 1996).
Thymic weight is reduced in these mice for up to 7 days following an i.p. dose of 200
mg/kg of propanil (Barnett and Gandy, 1989). By day 7, the thymus has begun to
recover from the initial atrophy (Cuff et al., 1996). After 14 days post-exposure, the
thymus has fully recovered from the original insult (Cuff et al., 1996). Analysis of the
circulating T cell populations in the mesenteric lymph nodes and the spleen 7 days postexposure shows that mature T cell numbers are unaffected as a result of the thymic
atrophy (Zhao et al., 1995). Failure to detect decreases in the mature T cell populations
of immune organs may indicate that thymic atrophy is an endpoint to determine the
extent of propanil exposure rather than a direct measure of damage to immune function.
The decrease in thymic weight is accompanied by a loss in total thymic
cellularity, as well as an overall decline in the number of T cells in the various
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developmental stages of maturation (Zhao et al., 1995). Exposure doses as low as 100
mg/kg decrease the number of all the CD3+ and CD3- subpopulations (Zhao et al., 1995).
Mice treated i.p. with 200 mg/kg propanil have the largest decrease in the percentage of
CD3+CD4+CD8+ (DP) thymocytes 4 days post-exposure (Cuff et al., 1996). This data
indicates that the DP cells are the most sensitive of the thymocyte populations (Cuff et
al., 1996). The decrease observed in the immature population results in a downstream
effect of decreasing the number of the more mature CD4+ single positive (SP) and CD8+
SP cells (Zhao et al., 1995; Cuff et al., 1996).
The primary mechanism by which propanil induces thymic atrophy is a result of
increased levels of glucocorticoids (Cuff et al., 1996; de la Rosa et al., 2005). Acute i.p.
propanil exposure with doses of 50 mg/kg in C57Bl/6 mice increases the levels of
corticosterone in the serum to approximately 1000 ng/ml compared to approximately 60
ng/ml for control mice (de la Rosa et al., 2005). The increase in corticosterone serum
levels peaks within one hour following propanil exposure and returns to baseline levels
within 24 hours (de la Rosa et al., 2005). Inhibition of the glucocorticoid receptors (GR)
with the GR antagonist RU486 or removal of the adrenal glands, the primary site for
glucocorticoid production, abrogates the thymic atrophy induced by propanil (Cuff et al.,
1996; de la Rosa et al., 2005). In response to the sudden loss in the thymocyte
populations, the recovery of the thymocyte population is generated by an increase in the
percentage of cycling DP and CD8+ SP cells 4 days post-exposure (Cuff et al., 1996).
However, the percentage of cycling thymocyte subpopulations returns to normal by day
7, indicating that recovery is initiated rapidly after exposure (Cuff et al., 1996).
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The extent of thymic atrophy induced by propanil can also be increased when
combined with other herbicides (de la Rosa et al., 2005). The herbicide 2,4dichlorophenoxyacetic acid (2,4-D) does not decrease the number of DP or CD4+ SP cells
following a 150 mg/kg i.p. exposure (de la Rosa et al., 2005). However, the addition of
150 mg/kg of 2,4-D combined with a 150 mg/kg dose of propanil can induce a greaterthan-additive decrease in the number of both the DP and CD4+ SP cell populations (de la
Rosa et al., 2005). This data demonstrates the potential for other chemicals to enhance
the toxicity of propanil (de la Rosa et al., 2005).
Analysis of T cell function after in vivo exposure to propanil has indicated that T
cells are relatively resistant to the toxic effects of propanil. As mentioned previously,
propanil exposure causes splenomegaly (Barnett and Gandy et al., 1989; Ambrose et al.,
1972). The spleen is also an important secondary lymphoid organ. Therefore, the spleen
was chosen for early immunotoxic characterization studies. Mixed lymphocyte reactions
(MLR) are typically used to characterize CD4+ function. MLR of spleen cells from mice
treated with an acute i.p. dose of propanil 1 week prior to harvest demonstrated that only
at the highest doses tested of 400 mg/kg was there a significant decrease in the MLR
(Barnett and Gandy, 1989). In vivo cell mediated immune responses were assessed using
the contact hypersensitivity reaction (CHR) (Barnett and Gandy, 1989). The CHR was
also decreased in animals treated with only the highest tested dose of 400 mg/kg (Barnett
and Gandy, 1989). Finally, proliferation of splenocytes from mice treated in vivo with
propanil was determined following ex vivo stimulation with the T cell mitogen,
Concanavalin A (ConA). Again, only animals treated with the highest tested dose had
significant reductions in proliferation (Barnett and Gandy, 1989). However, ConA
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stimulated splenocytes from animals treated i.p. with 200 mg/kg of propanil had a
significant reduction in IL-2 production (27% of control) and IL-6 production (45% of
control) (Zhao et al., 1998). Altogether, the studies characterizing the T cell toxicity of
propanil indicate that several endpoints are required to establish an accurate inference of
propanil’s toxicity.
Mechanistic studies on the regulation of IL-2 in T cells demonstrated that in vitro
propanil treatment decreases IL-2 transcription rate as well as IL-2 message stability
(Zhao et al., 1999). DNA binding of the IL-2 transcription factor, AP-1, is also reduced
for up to 4 hours post-exposure in propanil-treated cells (Brundage et al., 2004). In
addition, propanil reduces the phosphorylation and the total protein levels of the subunit
of AP-1, c-jun (Brundage et al., 2004). These data suggest that propanil decreases the Tcell production of IL-2 by suppressing the activity of one of the subunits of a key
transcription factor, however, the molecular mechanism by which propanil reduces
phosphorylation is unknown.
B cell toxicity and the humoral response
As mentioned previously, propanil was found to be myelotoxic and induce
splenomegaly. The bone marrow microenvironment is the site of B cell maturation prior
to release into circulation. The spleen is an important site for early and late antibody
production to bacterial pathogens (Martin et al., 2001; Zandvoort et al., 2002; Manz et
al., 2002). Approximately 40% of the lymphocytes in the spleen are B lymphocytes
(Salazar et al., 2005). Altogether, these organs represent two important sites for
evaluating the immunotoxic effects of propanil on B cells.
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Propanil exposure decreases the number of developing B cells in the bone marrow
available for maturation. B cell maturation proceeds from the pro-B cell to pre-B cell and
finally to the immature IgM+ B cell (Rosenberg et al., 1994). In vivo i.p. propanil
exposure at the lowest studied dose of 50 mg/kg decreased the number of murine pre-B
cells in the bone marrow (~50% of control) 7 days post-exposure (de la Rosa et al.,
2003). Immature IgM+ B cells are also decreased in number (~50% of control) at doses
of 150 mg/kg (de la Rosa et al., 2003). However, this decrease in immature B cells does
not result in a loss of circulating B cells as determined by an analysis of splenocyte
populations (Salazar et al., 2005). Total splenic B cell numbers, as well as the circulating
follicular B cell population, remain unchanged following propanil exposure (Salazar et
al., 2005).
Although propanil exposure does not effect the number of B cells in the
periphery, it can suppress B cell function. Exposure to 400 mg/kg of propanil suppresses
splenic B cell proliferation after ex vivo stimulation with the B cell mitogen
lipopolysaccharide (LPS) (Barnett and Gandy, 1989). Analysis of the antibody response
to both T-independent type 2 (TI-2) and T-dependent (TD) model antigens found that
these responses are more sensitive to propanil’s toxic effects than B cell proliferation
(Barnett and Gandy, 1989; Barnett et al., 1992). Exposure to propanil on day 0 followed
by immunization with sheep red blood cells (SRBC) on day 4 decreased the number of
SRBC plaque forming cells (PFC) in a dose dependent fashion (Barnett and Gandy,
1989). Fifty mg/kg of propanil was the lowest dose to significantly reduce the number of
SRBC PFC (67.5% of control) (Barnett and Gandy, 1989). Higher doses of propanil and
DCA, 200 mg/kg and 150 mg/kg, respectively, were found to decrease the number of
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PFC in animals immunized with DNP-Ficoll 4 days following propanil exposure (75% of
control) (Barnett et al., 1992). Altogether, these reports suggest that propanil exerts
immunotoxic effects either directly on B cells or their supporting microenvironment
critical for their normal function.
Adaptive immune response to bacterial challenges
In general, the collective in vivo studies on immune function indicate that propanil
has suppressive effects on the immune system. Challenging the immune system with live
bacteria provides important information toward understanding the relevance of altered
immune function on individual lymphocyte populations. Live bacterial challenge studies
provide information demonstrating the effect of decreased immune cell function on
clearing infections caused by common pathogens. These studies are important for
predicting risk of infection that is associated with a specific level of immunotoxicity.
The toxic effects of propanil on the cell-mediated immune response were studied
using a Listeria monocytogenes infection model in C57BL/6 mice (Watson et al., 2000).
L. monocytogenes is an intracellular pathogen that requires an effective cell-mediated
immune response to clear the infection. Animals were exposed to propanil and
challenged with live L. monocytogenes. Ex vivo Con A and heat-killed L. monocytogenes
(HKLM) stimulated splenocyte and liver cultures from the propanil-treated and L.
monocytogenes challenged animals had an approximate 50% reduction in IFN-γ
production (Watson et al., 2000). However, analysis of spleen and liver endogenous
cytokine levels from propanil-treated and L. monocytogenes infected animals showed no
significant differences in IL-6, IFN-γ, TNF-α, and IL-1β when compared to L.
monocytogenes-infected control animals (Watson et al., 2000). Additionally, animals
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treated with 200 mg/kg of propanil and a LD50 of L. monocytogenes did not demonstrate
any greater susceptibility to infection than control animals (Watson et al., 2000). This
indicates that a 200 mg/kg exposure to propanil produces immunotoxic effects on cellmediated immunocytes measured in vitro, but does not significantly affect the host’s
ability to mount an effective immune response. A limitation of this study is that L.
monocytogenes infections can be initially controlled in mice lacking an adequate
cytotoxic T cell response (Bancroft et al., 1991). However, there have been no studies
reported to date characterizing the effect of an acute propanil exposure on the immune
response to a pathogen that predominantly requires a competent cytotoxic T cell response
to clear the infection.

2,4-D
Background
2,4-D is a chlorinated phenoxy herbicide used for the control of broadleaf weeds
throughout the year in both the public and private sector. 2,4-D is the most used pesticide
ingredient in the home and garden sector in the United States and is the fifth most used
active ingredient in the agricultural sector. 2,4-D is predominantly used in the Midwest,
Great Plains, and the Northwest (U.S. EPA OFFICE OF PESTICIDE PROGRAMS,
2005).
2,4-D is readily metabolized in both the soil and the water. The half-life of 2,4-D
in the water under aerobic and anaerobic conditions is 15 and 312 days, respectively.
The half-life in the soil is approximately 59 days. Aerobic microbial metabolism is the
major mechanism by which 2,4-D is degraded in both the water and soil. The major
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metabolite of aerobic aquatic degradation is 2-chlorohydroquinone. Minor metabolites
from aerobic microbial degradation include 2,4-dichlorophenol (2,4-DCP) and carbon
dioxide. Conversely, anaerobic aquatic degradation results in the predominant formation
of 2,4-DCP and carbon dioxide. The major metabolite of microbial degradation of 2,4-D
in the soil yields 2,4-DCP (Veeh et al., 1996).
The most common routes of exposure for 2,4-D include dermal and oral exposure,
and to a lesser extent, inhalation (Garabrant et al., 2002). Despite the rapid degradation of
2,4-D in the environment, exposure to humans is widespread. An analysis of 1000
randomly selected adults residing in the U.S. found that 12% had measurable levels of
2,4-D in the urine and 64% had detectable concentrations of the metabolite 2,4-DCP (Hill
et al., 1995). The median and maximum concentration of 2,4-D in the urine was 1.8
µg/liter and 37 µg/liter, respectively (Hill et al., 1995). Following oral exposure in
Fischer 344 rats, 2,4-D concentrations peak within the blood in 10-20 minutes (Pelletier
et al., 1989). Dermal exposures in rats demonstrates that 2,4-D is rapidly absorbed
similarly to oral exposure and peaks 30 minutes post-exposure (Pelletier et al., 1989).
Upon entry into humans, 2,4-D is not metabolized (Knopp et al., 1992). 2,4-D is widely
distributed throughout the body due to its water solubility and does not accumulate to any
specific organ (Pelletier et al., 1989). The half-life of 2,4-D in the urine is approximately
17 hours and 11 hours in the plasma (Sauerhoff et al., 1977). Due to the rapid clearance,
inability to be metabolized, or locate to a particular tissue, 2,4-D is not believed to
accumulate in repeatedly exposed humans (Garabrant and Philbert, 2002).
General toxicity
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The toxicity of 2,4-D has been extensively studied. Numerous reports have
evaluated the potential of 2,4-D to cause reproductive, carcinogenic, neurological,
endocrinological and immunotoxic effects. The acceptable daily intake for 2,4-D as
established by the World Health Organization (WHO) is .013 mg/kg/day (Zeljezic et al.,
2004). The conclusions from these studies have suggested that 2,4-D has very little
overall toxicity (Munro et al., 2002).
A number of genotoxic assays performed in a fibroblastic cell line found that 2,4D does not increase the amount of DNA repair (Jacobi et al., 1991; Clausen et al., 1990;
Galloway et al., 1987). However, lymphocytes from human donors were exposed to a
commercial formulation of 2,4-D in vitro and demonstrated that chromosomal aberrations
were increased at concentrations that have been established by the WHO to lack any
associated health risks (Zeljezic and Garaj-Vrhovac, 2004). The duration and
concentration of lymphocyte exposure to 2,4-D has not been determined, thereby
preventing an accurate assessment of genotoxic risks for lymphocytes (Zeljezic and
Garaj-Vrhovac, 2004). Lymphocytes from humans exposed to 2,4-D in an occupational
setting were analyzed for sister chromatid exchange (SCE) frequency and found no
significant changes in SCE frequency in 2,4-D workers (Linnainmaa, 1983). Altogether,
the literature supports the hypothesis that 2,4-D does not increase the risk for developing
cancer (Munro et al., 2002).
Adverse neurotoxic effects such as myotonia, characterized by difficulty relaxing
skeletal muscles, can be observed in animals treated with high doses of 2,4-D (50-500
mg/kg) (Elo et al., 1989). Locomotor effects have also been observed in rats at doses as
low as 15 mg/kg/day, but these effects were transient (Mattsson et al., 1997). Other
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potentially lasting effects such as demyelination in the CNS have not been observed in
animals (Garabrant and Philbert, 2002). Since the concentration of 2,4-D required to
induce neurotoxic effects also causes systemic toxicity, 2,4-D is considered to be mildly
toxic to the nervous system (Garabrant and Philbert, 2002).
Reproductive toxicity following 2,4-D exposure has been assessed in a number of
animal studies. Maternal rats and rabbits exposed to doses in excess of 90 mg/kg/day had
litters with reduced fetal weights and increased fetal variations (Charles et al., 2001).
Male mice and rats exposed chronically to 2,4-D did not produce any changes in the
testes and did not affect reproductivity (Charles et al., 2001; Charles et al., 1996). There
have been no published studies demonstrating that 2,4-D exposure induces reproductive
or teratogenic effects in humans (Garabrant and Philbert, 2002; Munro et al., 2002).
The ability of 2,4-D to disrupt the endocrine system is of recent interest and less
studied compared with more common toxicological endpoints. The ability of 2,4-D to
bind to the estrogen receptor was studied using an in vitro model in MCF-7 breast cancer
cells (Lin and Garry, 2000). 2,4-D was found to induce estrogen receptor mediated
growth at concentrations of 1 µg/ml (Lin and Garry, 2000). This concentration was
roughly 500-fold less efficacious than E2 and is not considered to be estrogenic (Lin and
Garry, 2000). Another approach analyzing the enzymes responsible for metabolizing E2
found that rats exposed to 375 mg/kg of 2,4-D had elevated amounts of CYP1A and
CYP1B in the liver, kidney, and the mammary gland (Badawi et al., 2000). These
increased enzyme levels corresponded to a marked increase in estradiol and estrone
(Badawi et al., 2000). However, further dose response studies are needed to
appropriately quantify the sensitivity for this effect. Finally, a preliminary study in
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amphibians found that 2,4-D inhibited progesterone-dependent oocyte maturation, as well
as, disrupt the actin cytoskeleton of oocytes (Lin and Garry, 2000). Additional studies
are required to determine if 2,4-D is able to affect the progesterone pathway in mammals.
Immunotoxicity
Immunotoxic studies have suggested that 2,4-D has modest toxicity. Exposure to
2,4-D in CD-1 mice via a dermal administration and an ip immunization of sheep red
blood cells (SRBC) on the following day decreased the number of SRBC-specific plaque
forming cells (PFC) on day 5 post-immunization (Blakley et al., 1986). The decrease in
SRBC-specific PFC was dose dependent (Blakley and Schiefer, 1986). The lowest
measured dose of 2,4-D to decrease SRBC-specific PFC was 100 mg/kg, which
decreased the PFC 10% from controls (Blakley and Schiefer, 1986). In addition, acute
dermal exposure did not affect the ex vivo proliferative responses of splenocytes to either
the T cell mitogen, ConA, or the B cell mitogen, LPS (Blakley and Schiefer, 1986).
Conversely, an acute oral exposure of 2,4-D in BDF1 mice via gastric intubation and
followed by an ip vaccination to SRBC on the next day, demonstrated that the number of
SRBC-specific PFC was increased when measured on the fifth day of immunization
(Blakley, 1986). The effect on PFC was not dose dependent and increased the number of
SRBC PFC 1.5 to 2.4-fold following exposures of 50 to 200 mg/kg (Blakley, 1986).
Animals treated with 2,4-D had normal proliferative responses in splenic T cells
following ConA stimulation (Blakley, 1986). This suggests that the variation in SRBC
PFC responses after oral or dermal exposure to 2,4-D is not likely due to changes in T
cell function (Blakley, 1986). A proposed hypothesis for enhancement versus
suppression of the antibody response in 2,4-D exposed animals is that 2,4-D acts as a
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hapten when given orally (Blakley, 1986). However, this hypothesis has not been
experimentally tested.
Since 2,4-D is widely used for many different commercial and private
applications, it is often applied in mixtures. Examining the effect of mixture interactions
on the immune response is a more relevant method for evaluating immunotoxicity of 2,4D. Initial studies demonstrate that mixture exposure with 2,4-D can enhance the
immunotoxic effect of a single 2,4-D exposure.
A common commercial mixture of 2,4-D is Tordon 202C, which contains a 1:16
ratio of the herbicide picloram and 2,4-D (Blakley, 1997). The lowest tested dose of 2.5
mg picloram/kg/day and 50 mg 2,4-D/kg/day decreased the antibody response to SRBC
33% after 26 days of daily oral exposure (Blakley, 1997). An analysis of the effects of a
single picloram or 2,4-D exposure was not performed, thereby preventing an
interpretation of the mixture interaction. Another commonly occurring herbicide mixture
includes propanil and 2,4-D. An acute ip exposure to 2,4-D did not affect pre-B or
immature IgM+ B cells 2 days post-exposure (de la Rosa et al., 2003). However, a 50
mg/kg mixture decreased both the pre-B and IgM+ B cells. When the propanil and 2,4-D
mixture effect was analyzed on thymocytes, 200 mg/kg of 2,4-D decreased the number of
CD4+CD8+ and CD4-CD8+. However, a 150/150 mixture decreased these thymocyte
populations the same magnitude as a single 200 mg/kg exposure of 2,4-D. These
findings suggest that the immunotoxic effects of 2,4-D may be enhanced when combined
with other active herbicide ingredients.
There is little direct evidence that 2,4-D exposure affects human immune
function. A published study on 10 farmers who used 2,4-D on their crops suggests that
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there may be a risk for short-term immunosuppression (Faustini et al., 1996). Blood
samples were analyzed 7 days pre-exposure, 1-12 days post-exposure, and 50-70 days
post exposure (Faustini et al., 1996). CD4+, CD8+ T cells, and NK cells were all reduced
1-12 days post exposure (Faustini et al., 1996). In addition, proliferative responses to
ConA were decreased 50% from pre-exposure samples (Faustini et al., 1996). By 50-70
days post exposure, the lymphocyte numbers and proliferation were normal. This data
indicates that occupational exposure to 2,4-D exerts immunotoxic effects seen in animal
studies. Given the widespread use of 2,4-D and its potential to be immunotoxic in
greater-than-additive fashion when combined with propanil, further studies evaluating
mixture effects on adaptive immune responses is warranted.

STREPTOCOCCUS PNEUMONIAE
Streptococcus pneumoniae is a gram-positive coccus that kills approximately 1
million children worldwide each year (Kruetzmann et al., 2003). The antibody response
to S. pneumoniae provides an excellent model for studying the humoral immune response
to both TI-2 and TD antigens. The immunodominant antigen that elicits the TI-2
response is the cell wall polysaccharide phosphorylcholine (PC). One of the surface
proteins that elicits a strong TD antibody response is pneumococcal surface protein A
(PspA). Both of these antigens are important targets for vaccine development since
robust antibody responses to these antigens are immunoprotective. In addition, these
antigens serve as virulence factors for the bacteria. PC enables the bacterium to transport
across endothelial and epithelial membranes (Cundell et al., 1995; Tuomanen et al.,
1995). PspA inhibits the function of complement (Tu et al., 1999).
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This section is divided into five parts concentrating on literature relevant to
regulation of the TI-2 antibody response. The first section will provide background
information on the spleen, specific sites in the spleen involved in the response, and
kinetics of the response. The second section will define the B cell subpopulations
responsible for producing TI-2 antibodies. The third and fourth sections will describe
mechanisms for enhancing or suppressing the TI-2 antibody response by the innate
immune system and T cells. The final section will briefly compare and contrast the PspA
and PC response for the purpose of identifying possible mechanisms for later discussion.
Site of humoral immune response
The central location for PC-specific antibody production is the spleen. The
necessity of the spleen is made apparent in individuals with asplenia. Splenectomized
patients are afflicted with chronic respiratory infections primarily caused by S.
pneumoniae (Davidson and Wall, 2001). In addition, splenectomized individuals do not
respond well to capsular polysaccharide vaccines (Davidson and Wall, 2001).
The marginal zone (MZ) in the spleen is the site primarily responsible for the TI-2
antibody responses (Guinamard et al., 2000). The MZ of the spleen is defined as the
compartment consisting of a broad band of cells surrounding the periarteriolar lymphoid
sheath (PALS) containing T cells and the B cell follicles (Vos et al., 2000). It has long
been known that children under 2 years of age have poor responses to polysaccharide
vaccines, which coincides with the maturation of MZ B cells (Timens et al., 1989). In
addition, TI-2 antigens rapidly localize to the MZ within 15 minutes after an ip injection
(Harms et al., 1996; van den Eertwegh et al., 1992). Studies in Pyk-2 deficient mice,
animals lacking a tyrosine kinase involved in growth factor receptor and chemokine
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stimulation, showed that these mice do not develop MZ B cells (Guinamard et al., 2000).
However, the B cell populations in the bone marrow, the B1 cells in the peritoneum, and
the serum Ig levels were all identical to wild type mice (Guinamard et al., 2000).
Subsequent immunization with TNP-Ficoll demonstrated that Pyk-/- mice had
dramatically reduced TNP-specific IgG2a (30% of control), IgG3 (2% of control), and
IgM (30% of control) serum titers (Guinamard et al., 2000). These observations strongly
support the hypothesis that MZ B cells are responsible for producing the TI-2 specific
antibodies.
As mentioned previously, TI-2 antigens are rapidly localized to the marginal
zone. TI-2 antigen ligation of the B cell receptor (BCR) triggers B cell migration to the
outer T cell borders in the spleen within the first 24 hours (Garcia et al., 1999b). By 48
hours, the number of TI-2 antigen specific B cells increases in the T cell zones, in the red
pulp, and along the red pulp: T zone junction (Vinuesa et al., 2001). At 2-5 days, the
antigen-specific B cells exponentially divide and differentiate into plasma cells primarily
in extrafollicular foci in the red pulp of the spleen (Vinuesa et al., 2001). B cell
proliferation is the most rapid between days 3 and 5 (Vinuesa et al., 2001). After day 7,
the number of plasma cells decreases during the second week of the response. After day
14, the number of plasma cells remains static for at least 90 days (Garcia et al., 1999b).
Responding B cell population
TI-2 responses are distinguished by early isotype class switching that occur more
rapidly than T-dependent responses to protein antigens (Wu et al., 1999). Isotype
switching is observed as early as 3-4 days following immunization with polysaccharides
(Leemans et al., 1999). Six days following heat-killed S. pneumoniae (HKSP)
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immunization, the IgG isotypes reach maximal levels (Wu et al., 2002). The
predominant isotypes produced to PC following HKSP vaccination are IgG3 and IgG2b
and to a lesser extent IgG1 and IgG2a (Wu et al., 1999).
The composition of responding B cells to a TI-2 response are predominantly high
affinity B cells. Two days following antigen presentation, there are a 3-fold greater
number of high affinity B cells entering cell cycle compared to low affinity B cells (Shih
et al., 2002). The three major idiotypes specific for PC that dominate the early humoral
response are T15, M167 or M511, and M603 (Perlmutter et al., 1984). T15 antibodies
have the highest affinity of the three idiotypes. T15 is also the idiotype expressed by the
majority of PC-specific antibody secreting cells (ASC) (Feeney et al., 1989; Martin et al.,
2001). These idiotypes have also been shown to undergo very little somatic
hypermutation and do not enter germinal centers (Feeney and Thuerauf, 1989; Wiens et
al., 2003). T15 plasmablasts found in both the spleen and peritoneal cavity largely
express the B1 B cell phenotype 3 days post immunization (Martin et al., 2001). The
composition of MZ plasmablasts and B1 blasts is dependent on the route and dose of
antigen administration (Martin et al., 2001). A high dose of HKSP (Sharer et al., 2003)
given iv generates a larger T15 antibody response than a high dose given ip (Martin et al.,
2001). Low doses (Van Ravenzwaay et al., 2003) given iv produce a reduced antibody
response that is comparable to the high ip response. However, low ip doses initiate
strong peritoneal B1 responses, which prevent sufficient amounts of antigen to reach the
spleen thereby preventing a local splenic response (Martin et al., 2001). It is currently
unknown what the peritoneal B1 cells, splenic B1 cells, and MZ B cells contribute to the
PC-specific serum titers.
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Numerous studies reporting the importance of both MZ B cells and B1 cells in the
TI-2 response have failed to reconcile the conflicting data demonstrating the
contributions of these two B cell populations in TI-2 antibody responses. A recent report
performed in transgenic mice (PV1TgL) containing B cells that are specific only for a
synthetic TI-2 like Ag (PVP-360) suggests that B-1a cells are derived from MZ B cells
(Whitmore et al., 2004). Naïve PV1TgL mice do not express B-1 B cells but contain
splenic MZ B cells. Three days and 5 days after immunization, antigen-specific B-1a
cells begin to appear in the spleen and peritoneal cavity, respectively (Whitmore et al.,
2004). By days 5 and 8, the B-1a populations are the predominant B cell populations in
the spleen and peritoneum, respectively. These data suggest that the MZ B cells may be
the precursor population for B1a cells (Whitmore et al., 2004). Altogether, these studies
demonstrated that PC responses require both MZ B cells and B1 B cells for TI-2 antibody
production.
Role of Innate Immunity
The MZ B cells are characterized by their high expression of the CD21/CD35
molecules on their surface. The CD21/CD35/CD19 coreceptor complex is critical for
recognizing and binding complement components on the B cell. CD35, complement
receptor 1 (CR1), binds the C3b and the C4b degradation components of the complement
cascade (Vos et al., 2000). CD21 (CR2) binds the complement component C3d. CD19
is a coactivator that is directly associated with CD21 and likely mediates the intracellular
signaling of CD21 (Fearon et al., 2000). The high expression of these complement
binding receptors suggests that complement activation has an important role in TI-2
responses.
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Components of the complement cascade are hypothesized to be one of the earliest
signals necessary for TI-2 recognition. One of the roles of complement receptors in TI-2
responses is to lower the activation requirements necessary for antibody production.
CD21/CD35 knockout mice vaccinated with 105 CFU HKSP and challenged with 5000
CFU of live S. pneumoniae had a survival rate of 33% compared to 100% survival rate
for wild type animals (Haas et al., 2002). However, increasing the immunization dose to
107 CFU HKSP for CD21/CD35-/- mice allowed all the mice to survive the live challenge
(Haas et al., 2002). This study suggests that stimulation of the complement receptors
lowers the threshold for B cell activation. Other reports have shown that both CD19 and
CD21 lower the threshold for antigen stimulation in vitro. Mongini et al. demonstrated
that CD21 and IgM receptor stimulation reduced the minimum concentration of antigen
bound to mIgM required for entry into S phase by 100-fold (Mongini et al., 1997).
Deletion of CD19 in mice reduced the number of high-affinity plasma cells in response to
an NP-Ficoll vaccination by approximately 40% (Shih et al., 2002). However, activation
of low-affinity plasma cells was completely abrogated in CD19-/- mice (Shih et al., 2002).
These results indicate that the role of complement receptors in the TI-2 response is to
lower the amount of antigen required for B cell activation.
Localization of antigen to the MZ is dependent on functional CR. Mice deficient
in either the complement component C3 or the complement receptors CR1/2 are unable
to localize TNP-Ficoll to the MZ (Guinamard et al., 2000; Shih et al., 2002). As
expected, C3-/- mice and mice depleted of complement via cobra venom factor
subsequently have reduced IgG and IgM serum titers to TI-2 antigens (Guinamard et al.,
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2000; Harms et al., 1996). These data demonstrate that complement dependent
localization of TI-2 antigens is crucial for normal antibody production.
The deposition of TI-2 antigens on the spleen occurs in specific sites and cell
types. For example, complement bound antigens accumulate on follicular dendritic cells
(FDC). FDC have high expression of both CD21 and CD35 (Peset Llopis et al., 1996).
Complement component C3d binds to Ab/Ag complexes, which form immune complexes
(IC) that are recognized by CD21 (Fearon and Carroll, 2000). The IC are then
transported to FDC and presented on its surface. Once presented, the IC are easily
recognized by MZ B cells thereby aiding their activation (Fearon and Carroll, 2000).
Because FDC present complement components efficiently, they are able to amplify an
antibody response. A series of studies demonstrated that FDC enhance the Ab response
10-1000 fold in a CR2 dependent manner to ovalbumin (Qin et al., 1998).
It is currently hypothesized that FDC have a role in the early isotype switching
during the Ab response to TI-2 antigens. This hypothesis is supported by several
findings. It has been observed that MZ B cells migrate to FDC within 24 hours following
iv injection of Ag (Whipple et al., 2004). Another study demonstrated that TI-2 antigens
do not require the presence of specific Ig to produce C3d binding and this allows for a
rapid uptake and presentation of TI-2 antigens by FDC thereby enabling rapid
recruitment and activation of B cells (Peset Llopis et al., 1996). When serum containing
nonspecific antibody for pneumococcal polysaccharides (PPS) and complement were
added to the spleens of vaccinated or naïve mice, no difference in PPS or C3d FDC
localization was observed between the two groups (Peset Llopis et al., 1996). However,
inactivation of complement in the serum reduces PPS and C3d localization to FDC (Peset
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et al., 1996). These studies suggest that a reduced requirement for specific Ig to initiate
C3d binding enables a rapid uptake and presentation by FDC in the case of TI-2 antigens,
thereby enabling rapid recruitment and activation of B cells (Peset Llopis et al., 1996).
Other antigen presenting cells (APC) involved in early TI-2 antigens presentation
and localization include MZ macrophages. MZ macrophages have been observed to
rapidly take up TI-2 antigens shortly after injection (van den Eertwegh et al., 1992).
Phagocytosis of TI-2 antigens by MZ macrophages occurs independent of complement
(van den Eertwegh et al., 1992). Splenic deposition of TI-2 antigens is also dependent on
the presence of MZ macrophages. Removal of MZ macrophages reduces the localization
of TI-2 antigens to both the red pulp of the spleen and the MZ, while increasing
deposition of antigens in the follicles (van den Eertwegh et al., 1992). The increased
localization of TI-2 antigens in the follicles corresponded with an increased humoral
response to the antigen (van den Eertwegh et al., 1992). This demonstrates that MZ
macrophages have an important role in regulation of the TI-2 response, which is largely
suppressive.
In addition to complement, other innate immune factors that regulate early isotype
switching to TI-2 antigens include pro-inflammatory and anti-inflammatory cytokines as
well as toll-like receptors (TLR). Neutralizing the pro-inflammatory cytokine TNF-α via
an injection with monoclonal antibody 1 day post-HKSP vaccination suppressed the IgG
anti-PC response 2-3 fold (Khan et al., 2002). Other pro-inflammatory cytokines such as
IL-6 and IFN-γ have been shown to moderately influence early PC isotype switching.
Mice deficient in IL-6 and IFN-γ have significantly reduced IgG2a and IgG2b serum
titers, respectively (Khan et al., 2002). The anti-inflammatory cytokines have the
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opposite effect on control of isotype switching. Mice deficient in IL-4 and IL-10
production have elevated IgG2a serum titers (2-fold) and increased IgG1 and IgG3 titers,
respectively (Khan et al., 2002). The peak splenic mRNA production for both the proinflammatory and anti-inflammatory cytokines occurs between 2-6 hours postvaccination and returns to baseline within 24 hours. This indicates that these cytokines
influence the beginning of the TI-2 response.
Other innate signaling molecules such as, toll-like receptors (TLR), also play a
role in antibody responses to polysaccharides. TLR2-/- mice have significantly reduced
PC titers 7 days following vaccination with either purified polysaccharides or HKSP
(Khan et al., 2005; Sen et al., 2005). Survival to a lethal challenge of S. pneumoniae is
also mildly compromised in naive TLR2-/- mice (Khan et al., 2005). However,
vaccinated TLR2-/- mice survive a lethal challenge similarly to normal mice (Khan et al.,
2005). In addition, TLR stimulation enhances a polysaccharide response. Mice treated
once with the TLR9 ligand unmethylated CpG-containing oligodeoxynucleotide (CpGODN) and alum and vaccinated twice with purified polysaccharide have enhanced
primary and secondary antibody titers (Sen et al., 2006). CpG and alum treatment
produced the greatest enhancement on day 21 (Sen et al., 2006). This data suggests that
TLR are important for stimulating the TI-2 antibody response.
Role of T cells
The precise role of T cells in regulating the TI-2 humoral response is poorly
understood. T cells are required for normal TI-2 responses. However, T cell deficient
mice are able to produce antibody responses to polysaccharides, albeit, very poorly
(Briles et al., 1982b). Mice deficient in αβ T cells have a 6-10 fold reduction in IgG3,
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IgG2b, IgG1, but not IgM PC specific serum antibody, indicating their importance for
isotype switching (Wu et al., 1999). Removal of γδ T cells, however, does not
significantly affect PC serum titers (Wu et al., 1999). The relative importance of CD4+
and CD8+ T cells has produced conflicting results. CD4+ T cells are more effective at
stimulating the anti-PC serum response than CD8+ T cells following HKSP vaccination
(Wu et al., 2002). Injection of 2x106 CD4+ T cells into athymic mice increased the IgG
PC-specific serum response approximately 100-fold compared to a 5-fold increase in
animals given CD8+ T cells (Wu et al., 2002). However, more recent findings suggest
that CD8+ T cells have a greater impact on TI-2 antibody responses than CD4+ T cells
(Kobrynski et al., 2005). CD8-/- mice vaccinated with 23-valent pneumococcal
polysaccharide vaccine Pneumovax failed to produce detectable polysaccharide antibody
in the serum. In contrast, CD4-/- mice did not have significantly different titers compared
to wt mice in response to the Pneumovax vaccination (Kobrynski et al., 2005). A
possible explanation for the discrepancy between these studies is that CD8+ cells are
involved in responses to soluble polysaccharides and CD4+ cells are critical for whole
bacterial responses (Kobrynski et al., 2005).
It has long been known that polysaccharide antigens cannot be presented on a
MHC molecule. However, it is apparent that T cells contribute to PC antibody responses.
Recent data suggests that T cells are activated in a noncognate fashion, which does not
involve T cell receptor (TCR) antigen recognition in the context of MHC. Transgenic
mice with T cells expressing only a TCR that is incapable of responding to a protein Ag
did not affect PC-specific serum titers following HKSP vaccination (Wu et al., 2002). In
addition, transgenic mice deficient in MHCII peptide loading have normal serum PC
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titers (Wu et al., 2002). These results indicate that specific recognition of antigen by the
TCR is not required for normal TI-2 antibody responses.
Several studies have demonstrated that other T cell coactivating molecules are
important for noncognate T cell polysaccharide responses. These coactivators have also
been shown to be important for isotype switching. For example, studies have shown that
B7:CD28 interactions are required for normal TI-2 responses. Blockade of B7
interactions with CD28 via in vivo administration of CTLA-4 Ig prior to HKSP
vaccination suppresses PC-specific IgG sera titers but does not affect PC-specific IgM
titers (Wu et al., 2002; Wu et al., 1999).
CD28 stimulation on T cells also upregulates the expression of CD137 (4-1BB)
on T cells (Wu et al., 2003). Ligands for CD137 are found on APC such as dendritic
cells and B cells. Several experiments have demonstrated the importance of CD137 in
the TI-2 response. Mice deficient in CD137 expression have significantly reduced IgM
and IgG anti-PC responses following HKSP vaccination (Wu et al., 2003). In addition, in
vivo administration of anti-CD137 mAb to HKSP vaccinated mice increases proliferation
in splenic CD4+ T cells in a B7 dependent manner 14 days post-immunization (Wu et al.,
2003). Anti-CD137 administration also was found to increase B cell and CD8+ T cell
proliferation (Wu et al., 2003). These data demonstrate that CD28 and CD137
cooperatively regulate splenic proliferation and isotype switching following HKSP
vaccination.
A third coactivating molecule on the T cell that is also necessary for PC Ig
production is CD40L. CD40L-KO mice have a marked reduction in anti-PC IgM and a
complete abrogation of anti-PC IgG responses following HKSP vaccination (Wu et al.,
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1999). Antibodies specific for CD40 also act as an adjuvant for T-independent antibody
responses. Anti-CD40 treatment increases the number of NP-specific ASC 25-fold
following NP-Ficoll immunization (Garcia et al., 1999a). The increase in NP-specific
ASC does not occur until 6 days post-immunization (Garcia et al., 1999a). The growth of
plasmablasts is also sustained in the red pulp as demonstrated by immunohistochemistry
(Garcia et al., 1999a). These data suggests that CD40 ligation increases the TI-2
response by extending proliferation rather than increasing the number of B cells recruited
to the response.
Finally, CD1, the MHC class I-like molecule, presents several types of glycolipids
and nonpeptide Ags (Kobrynski et al., 2005). Mice that do not express CD1 have
undetectable polysaccharide serum titers following Pneumovax vaccination (Kobrynski et
al., 2005). CD1 expressing APC are hypothesized to present polysaccharide antigens to
CD8+ T cells, thereby contributing to their activation. β2m-/- mice, which lack functional
CD1, MHC class I, and FcRn, have suppressed polysaccharide antibody responses
following Pneumovax vaccination (Kobrynski et al., 2005). However, reconstitution of
β2m-/- mice with normal CD8+, B cells, and macrophage/monocytes restored the
polysaccharide antibody response to those of normal mice (Kobrynski et al., 2005).
Altogether, these data demonstrate the panoply of coactivators that affect PC responses.
PspA response
This section will briefly compare and contrast the major differences between the
development of the antibody response to the TD protein antigen, PspA, with the PC
antibody response. The differences between the PspA response and PC response are due
primarily to the TD and TI-2 nature of the responses. T-dependent responses involve
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cognate T cell responses, affinity maturation of B cells in germinal centers, and high
antibody output during the second week of the antibody response. Both TD and TI-2
responses require CD21 receptors, early cytokine production, and T cell-associated
coreceptors.
TD antigens, such as PspA, are processed and presented by several types of APC
such as dendritic cells, macrophages, and B cells. The antigen bound to APC then
migrates to the PALS region of the spleen and present the antigen to T cells. B cells
migrate through the high endothelial venules (HEV) into the T cell zone. B cells
expressing a specific mIg for the immunizing antigen are upheld. Next, a primary focus
of activated B cells and T cells localize at the T:B cell border as early as 2 days postimmunization (Jacob et al., 1991). B cells rapidly proliferate in the primary foci, which
peaks by day 8 (Jacob et al., 1991). Between 4 and 12 days, some of these B cells in the
primary foci will continue to differentiate into plasma cells and migrate to the red pulp
where they will produce antibody of low affinity during the primary phase of the TD
response (Liu et al., 1991).
The production of high affinity antibodies during TD responses depends on the
formation of germinal centers. Germinal centers are characterized by three cellular
components: FDC, B cells, and T cells (Han et al., 1995). Formation of germinal centers
is observed by day 8 and persists until day 16 in the spleen (Jacob et al., 1991). Germinal
center formation requires several costimulating molecules including those that are also
required for PC responses.
CD21/CD35, CD40L, and B7 costimulation are all required for establishment and
maintenance of germinal centers. B cells that do not express CD21 and CD35 fail to
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survive selection in germinal centers (Fischer et al., 1998). Deletion of both CD21 and
CD35 on B cells also markedly reduces serum antibody titers to TD antigens (Croix et
al., 1996). Administration of anti-CD40L antibody at the time of vaccination with a TD
antigen severely reduces both germinal center formation and the sera antibody titers (Han
et al., 1995). CD40L is also necessary for maintaining germinal centers as demonstrated
when anti-CD40L is administered late in the response after germinal centers have already
formed (Han et al., 1995). In addition to CD40L, B7-2 is necessary for normal germinal
center formation. Administration of anti-B7-2 antibody at the time of vaccination
decreases the number of germinal centers formed and serum titers by 50% (Han et al.,
1995).
PspA-specific antibodies are measurable in the serum by day 6 and maximal by
day 10 (Wu et al., 2000). The predominant isotypes produced are IgG2b, IgG1, and
IgG2a (Wu et al., 1999). CD4+ T cell help is required for at least the first 6 days during
the PspA response (Wu et al., 2000). However, PC responses only require CD4+ T cell
help for the first 2 days (Khan et al., 2004).
As mentioned previously, costimulatory molecules present on T cells are required
for normal antibody responses and isotype switching for TD and TI-2 responses. B7-2
but not B7-1 stimulation is necessary for normal PspA responses (Wu et al., 2000). In
addition, mice deficient in CD40L have nearly undetectable anti-PspA IgG responses
(Wortham et al., 1998). As opposed to the PC response, deletion of CD137 does not
affect the PspA response (Wu et al., 2003).
Studies suggest that early cytokine production has a greater impact on the PspA
response compared to the PC response. TNF-α is required during the first 48 hours
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following vaccination for the PspA response (Khan et al., 2002). Other proinflammatory cytokines such as IFN-γ and IL-6 are also required for IgG PspA switching
(Khan et al., 2002). Lack of anti-inflammatory cytokines IL-4 and IL-10 were both
found to increase IgG anti-PspA titers (Khan et al., 2002). The effect of IL-10 deletion
produced a similar effect of general IgG increase to both PC and PspA antigens, however
the increase was not consistently significant (Khan et al., 2002).

ENDOCRINE REGULATION OF THE IMMUNE SYTEM
Endocrine regulation of the immune system is a well-established phenomenon.
The predominant classes of sex steroids produced by the gonads that regulate the immune
response are estrogens, androgens, and progestins. The humoral immune response, in
particular, is strongly influenced by sex hormones. This is evidenced by a number of
observations. Autoantibody-mediated diseases afflict females at a much higher rate than
males. For example, systemic lupus erythematosus (SLE) and Sjögrens’ syndrome afflict
women 9 times more frequently than men (Ansar et al., 1985). In addition, female mice
have higher IgM and IgG serum titers than males (Eidinger et al., 1972).
This section will provide background information on previous hormone studies
that identified immunomodulating effects leading to altered antibody responses. The
three major classes of sex hormones are discussed. The effect of estrogen on the humoral
response is given the greatest emphasis. The estrogen section will also present data
demonstrating similar immunomodulating effects on the antibody response, thymus, and
BM that is observed in both 17β-estradiol (E2) and propanil-treated animals.
ESTROGEN
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Autoimmune vs. nonautoimmune animals
The sex hormone E2 is one of the first steroid hormones to be identified as an
immunomodulator. Early studies were performed in the autoimmune mouse strain,
NZB/W. This strain will spontaneously develop lupus-like symptoms that eventually are
lethal.
Initial studies found that when male NZB/W mice were castrated and treated with
E2, the mortality rate was greatly increased and resembled the mortality rate of female
NZB/W mice (Roubinian et al., 1978). Subsequent studies found that E2 increased the
antibody responses in autoimmune mice (Brick et al., 1985). Castrated male NZB/W
mice treated with E2 for 10 weeks increased the number of IgM PFC to the TI-2 antigen
TNP-Ficoll 3-4-fold (Brick et al., 1985). E2 also increased the number of IgG and IgM
PFC 3-fold to the TI-1 antigen, TNP-LPS. The IgG and IgM PFC responses to the TD
antigen SRBC was increased 2-fold following E2 treatment (Brick et al., 1985). In
contrast, nonautoimmune DBA/2 mice did not have significantly changed PFC to TNPFicoll, TNP-LPS, or SRBC following identical E2 treatment (Brick et al., 1985). These
early studies suggested that E2 stimulates the antibody response only in autoimmune
mice.
Subsequent studies established that E2 exposure increases the antibody responses
in nonautoimmune rats and mice, as well. Male Sprague Dawley rats treated with E2 3
days prior to SRBC immunization had a 4-fold increase in antibody titers 6 days postimmunization (Myers and Petersen, 1985). E2 treatment 3 days prior to the secondary
immunization also yielded a similar increase in antibody titers (Myers and Petersen,
1985). However, in contrast to earlier findings demonstrating that E2 increases in the
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number of PFC, the number of PFC was not affected in the nonautoimmune mice
suggesting that E2 treatment increased antibody synthesis in the plasma cells (Myers and
Petersen, 1985).
A more prolonged exposure to E2 induced a greater enhancement of the humoral
response. Castrated C57BL/6 mice were chronically exposed to E2 via pellet
implantation for 4-6 months. The total number of IgG and IgM ASC in the spleen were
increased 6-fold and 3-fold, respectively (Verthelyi and Ahmed, 1998). The chronic E2
exposure is characterized by a decrease in both the percent and number of B cells in the
spleen, which suggests that more splenic B cells become activated (Verthelyi and Ahmed,
1998). The total number of IgG bone marrow ASC was also increased 12-fold in E2
exposed mice (Verthelyi and Ahmed, 1998). In addition to increasing the number of
ASC in the spleen and BM, the amount of immunoglobulin produced by each plasma cell
is also increased (Verthelyi and Ahmed, 1998). Morphometric analysis of the spots
obtained from ELISPOT assays demonstrated that the density and area of the splenic and
BM ASC were significantly increased in chronically E2 treated mice (Verthelyi and
Ahmed, 1998). Finally, vaccination of the E2 exposed mice with a variety of
autoantigens such as dsDNA and actin or killed whole bacteria such as Actinobacillus
pleurpneumoniae or Brucella abortus yielded increased antibody serum titers to all tested
antigens (Verthelyi, and Ahmed, 1998).
Altogether, these data established that E2 increases the antibody response in both
nonautoimmune and autoimmune animals. The antibody response is increased both by
increasing the number of plasma cells and increasing the immunoglobulin synthesis by
each plasma cell. The data also suggest that the increased response is the result of
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polyclonal activation. However, the initial evidence presented conflicting data on the
duration of an E2 exposure required for an increased antibody response.
A conclusive time course of E2 exposure necessary to enhance the humoral
response is currently unknown. For example, peripheral blood mononuclear cells
(PBMC) from rhesus macaque females treated for 18 hours with E2 increases the percent
of IgG and IgA ASC (Lu et al., 2002). In contrast to the macaque studies, the lupus
prone BWF1 mice require 2 months of chronic E2 pellet exposure until IgG and IgM
anti-DNA serum titers are increased (Yurino et al., 2004). Variation in animal models
and lack of antibody kinetic studies precludes a conclusion of the duration of E2 exposure
required for an enhanced response.
E2 sensitive B cell subpopulations
It is hypothesized that the amplification of the ASC by E2 disproportionately
affects certain B cell subpopulations. The B cell subpopulations, B1 B cells and MZ B
cells, have both been shown to be targets for E2 induced proliferation and activation. B1
B cells from BWF1 mice cultured with E2 for 4 days had an approximate 2-fold increase
in IgM production (Yurino et al., 2004). However, the classically defined B cell
population, B2 B cells, cultured under identical conditions did not produce significantly
different concentrations of IgM (Yurino et al., 2004). Another study found that B1 B
cells from C57BL/6 mice exposed to E2 for 2-3 months and pretreated with bromelain
had increased numbers of splenic bromelain-specific PFC. However, the number of B2 B
cell PFC in the spleen was not affected (Ansar et al., 1989).
The MZ B cell population is also sensitive to the effects of E2. R4A-IgG2b
BALB/c mice are a nonautoimmune strain of mouse that produce an easily detectable
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autoimmune B cell that is normally removed during the course of maturation (Grimaldi et
al., 2006). When these mice are treated with E2 chronically, they develop a lupus-like
phenotype (Grimaldi et al., 2001). Phenotypic analysis of the splenic anti-DNA ASC
demonstrates that MZ B cells are increased 4-fold compared to control animals (Grimaldi
et al., 2001). In contrast, follicular B cells are not significantly increased (Grimaldi and
Diamond et al., 2001). Altogether, these studies suggest that the E2-induced increase in
ASC is not the result of polyclonal activation, since particular subsets are affected. These
data also suggests that the subpopulations of B cells affected by E2 exposure are also
involved in the production of TI-2 antibodies.
Mechanisms for E2-induced antibody enhancement
The expression of ERα has been suggested to be the receptor regulating the
increased antibody response. The ERα and ERβ are expressed on lymphocytes including
B cells, suggesting a mechanism for a direct effect of E2 on B cells (Grimaldi et al.,
2002). Analysis of ER mRNA expression in peritoneal B1 and splenic B2 B cells from
8-12 month old BWF1 mice treated chronically with E2 demonstrated that ERα is
significantly increased in B1 B cells compared to control animals (Yurino et al., 2004).
However, ERα expression in B2 B cells is unaffected (Yurino et al., 2004). ERα has
been shown to regulate the increased humoral immune response following chronic E2
exposure. Nonautoimmune C57BL/6J/129 castrated male mice treated with E2 5
days/week for 2.5 weeks have significantly increased numbers of IgA, IgG, and IgM
ASC in both the spleen and BM (Erlandsson et al., 2003). Deletion of ERα in mice
abrogates the increased ASC in the spleen or BM (Erlandsson et al., 2003). However,
ERβ-/- mice had similar ASC responses as control mice (Erlandsson et al., 2003).
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Altogether, these data suggest that the E2-induced B cell activation is mediated through
ERα.
E2 exposure elicits a number of changes in the genetic expression profile of B
cells that decreases tolerance. BALB/c mice treated with E2 for 3-6 weeks have
increased expression of the proteins VCAM-1 (40%), CD22 (40%), SHP-1 (20%), and
Bcl-2 (20%) (Grimaldi et al., 2002). VCAM-1 functions as a ligand for VLA-4 and is
hypothesized to protect B cells from apoptosis during early B cell development. CD22
and SHP-1 regulate the antigen threshold required for B cell activation. Bcl-2 increases
survival of autoreactive B cells. The percent increase in these proteins induced by E2 is
sufficient to alter B cell survival (Grimaldi et al., 2002).
It is hypothesized that increased expression of these proteins decreases the
amount of stimulation required for activation and protects against apoptosis during B cell
development. For example, Bcl-2 expression is also increased in the bone marrow of
pro/pre B cells and immature B cells (Grimaldi et al., 2002). Supporting experiments
show that E2 exposure decreases the percentages of BM B220+ cells, but transitional
splenic type 2 B cells, which differentiate into mature splenic B cells, are increased
(Grimaldi et al., 2001). In addition, transitional splenocytes from E2-treated mice
demonstrated that these cells were resistant to apoptosis (Grimaldi et al., 2002). These
data suggest that certain B cells during development in both the BM and spleen have antiapoptotic expression patterns that results in increased survival.
Other studies evaluating the effect of E2 on B cell maturation revealed that
autoreactive B cells are eliminated from circulation, albeit less effectively than in normal
mice (Grimaldi et al., 2006). R4A-IgG2b BALB/c mice treated with E2 for 5-6 weeks
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have a 4-fold increase in mature autoreactive B cells compared with control animals
(Grimaldi et al., 2006). Autoreactive B cells survive in greater numbers throughout
maturation in the BM and the spleen (Grimaldi et al., 2006). High affinity autoreactive B
cells survived in slightly greater numbers than low affinity autoreactive B cells in E2
treated mice to enter into the splenic transitional pool from the BM, suggesting that some
autoreactive B cells are eliminated in the BM similarly to normal animals (Grimaldi et
al., 2006). However, E2 dramatically increased the number of high affinity autoreactive
B cells that survived the splenic transitional stages to enter the mature B cell population
(Grimaldi et al., 2006). Normal mice had a 3-fold reduction in high affinity autoreactive
B cells during the transitional to mature stages, but the number of high affinity
autoreactive B cells in E2 treated mice was not reduced (Grimaldi et al., 2006).
Interestingly, E2 treatment did not affect the deletion of low affinity autoreactive B cells
during the differentiation of transitional B cells into mature B cells (Grimaldi et al.,
2006). These data indicate that E2 increases the number of autoreactive B cells by
impairing the removal of high affinity autoreactive B cells during the immature and
transitional phases of maturation.
Effects of E2 on B cell maturation in the BM
The effects of E2 on lymphopoiesis further upstream in the B cell maturation
stages in the BM indicate a suppressive effect. The number of B220+ cells in the BM is
decreased 5-fold following 2.5 weeks of treatment in C57BL/6J/129 castrated mice
(Erlandsson et al., 2003). Furthermore, the E2 decreases the number of pro-B cells, preB cells, and immature IgM+ B cells 70-80% compared to control animals (Erlandsson et
al., 2003). Selected deletion of the ERα and ERβ in mice demonstrated that both

39

receptors are required for the E2-mediated decrease in the pro-B and IgM+ B cell
populations (Erlandsson et al., 2003). ERα alone regulates the E2-mediated deletion of
pre-B cells (Erlandsson et al., 2003).
Effects of E2 on the thymus
E2 also affects T cell development by inducing thymic atrophy and T cell
apoptosis. E2 decreases the thymocyte population approximately 80% of controls
(Screpanti et al., 1989). The decrease is primarily in the CD4+CD8+ population
(Screpanti et al., 1989). The mechanism regulating E2-mediated thymic atrophy is
Fas/FasL dependent (Do et al., 2002). In contrast with antibody responses and
lymphopoeisis, E2-mediated thymic atrophy requires both ERs for the maximal effect
(Erlandsson et al., 2001). The increase in thymic atrophy is correlated with changes in
the populations of T cells in the spleen of developing mice, however, no studies have
been performed to determine if these changes affect adaptive immune responses
(Erlandsson et al., 2001). Altogether, these data emphasize the diverse
immunomodulating affects of estrogen.
PROGESTERONE
The other major immumodulatory female sex hormone is progesterone. Analysis
of the effects of progesterone on immune function and antibody production suggest an
inhibitory or an opposing effect to estradiol. In vitro progesterone treatment on PBMC
from rhesus macaques inhibits the number of IgG and IgA ASC approximately 90% from
controls (Lu et al., 2002). Progesterone has also been found to induce TH2 cytokine
production. In vitro culture with progesterone of human cloned T cells from multiple
sclerosis patients induced all of the clones to produce IL-4 and suppressed inflammatory
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cytokine production (Correale et al., 1998). The progesterone regulated protein,
progesterone induced blocking factor (PIBF), regulates some of the immunomodulatory
effects of progesterone. In vitro treatment with PIBF on ConA stimulated murine splenic
CD4+ and CD8+ T cells induced both cell populations to produce the TH2 cytokines IL-4,
IL-10, and IL-3 (Szekeres-Bartho and Wegmann, 1996). However, the expression of the
TH1 cytokine, IFN-γ, was not affected (Szekeres-Bartho and Wegmann, 1996).
Progesterone may downregulate the antibody response by also affecting apoptosis and
bcl-2 expression. Progesterone decreases the expression of bcl-2 in estrogen treated
Jurkat T cells and increases apoptosis (McMurray et al., 2001). It is currently unknown if
lymphocytes express progesterone receptors (Bouman et al., 2005). These data suggest
that progesterone antagonizes the effects of estrogen.
Progesterone is hypothesized to have the greatest affect on mucosal immune
responses. Subcutaneous progesterone exposure increased the number of antigen specific
ASC in the vagina and the uterus following intranasal or vaginal immunization with
cholera toxin B (Johansson et al., 1998). An opposing study demonstrated that
progesterone exposure decreases resistance to a viral challenge (Gallichan and Rosenthal,
1996). Mice treated with progesterone prior to i.n. immunization with glycoprotein B
from herpes simplex virus increased the ratio of IgG to IgA vaginal titers (Gallichan and
Rosenthal, 1996). In addition, progesterone administration or elevated levels of
progesterone associated with the diestrus stage of the estrus cycle increase viral load
following vaginal HSV challenge (Gallichan and Rosenthal, 1996). Altogether, these
data present a contrasting set of data concerning the effect of progesterone on mucosal
challenges that differs according to antigen exposure.
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ANDROGENS
Androgens represent the third major sex hormone produced by the gonads.
Numerous studies have demonstrated that testosterone suppresses the humoral response.
The androgen receptor is expressed on B cells (Benten et al., 2002). NZB/W female
mice chronically treated with testosterone had a 3-5 fold increase in survival time
compared to controls (Roubinian et al., 1979). In addition, female OVX NZB/W mice
treated with testosterone had a 2-fold reduction in the number of IgM PFC following
TNP-Ficoll immunization (Brick et al., 1985). The numbers of IgG and IgM PFC were
also reduced in the testosterone treated females 2-3 fold following TNP-LPS
immunization (Brick et al., 1985). Androgen replacement therapy in patients with
Klinefelter’s syndrome demonstrated a significant reduction in serum IgA, IgG, and IgM
serum titers (Kocar et al., 2000). Experiments suggest that compounds that are
antiandrogenic do not have contrasting effects on the immune system. The antiandrogen,
flutamide, does not significantly affect the anti-IgM response following SRBC
immunization and chronic flutamide treatment (O'Connor et al., 2002; Ladics et al.,
1998). These studies indicate that androgens are immunosuppressive with regards to
humoral responses and antiandrogens are neither immunostimulatory nor
immunosuppressive.

SUMMARY
These experiments employed the HKSP immunization model to study the effects
of herbicide exposure on the humoral immune response. Previous reports demonstrated a
number of immunotoxic effects induced by propanil and 2,4-D. These studies were
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conducted to determine if these previously observed immunotoxic effects affect an
adaptive immune response to a common bacteria.
The experiments in Chapter 2 establish an environmentally relevant route of
herbicide exposure to study these immunotoxic effects. Chapter 3 characterizes the
effects of propanil, 2,4-D, and 1:1 mixture of the two herbicides on the PC and PspAspecific responses following HKSP immunization. Chapter 4 determines if propanil
selectively enhances TI-2 antibody responses as well as determine the time of exposure
and antigen concentration requirements for the enhanced antibody response. Chapter 5
examines the role of the endocrine system in the enhanced antibody response following
propanil exposure. Finally, Chapter 6 explores the effect of the propanil-induced
antibody enhancement on the survival to a virulent S. pneumoniae challenge.
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CHAPTER 2: COMPARISON BETWEEN ASPIRATION
AND IP ROUTES OF HERBICIDE EXPOSURE ON THE
IMMUNE SYSTEM
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INTRODUCTION
Previous published data on the immunotoxic effects of propanil exposure have
been performed using an ip exposure (de la Rosa et al., 2005). As mentioned in the
General Introduction, human exposure to propanil occurs primarily via inhalational,
dermal and oral routes. The goal of these experiments is to establish a model to study an
environmentally relevant route of exposure for propanil. This new exposure model will
be applied to contrast and compare the effects of propanil exposure on immune function
that has previously been established to be susceptible following ip exposure. In addition,
mixture interactions will be studied in the new exposure model.
An aspiration route of exposure was chosen based on the result of preliminary
experiments performed in the laboratory. Dermal studies found that propanil was not
readily transported across the skin (data not shown). As mentioned in the General
Introduction, previous experiments have demonstrated that oral exposures to propanil
require approximately twice the concentration to induce the same toxicity as ip exposures
(Xie et al., 1997b). For these reasons, an inhalational model was studied.
Propanil has previously been shown to induce thymic atrophy that is easily
measured by decreases in thymic weight and in the number of thymocyte subpopulations
(de la Rosa et al., 2005). In addition, 2,4-D induces a greater-than-additive effect on the
thymus when administered with propanil (de la Rosa et al., 2005). One of the common
routes of occupational exposure to 2,4-D includes inhalation (Garabrant and Philbert,
2002). For these reasons, thymic atrophy was chosen as the endpoint for evaluating the
efficacy of herbicide exposure by aspiration. Long-term goals for this research include
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evaluating the effects on a humoral response following vaccination. Therefore, the
effects of an aspiration exposure were also studied in HKSP immunized animals.

METHODS
Animals
Six to eight week old C57Bl/6 female mice were purchased from Hill Top Lab
Animals (Scottdale, PA). Mice were housed in microisolator cages in pathogen free
conditions at West Virginia University’s animal facility. Mice were kept on a 12 hr lightdark cycle and allowed to acclimate to the facility for 1 week. These studies were
conducted in accordance with all federal and institutional guidelines for animal use and
were approved by the West Virginia University Institutional Animal Care and Use
Committee.
Pesticides
Propanil, 3,4-dichloropropionanilide, 99% pure was purchased from Chem
Service. 2,4-D, Dimethylamine salt of 2,4-dichlorophenoxyacetic acid was purchased
from Universal Cooperatives. 2,4-dichlorophenoxyacetic acid, 99.5% pure was
purchased from Chem Service.
Herbicide exposures
For aspiration, pesticides were diluted in 12 µl of olive oil and 8 µl DMSO.
Three or 4 mg of purified pesticide was dissolved in DMSO/olive oil for a 150-mg/kg or
200 mg/kg treatment, respectively. Mixture exposures were prepared by dissolving both
herbicides in the 20µl olive oil and DMSO solution. Animals were lightly anesthesized
with 150 µl of a 5mg/ml solution of Nembutal prior to pesticide exposure. Mice were
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suspended vertically and the tongue was extended with forceps to prevent swallowing of
the herbicides. Herbicides were pipetted at the base of the tongue and subsequently
inhaled.
For ip exposures, propanil was dissolved in peanut oil at a concentration of 15
mg/ml or 20 mg/ml for 150 mg/kg or 200 mg/kg exposures. Commercial formulation of
2,4-D was diluted in sterile PBS at the appropriate concentration for a 150 mg/kg or 200
mg/kg injection. Herbicides were injected ip in 200 µl volumes.
Bacterial preparation and immunization with R36A
S. pneumoniae strain R36A, an avirulent, nonencapsulated strain, was grown to
mid-log phase in Todd-Hewitt broth (Becton Dickinson, Sparks, MD) + .05% yeast
extract (Becton Dickinson) and stored at –80°C. For immunization, stock was cultured in
a candle jar for 18 hrs at 37°C on blood agar plates (Becton Dickinson). A few
characteristic colonies were selected and suspended in 200 ml Todd-Hewitt broth + .05%
yeast extract. Bacteria were grown at 37°C to an absorbance reading at 650nm of 0.4 and
heat killed for 4 hours in a 60°C water bath. A final concentration of 109 CFU/ml was
established in PBS based on colony counts. Sterility was confirmed by culture. Heatkilled stock was stored at -20°C in 1 ml aliquots. Mice were immunized ip with 2x108
CFU on the same day as herbicide exposure.
Organ preparation
Mice were euthanized with 100 µl Nembutal Sodium Solution (50 mg/ml, Abbott
Laboratories, North Chicago, IL). Spleen and thymus wet weights were recorded.
Spleens were mechanically dissociated through Spectra nylon mesh (Spectrum Labs,
Rancho Dominguez, CA) in complete cell media containing RPMI-1640 (BioWhitaker,
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Walkersville, MD), 10% heat inactivated fetal bovine serum (FBS, Hyclone Laboratories,
Inc, Logan, UT), 10 mM HEPES (Sigma), 1 mM L- glutamine (Gibco, Rockville, MD),
5x10-5 M 2-mercaptoethanol (Sigma), 100 U/ml penicillin (Gibco), and 100 µg/ml
streptomycin (Gibco). Thymuses were mechanically dissociated between microscope
slides in complete cell media. Red blood cells in the spleen and thymus were lysed with
Tris-buffered ammonium chloride. Cell suspensions were washed twice and counted
using a hemacytometer. Viability was determined using Trypan blue dye exclusion.
Measurement of antibody secreting B cells (ASC) in the spleen
Acrowell 96 well filter plates (Pall Life Sciences, Ann Arbor, MI) were coated
with 50 µl PC-BSA (Biosearch Technologies, Novato, CA) (10 µg/ml) overnight at 4°C.
In all subsequent steps, plates were washed with PBS + .01% Tween-20. Plates were
blocked with 200 µl/well complete medium + 25% FBS for 2 hours at 37°C. Plates were
washed and cells (100 µl/well) were then added at a concentration of 5x106 cells/ml or
1x106 cells/ml. All samples were plated in triplicate. Plates were incubated for 4-6 hours
at 37°C in a 5% CO2 incubator. After washing, goat anti-mouse alkaline phosphatase
(AP) conjugated IgG or IgM antibodies (Southern Biotechnology Associates,
Birmingham, AL), diluted 1/250 in PBS + 1%BSA + .05% Tween-20, were added to the
appropriate wells (100 µl/well). Plates were incubated overnight at 4°C and washed.
SIGMAFAST 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium tablets
(Sigma-Aldrich, St. Louis, MO) were dissolved in distilled water and added at 100 µl/
well. Color development was stopped by washing with distilled water. The number of
spots/well was counted using a dissection microscope (Olympus Optical Co., Melville,
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NY). The number of ASC was calculated by using the mean number of spots from
triplicate wells. The number of ASC was normalized to 1x106 B cells.
Flow cytometric analysis
Splenic cells were stained with the appropriate combinations of rat anti-mouse
B220-APC (RA3-6B2), rat anti-mouse CD4-FITC (GK1.5), or rat anti-mouse CD8α-PE
(53-6.7) (BD PharMingen, San Diego, CA). All steps were performed in PBS
supplemented with 1% FBS and 0.04% sodium azide (Sigma). Briefly, 1 x 106 cells were
stained in a total volume of 25 µl of antibodies at the appropriate concentrations for 25
minutes on ice in the dark. After incubation, cells were washed twice and fixed in 0.04%
paraformaldehyde overnight at 4°C (Fisher Scientific, Pittsburgh, PA). The following
day cells were washed twice to remove the paraformaldehyde and resuspended in 1 ml of
staining media. For each sample, 10,000 cells were collected for analysis on a BectonDickinson FACScan (Becton Dickinson Immunocytometry Systems, Mansfield, MA).
Analysis was performed using WinMDI software (Joseph Trotter, Scripps Institute, San
Diego, CA). Population percentages, obtained from flow cytometric analysis, were used
to calculate the absolute cell number by multiplying the percentage of cells in a
population by the total number of cells harvested per organ.
Statistics
One-way analysis of variance (ANOVA) was performed for all statistical analyses
using a Tukey-Kramer t-test to perform multiple comparisons between all treatment
groups. A significance level of p ≤ 0.05 was used for all tests. Statistical analysis was
performed using JMP software (SAS Institute Inc., Cary, NC). All experiments were
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performed 3 or more times with similar results. The figures are representative data from
one experiment.

RESULTS
Aspirated herbicides decrease thymic weight similarly to an ip injection.
Mice were treated with either a 150 mg/kg or 200 mg/kg concentration of
herbicides. Animals were exposed to either individual propanil or 2,4-D treatments or a
1:1 mixture of the two herbicides. Mice were exposed to the herbicides via either an ip or
aspiration route of exposure. Animals that received the herbicides via the aspiration route
did not remain unconscious as long as animals receiving herbicides via the ip route.
Propanil-treated mice exposed via the aspiration route were unconscious for
approximately 45 min compared to 30 min in animals receiving Nembutal alone.
However, ip injected mice receiving propanil were unconscious for 6-8 hours. A 150/150
mg/kg ip mixture herbicide exposure to the mixture of herbicides significantly decreased
the thymic weights in a greater-than-additive fashion compared to the single herbicide
exposures (Figure 1). Aspiration exposure to the mixture of herbicides was not
significantly different from the ip mixture exposure (Figure 1). In addition, 150 mg/kg
single herbicide exposures were not significantly different between both aspiration and ip
routes of exposure (Figure 1). Aspirated or ip injected 200 mg/kg single propanil and
aspirated or ip injected mixture herbicide exposures produced statistically similar thymic
atrophy (Figure 1). However, single 2,4-D exposure was an approximate LD50 when the
herbicide was aspirated (data not shown). Surviving mice exposed to 2,4-D by aspiration
induced similar decreases in thymus size compared to ip injected animals (Figure 1).
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Aspirated herbicides decrease the number of thymocytes similar to ip injected
herbicides.
Thymocyte populations were analyzed from the thymuses of herbicide-treated
animals. The total number of thymocytes from 150 mg/kg and 200 mg/kg in mixture
treated animals were decreased similarly in both aspirated or ip injected groups (Figure
2). Aspirated 200 mg/kg propanil and 2,4-D significantly decreased the number of
thymocytes compared to aspirated controls (Figure 2). In contrast, ip injected 200 mg/kg
propanil and 2,4-D were not significantly decreased from ip vehicle controls (Figure 2).
Analysis of the CD4+CD8+, CD4+CD8-, and CD4-CD8+ subpopulations
demonstrate a similar magnitude of reduction in mixture treated animals via either the
aspiration or ip route of exposure (Figures 3A, 3B, 3C). Single exposures produced
similar decreases in thymocyte subpopulations regardless of aspiration or ip injection
(Figures 3A, 3B, 3C). The statistical significance of single exposures varied with
concentration and route of exposure, however, the general effect of the herbicides on the
thymocyte subpopulations is similar regardless of the route of exposure (Figures 3A, 3B,
3C).
Aspirated herbicides do not affect the number of ASC.
Since herbicide exposure induced thymic atrophy similarly in aspirated and ip
injected animals, the effect of aspirated herbicides on the antibody response to an ip
HKSP immunization was examined. Previous experiments demonstrated that propanil
and 2,4-D mixture exposure increases the number of PC-specific ASC following HKSP
immunization (de la Rosa dissertation). Mice were immunized with HKSP and treated
with herbicides via either aspiration or ip injection. Mixture herbicide exposure
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increased the number of IgG and IgM PC-specific ASC when animals were ip injected
with a 150/150 mg/kg herbicide mixture (Figure 4). However, aspirated herbicides did
not significantly increase the number of PC-specific ASC compared to aspirated vehicle
mice (Figure 4).

DISCUSSION
These experiments begin to explore how the toxic effects of the herbicides 2,4-D
and propanil differ when animals are exposed via different routes. These experiments use
established immunotoxic effects induced by ip exposure to evaluate the efficacy of an
environmental route of exposure on immune function. Propanil and mixture treatments
produced similar immunotoxic effects on the thymus when animals were aspirated or ip
injected. 2,4-D treatments were more lethal when animals were aspirated instead of ip
injected. The cause of increased mortality for aspirated 2,4-D compared to ip or dermal
exposures is not currently known. However, the thymic atrophy induced in the surviving
animals was similar in both exposure models. Animals exposed to herbicides via
aspiration did not have significantly different antibody responses. Altogether, these data
demonstrate the importance of considering exposure routes when evaluating the toxicity
of chemical exposures.
Propanil induces thymic atrophy by increasing glucocorticoids in ip injected mice.
Although aspirated propanil treatment induces similar thymic atrophy as ip injection, the
mechanism has not been studied. However, given the similarity of the response in ip vs.
aspiration, it is plausible that the mechanisms are the same. Aspirated herbicides did not
exhibit the overt neurotoxicity that is observed in ip injected animals. This result
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suggests that the hind leg paralysis and the period of unconsciousness induced by the
toxicity from ip injected herbicides is not involved in thymic atrophy.
The route of immunization and the site of the antibody response might be
responsible for the inability of aspirated herbicides to enhance the antibody response. IP
immunizations typically pass through the subdiaphragmatic lymphatics (Smith et al.,
1996). Since the mechanism that is responsible for enhancing the antibody response
following herbicide exposure is probably different from the one regulating thymic
atrophy, it is unknown what is required for splenic effects. Respiratory exposure to
herbicides may induce a more localized effect. Since ip immunization does not produce
strong antibody responses in the lung, a different route of immunization may be
necessary. Follow-up studies may utilize an antigen that elicits a strong local antibody
response via respiratory challenge. Preliminary experiments with live aspirated S.
pneumoniae were unsuccessful due to a high mortality associated with herbicide and
bacterial challenge. Death was observed within hours of exposure, suggesting acute
respiratory distress. Future experiments may attempt an immunization several days prior
to herbicide exposure to allow for complete clearance of the antigen and a reduction in
inflammation.
Altogether, these data demonstrate the importance of route of administration
when analyzing toxicity of chemical exposure. Thymic atrophy is readily induced by
herbicide exposure and the sensitivity of the assay may serve as an endpoint for
determining pesticide exposure. However, effects on humoral responses are dependent
on the primary site of antibody production.
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Figure 1. Aspirated herbicides decrease thymic weight similarly to ip injection.
C57BL/6 female mice (5/group) were treated with vehicle control, 150 or 200 mg/kg
propanil, 150 or 200 mg/kg 2,4-D, or a 150/150 or 200/200 mixture. Mice were exposed
via aspiration or ip injection and thymic weights were recorded on day 2. Values
represent the mean ± SD. * Significantly different from vehicle, p ≤ .05. # indicates a
mixture interaction.
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Figure 2. Aspirated herbicides decrease the number of thymocytes similarly to ip
injection.
C57BL/6 female mice (5/group) were treated with vehicle control, 150 or 200 mg/kg
propanil, 150 or 200 mg/kg 2,4-D, or a 150/150 or 200/200 mixture. Mice were exposed
via aspiration or ip injection and thymocyte numbers were counted on day 2. Values
represent the mean number of thymocytes ± SD. * Significantly different from vehicle, p
≤ .05. # indicates a mixture interaction.

55

3.0

Vehicle

200 mg/kg

150 mg/kg

2.5
2.0

#

*

1.5

#

#
1.0

* * *#
*
*

*

0.5
0.0

asp. i.p.

C.
Number of Thymocytes (x107)

B.

CD4+CD8- Thymocytes
Number of thymocytes (x 106)

Number of Thymocytes (x 107)

A.

25

18

CD4-CD8+ Thymocytes
Vehicle

150 mg/kg

200 mg/kg

16
14
12
10

#

8

#

6
4

#

2

*

#

*

*

0

asp. i.p.

asp. i.p.

asp. i.p.

CD4+CD8+ Thymocytes
Vehicle

150 mg/kg

200 mg/kg

20
15
10
5

#

*

#

#

*

*

*
*

0

asp. i.p.

Vehicle Asp

Vehicle i.p.

Propanil Asp

Propanil i.p.

2,4-D Asp

2,4-D i.p.

Mix Asp

Mix i.p.

#

* **

asp. i.p.

Figure 3. Aspirated herbicides decrease thymocyte subpopulations similar to ip
injection.
C57BL/6 female mice (5/group) were treated with vehicle control, 150 or 200 mg/kg
propanil, 150 or 200 mg/kg 2,4-D, or a 150/150 or 200/200 mixture. Mice were exposed
via aspiration or ip injection. The thymocyte subpopulations (A) CD4+CD8-, (B) CD4CD8+, and (C) CD4+CD8+ were enumerated by flow cytometry on day 2. Values
represent the mean number of thymocytes ± SD. * Significantly different from vehicle, p
≤ .05. # indicates a mixture interaction.
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Figure 4. Aspirated herbicides do not affect the number of PC-specific ASC.
C57BL/6 female mice (5/group) were treated via aspiration or ip injection with vehicle
control or a 150/150 mixture and vaccinated ip with 2x108 CFU HKSP. Numbers of PCspecific IgG and IgM ASC were determined by ELISPOT assay on day 7. Values
represent the mean ± SD of ASC/1x106 B cells. * Significantly different from vehicle, p
≤ .05.
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ABSTRACT
Propanil (3,4-dichloropropionanilide) and 2,4-D (2,4-dichlorophenoxyacetic acid)
are commonly used herbicides that have toxic effects on the immune system. The present
study determined the effect of exposure to these chemicals on the immune response to a
bacterial vaccine. The antibody responses to the T-independent type 2 antigen,
phosphorylcholine (PC) and the T-dependent antigen, pneumococcal surface protein A
(PspA) were characterized in C57BL/6 mice following heat-killed Streptococcus
pneumoniae (HKSP) immunization and single or mixture herbicide exposure. Propanil
exposure significantly increased the number of PC-specific IgM, IgG2b, and IgG3
antibody secreting B cells (ASC) in the spleen 4-6 fold over control animals in a dose
dependent manner. However, the number of ASC in the bone marrow and serum titers
were comparable in control and propanil-treated mice. In contrast, 2,4-D exposure
decreased the number of PC-specific IgM and IgG bone marrow ASC 2-3 fold from
control animals. The decrease in bone marrow ASC in 2,4-D-treated mice corresponded
to a 3-4 fold decrease in PC-specific IgM, IgG2b, and IgG3 serum titers compared to
control mice. The number of ASC in the spleens of 2,4-D-treated mice was, however,
comparable to control mice. The antibody response to PspA was not affected by any of
the treatments. There were no mixture interactions between the two herbicides in any of
the responses measured. These results characterize the primary PC-specific antibody
response in the bone marrow, spleen, and serum following HKSP vaccination and
herbicide exposure. The differential effects of propanil and 2,4-D on the antibody
response to a bacterial vaccine demonstrate the potential of chemical exposure to
augment or suppress immune responses to vaccines and infectious diseases.
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INTRODUCTION
The class of pesticides, commonly referred to as herbicides, is extensively used
both commercially and by individuals making them ubiquitous in the environment. The
immune system, in particular, is reported to be sensitive to the toxic effects of herbicides
(Faustini et al., 1996; Short and Colborn, 1999). Since infectious diseases are a major
cause of morbidity and mortality worldwide, it is important to determine if exposure to
these compounds compromises the immune response to an infection. 2,4dichlorophenoxyacetic acid (2,4-D) and 3,4-dichloropropionanalide (propanil) are
commonly used herbicides marketed as a chemical mixture under the product names of
NOX-D and Herbanil 368 (Crop Protection Handbook, 2003). Previous research has
demonstrated that 2,4-D and propanil are immunotoxic to the primary immune organs
and to specific immune cell functions, however, the effects of an exposure to a mixture of
these herbicides on an in vivo immune response has not been studied (de la Rosa et al.,
2003; de la Rosa et al., 2005; Barnett and Gandy, 1989; Blakley, 1997). This study was
performed to determine if exposure to these herbicides, either alone or as a mixture,
altered the primary humoral immune response to the model bacterial vaccine, heat-killed
Streptococcus pneumoniae (HKSP).
Propanil is an amide class herbicide that induces thymic atrophy and
splenomegaly. Numerous studies have established that exposure to propanil can inhibit
the function of a variety of immune cell populations including macrophages, T cells, and
natural killer cells (Barnett and Gandy, 1989; Barnett et al., 1992; Xie et al., 1997; Zhao
et al., 1998). Murine studies have demonstrated that propanil inhibits the antibody
response in the spleen to the model T cell-independent-type 2 (TI-2) antigen DNP-Ficoll
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and the T-dependent (TD) antigen sheep red blood cells (SRBC) (Barnett and Gandy,
1989; Barnett et al., 1992). 2,4-D is a chlorinated phenoxy compound designed as a
synthetic form of the plant hormone auxin (Munro et al., 2002). Reports on the
immunotoxic effects of 2,4-D are inconclusive. Studies using a mouse model
demonstrated that oral exposure to 2,4-D at the time of vaccination with SRBC increased
the number of antibody producing cells (ASC) in the spleen (Blakley, 1986). Conversely,
another report found that exposure to a mixture of 2,4-D and the herbicide picloram
decreased the number of plaque-forming cells in the spleen following SRBC vaccination
(Blakley, 1997). Thus, additional studies are needed to determine the effects of 2,4-D on
the humoral immune response.
S. pneumoniae kills approximately 1 million children aged 5 years or younger
annually and remains one of the most common causes of pneumococcal death worldwide.
Due to its prevalence, it is a well-characterized model for studying the humoral immune
response. Vaccination with HKSP elicits a TD antibody response and a TI-2 antibody
response (Wu et al., 1999). Pneumococcal surface protein A (PspA) is a TD antigen on
S. pneumoniae that acts as a virulence factor by inhibiting the functions of complement
(Tu et al., 1999). Phosphorylcholine (PC) is a cell wall polysaccharide and the
immunodominant antigen that elicits the TI-2 antibody response. PC is a virulence factor
that functions by transporting the bacterium across the epithelial and endothelial
membranes (Cundell et al., 1995; Tuomanen et al., 1995). Current vaccine strategies use
a 23-valent polysaccharide vaccine or a 7-valent conjugate vaccine, both of which
produce a robust anti-polysaccharide response (Bogaert et al., 2004). The kinetics of the
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serum antibody response and the predominant isotypes produced to PspA and PC are well
characterized (Wu et al., 2000; Wu et al., 1999).
Our laboratory focuses on studying potential synergistic effects on the immune
system following exposure to a mixture of propanil and 2,4-D. Previous studies show
that exposure to either propanil or 2,4-D alone induced thymic atrophy and reduced the
number of double positive (CD4+CD8+) thymocytes (de la Rosa et al., 2005). In the bone
marrow, exposure to either herbicide alone decreased the number of pre-B
(B220+CD43+IgMlo) cells and IgM+ B (B220+CD43-IgMhi) cells (de la Rosa et al., 2003).
However, exposure to the mixture of propanil and 2,4-D caused greater-than-additive
decreases in the same cell populations in the thymus and bone marrow suggesting that
interactions of the mixture increased the toxicity of the individual chemicals (de la Rosa
et al., 2003; de la Rosa et al., 2005).
Based on the previous reports on the immunotoxic effects of propanil and 2,4-D,
it was originally hypothesized that exposure to the herbicides would inhibit the humoral
immune response after vaccination with HKSP and that exposure to the mixture would be
more immunotoxic than the individual compounds. However, in contrast to the
hypothesis, the results demonstrated that propanil and 2,4-D differentially affected the
immune response to HKSP and there were no apparent interactions between the two
herbicides. Exposure to propanil significantly increased the number of PC-specific ASC
in the spleen. 2,4-D had no effect on the PC response in the spleen but significantly
decreased the number of PC-specific ASC in the bone marrow. The decrease in ASC in
the bone marrow after exposure to 2,4-D correlated with a significant decrease in the PCspecific serum antibody titers. There was no effect on the response to PspA by any of the
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treatments. In addition, these results extend our knowledge of the humoral immune
response to vaccination with HKSP by characterizing the primary antibody response to
PC in the bone marrow and the spleen in conjunction with the serum antibody response.
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MATERIALS AND METHODS
Mice.
Six to eight week old C57Bl/6 female mice were purchased from Charles River
Farms (Wilmington, DE). Mice were housed in microisolator cages in pathogen free
conditions at West Virginia University’s animal facility. Mice were kept on a 12 hr lightdark cycle and allowed to acclimate to the facility for 1 week. Food and water was
provided ad libidum. These studies were conducted in accordance with all federal and
institutional guidelines for animal use and were approved by the West Virginia
University Institutional Animal Care and Use Committee.
Chemicals.
Propanil (3,4-dichloropropionanilide, 99% pure) was purchased from Chem
Service (West Chester, PA). Commercial-grade 2,4-D amine (47.2% dimethylamine salt
of 2,4-dichlorophenoxyacetic acid, 52.8% inert ingredients, Universal Cooperatives, Inc.,
Minneapolis, MN) was purchased from Southern States Cooperative (Morgantown, WV).
Bacterial preparation and immunization.
S. pneumoniae strain R36A (a gift from Meenal Elliott, West Virginia University)
an avirulent, nonencapsulated strain, was used for all experiments. Strain R36A was
chosen because it is a commonly used strain of S. pneumoniae and the kinetics of the
serum antibody response and the predominant isotypes to PC and PspA have been well
established (Wu et al., 1999; Wu et al., 2000). Strain R36A was grown to mid-log phase
in Todd-Hewitt broth (Becton Dickinson, Sparks, MD) + .05% yeast extract (Becton
Dickinson) and stored at –70°C. For immunization, stock was cultured in a candle jar for
18 hrs at 37°C on blood agar plates (Becton Dickinson). A few characteristic colonies
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were selected and suspended in 200 ml Todd-Hewitt broth + .05% yeast extract. Bacteria
were grown at 37°C to an absorbance reading at 650nm of 0.4. Bacteria were heat killed
for 4 hours at 60°C. A final concentration of 109 CFU/ml was established in PBS based
on colony counts. Sterility was confirmed by culture. Heat-killed stock was stored at 20°C in 1 ml aliquots. Mice were immunized intraperitoneally (i.p.) with 2x108 CFU.
Exposure of mice to herbicides.
Mice (5-6/ group) were treated with either single doses of herbicides (propanil or
2,4-D) or a 1:1 mixture of both herbicides by i.p. injection within one hour of HKSP
vaccination. Mice were treated with a range of concentrations of herbicide based on
milligrams of herbicide/ kilogram of body weight (mg/kg). Propanil was dissolved in
peanut oil and animals were treated with 25, 50, 100, or 150 mg/kg. 2,4-D was diluted in
sterile PBS and mice were treated with 150 mg/kg. 2,4-D concentration was based on the
amount of active 2,4-D in the commercial preparation. The route of exposure and the
doses used were based on previous studies that demonstrated a mixture interaction at 150
mg/kg propanil and 150 mg/kg 2,4-D on thymocyte populations (de la Rosa et al., 2005).
Control animals were treated with the vehicle peanut oil only as previous studies
determined that there was no difference between animals treated with the peanut oil
vehicle compared to the PBS vehicle.
Preparation of spleen and bone marrow cell suspensions.
Mice were euthanized with 100 µl Nembutal Sodium Solution (50 mg/ml, Abbott
Laboratories, North Chicago, IL) on days 3, 5, 7, 10, and 14 following herbicide exposure
and vaccination. Spleen wet weights were recorded. Spleens were mechanically
dissociated through Spectra nylon mesh (Spectrum Labs, Rancho Dominguez, CA) in
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complete cell media containing RPMI-1640 (BioWhitaker, Walkersville, MD), 10% heat
inactivated fetal bovine serum (FBS, Hyclone Laboratories, Inc, Logan, UT), 10 mM
HEPES (Sigma, St. Louis, MO), 1 mM L- glutamine (Gibco, Rockville, MD), 5x10-5 M
2-mercaptoethanol (Sigma), 100 U/ml penicillin (Gibco), and 100 µg/ml streptomycin
(Gibco). To collect bone marrow cells, one hind leg was removed from each animal.
Femur and tibia were flushed with complete media for single cell suspensions. Red
blood cells in the spleen and bone marrow populations were lysed with Tris-buffered
ammonium chloride. Cell suspensions were washed twice and counted by
hemacytometer in Trypan blue.
Flow cytometric analysis.
Cells were stained with the appropriate combinations of rat anti-mouse B220APC (RA3-6B2), rat anti-mouse CD23-PE (B3B4), rat anti-mouse CD21-FITC (7G6), rat
anti-mouse CD4-FITC (GK1.5), or rat anti-mouse CD8α-PE (53-6.7) (all from BD
PharMingen, San Diego, CA). All steps were performed in PBS supplemented with 1%
FBS and 0.04% sodium azide (Sigma). Briefly, 1 x 106 cells were stained in a total
volume of 25 µl of antibodies at the appropriate concentrations for 25 minutes on ice in
the dark. After incubation, cells were washed twice and fixed in 0.04%
paraformaldehyde overnight at 40C (Fisher Scientific, Pittsburgh, PA). The following
day cells were washed twice to remove the paraformaldehyde and resuspended in 1 ml of
staining media. For each sample, 10,000 cells were collected for analysis on a BectonDickinson FACScan (Becton Dickinson Immunocytometry Systems, Mansfield, MA).
Analysis was performed using WinMDI software (Joseph Trotter, Scripps Institute, San
Diego, CA). Population percentages, obtained from flow cytometric analysis, were used
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to calculate the absolute cell number by multiplying the percentage of cells in a
population by the total number of cells harvested per organ. Marginal zone B cells are
defined as B220+CD21/35hi CD23neg/low, follicular B cells are defined as B220+CD21/35int
CD23hi (Oliver et al., 1997). B cells are defined as all cells that are B220+ and include
marginal zone B cells and follicular B cells.
Measurement of antibody secreting B cells (ASC) in the bone marrow and spleen.
Acrowell 96 well filter plates (Pall Life Sciences, Ann Arbor, MI) were coated
with 50 µl PC-BSA (Biosearch Technologies, Novato, CA) (10 µg/ml) or 50 µl PspA (10
µg/ml) (PspA was a generous gift from Clifford Snapper, USUHS) overnight at 4°C. In
all subsequent steps, plates were washed with PBS + .01% Tween-20. Plates were
blocked with 200 µl/well complete media + 25% FBS for 2 hours at 37°C. Plates were
washed and cells (100 µl/well) were then added at a concentration of 5x106 cells/ml or
1x106 cells/ml. All samples were plated in triplicate. Plates were incubated for 4-6 hours
at 37°C in a 5% CO2 incubator. Plates were washed and goat anti-mouse alkaline
phosphatase (AP) conjugated IgG, IgG1, IgG2a, IgG2b, IgG3, or IgM antibodies
(Southern Biotechnology Associates, Birmingham, AL), diluted 1/250 in PBS + 1%BSA
+ .05% Tween-20, were added to the appropriate wells (100 µl/well). Plates were
incubated overnight at 4°C and washed. SIGMAFAST 5-bromo-4-chloro-3-indolyl
phosphate/nitro blue tetrazolium tablets (Sigma-Aldrich, St. Louis, MO) were dissolved
in distilled water and added at 100 µl/ well. Color development was stopped by washing
with distilled water. The number of spots/well was counted using a dissection
microscope (Olympus Optical Co., Melville, NY). The number of ASC was calculated
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by using the mean number of spots from triplicate wells. Data are expressed as the
number of ASC per 1 x 106 B cells or as the number of ASC per spleen or bone marrow.
Measurement of PC- and PspA- specific titers.
Serum samples were prepared via blood collected from the heart. Immulon 2
plates (for PC) or Immulon 4 plates (for PspA) (ThermoLabsystems, Franklin, MA) were
coated overnight at 4°C with 5 µg/ml PC-BSA or 10 µg/ml PspA (50 µl/well). Plates
were washed, blocked with 3% BSA + PBS at 37°C for 2 hours. Plates were washed and
100 µl/well of twofold dilutions of sera in PBS +1% BSA were added starting at 1/400
for the IgG and IgM ELISAs and 1/250 for the IgG subclasses. Plates were then
incubated for 1 hour at 37°C and washed. AP conjugated antibodies (100 µl/well) were
added for 1 hour at 37°C. Plates were washed and phosphatase substrate tablets (SigmaAldrich) were dissolved in PNPP (p-Nitrophenyl Phosphate, Disodium Salt) substrate
buffer. Plates were developed and absorbance read at 405nm on a µQuant
spectrophotometer (Bio-Tek instruments, Winooski, VT) using KCJunior software (BioTek instruments). To determine the titer a standard pooled sera was diluted and plated on
each ELISA plate. The titer for each sample was determined by comparison to the
standard sera when the OD 405nm for the standard was 0.200 at a 1:3200 dilution for
IgM and IgG or at 1:2000 for IgG2b and IgG3. These dilutions were chosen because
they are in the linear part of the curve for the respective isotypes.
Measurement of ex vivo PC-specific antibody production.
Spleen cells were cultured in vitro with no additional stimulation for 5 days at
37°C and 5% CO2 at a concentration of 5x105 cells/ml in 500 µl complete media in 48
well tissue culture plates (Costar, Corning Inc., Acton, MA). All cultures were

69

performed in duplicate. The protein synthesis inhibitor cycloheximide was added to
replicate samples at a concentration of 75 µg/ml (50 µl/well) to distinguish the amount of
antibody produced de novo in culture from preformed antibody secreted during the
culture period (Dhanjal et al., 1992). Supernatants were collected and antibody ELISAs
were performed as described above. De novo antibody synthesis was determined by
subtracting the absorbance readings from cycloheximide treated cells from absorbance
readings from non-cycloheximide treated cells.
Statistics.
One-way analysis of variance (ANOVA) was performed for all statistical analyses
using a Dunnett’s t-test to compare herbicide treated animals with control animals. A
significance level of p ≤ 0.05 was used for all tests. Identification of possible mixture
interactions was determined using a partial factorial design. A mixture interaction was
defined as the sum of the responses of the individual components of the mixture is
significantly different from the response of the mixture treatment. Statistical analysis
was performed using JMP software (SAS Institute Inc., Cary, NC). All experiments were
performed 3 or more times with similar results. The figures are representative data from
one experiment.
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RESULTS
Propanil exposure increased the number of PC-specific antibody secreting B cells in
the spleen.
To determine if propanil and 2,4-D had either individual effects or cooperative
effects on the humoral response in the spleen, mice were vaccinated with HKSP and
treated with either a single dose of propanil (150 mg/kg), 2,4-D (150 mg/kg), or a mixture
(150/150 mg/kg). Serum titers to the PC antigen are detectable by day 4 and peak at day
6-7 following HKSP vaccination (Wu et al., 2000; Wu et al., 1999). Splenic ASC have
been reported to peak 2-3 days prior to serum titers (Verheul et al., 1990). Based on
these reports, days 3, 5, 7, and 10 post-exposure were chosen to analyze the in vivo time
course of the PC-specific antibody response.
Initial experiments in vehicle control animals immunized with HKSP
demonstrated that IgM ASC were detectable at day 3 (30 + 10 ASC/1 x 106 B cells,
Figure 1A) and peak 5 to 7 days post-exposure (144 + 73 ASC and 252 + 42 ASC,
respectively, Figure 1A). There was no statistical difference between day 5 and day 7.
By day 10, the number of splenic ASC in control animals had decreased 2-fold (83 + 35
ASC). The predominant isotypes produced were IgM, IgG2b, and IgG3 and all had
similar kinetics (Figure 1A, 1B, and 1C, respectively). Comparable results were obtained
when the number of ASC per spleen were determined (Figure 1D, 1E, and 1F). IgG1 and
IgG2a were below the limit of detection by ELISPOT at all time points.
Following exposure to propanil or the mixture of propanil and 2,4-D, the number
of PC-specific IgM (Figure 1A, 1D), IgG2b (Figure 1B, 1E), and IgG3 (Figure 1C, 1F)
ASC were significantly increased 5 days after immunization (3-4 fold over vehicle
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control). Similar fold increases were determined for the number of ASC per whole organ
(Figure 1D, 1E, 1F) and for the number of ASC normalized to one million B cells (Figure
1A, 1B, 1C) in all experiments. There was a statistically significant 4-6-fold increase in
the number of IgM, IgG2b, and IgG3 ASC in the animals treated with propanil alone or
the mixture at day 7 post-exposure (Figure 1A - 1F). By day 10, the number of ASC was
declining in all groups, but was still significantly increased 3.5 fold in propanil and
mixture-treated animals over control animals (Figure 1A - 1F). 2,4-D exposure alone did
not alter the splenic ASC response compared to the control at any of the days measured
(Figure 1A - 1F). Propanil and mixture-treated animals produced statistically similar
ASC responses in the spleen, which suggests that the propanil component of the mixture
is responsible for the increase in ASC in the spleen.
Previous studies had demonstrated that propanil treatment induces splenomegaly
(Barnett and Gandy, 1989). The spleen weights were determined after herbicide
exposure and HKSP vaccination. Propanil and the mixture of propanil and 2,4-D, but not
2,4-D alone, caused an increase in spleen weight at 7 and 10 days post-exposure (Figure
2). However, flow cytometric analysis of the major cell populations in the spleen at all
time points determined that there were no significant changes in any of the treatment
groups in the number of total B220+ B cells, CD21/35hi CD23neg/low marginal zone B
cells, CD21/35int CD23hi follicular B cells, CD4+ T cells, and CD8+ T cells (Table 1,
representative data from day 7 post-exposure and vaccination).

The total number of

bone marrow cells was also comparable for the vehicle (28.5 ± 1.8 x 106), propanil (27.6
± 3.5 x 106), 2,4-D (25.4 ± 3.8 x 106), and mixture treated groups (27.4 ± 3.2 x 106).
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Additional experiments were performed to determine the dose response to
propanil that enhanced the ASC response in the spleen. The lowest observed adverse
effect level (LOAEL) dose of propanil that induced an increase in PC-specific ASC over
control animals was 50 mg/kg (Figure 3A – 3F). A 25 mg/kg dose of propanil failed to
increase the number of splenic ASC over control animals (Figure 3A – 3F). A higher
dose of propanil of 200 mg/kg increased the ASC response 4-6 fold, similar to the 150
mg/kg dose (data not shown).
Ex vivo splenic antibody production is increased in propanil-treated mice.
To determine if there was a concomitant increase in antibody production from the
spleens of animals that had an increase in ASC, spleens were harvested 7 days postexposure and immunization and cultured in vitro for 5 days. The supernatants were
harvested and IgM and total IgG determined by ELISA. Spleen cells from propanil and
mixture-treated animals produced antibody at concentrations 3-4 fold higher than spleen
cells from the vehicle control or 2,4-D- treated animals (Figures 4A and 4B). Analyses
performed from day 5 and day 10 post-exposure and immunization had similar results
(data not shown).
2,4-D decreased the number of PC-specific ASC in the bone marrow.
The number of PC-specific ASC in the bone marrow was also measured on days
3, 5, 7, and 10 post-exposure and vaccination. Individual isotypes were not detectable in
the bone marrow at days 3 and 5 after immunization. However, IgM and total IgG were
detectable at the early time points (Figure 5A – 5D). 2,4-D and mixture herbicide
exposure decreased the number of PC-specific IgM and IgG ASC in the bone marrow
approximately 2-fold by day 5 compared to the vehicle controls (Figure 5A – 5D). There
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was a significant decrease at days 7 and 10 (2-3 fold) in ASC in the bone marrow
(Figures 5A – 5D). Propanil-treated animals had responses comparable to the vehicle
controls at all time points (Figure 5A – 5D). These results suggest that the 2,4-D
component of the mixture is responsible for the reduction in ASC in the bone marrow.
Propanil exposure did not increase the PC-specific titers, however 2,4-D exposure
decreased the PC-specific titers.
PC-specific titers were measured to determine if the increase in ASC in the
spleens of propanil-treated mice, or the decrease in bone marrow ASC in 2,4-D-treated
mice, altered serum titers. Individual isotypes were not detectable at day 3. Propanil and
vehicle control animals had comparable titers of IgM, IgG2b, and IgG3 at 5, 7, and 10
days post-exposure and immunization (Figure 6A, 6B, and 6C). These results
demonstrate that the increased splenic ASC in propanil-treated mice do not affect the
serum antibody titers. However, 2,4-D and mixture treatments significantly reduced the
PC-specific IgM, IgG2b, and IgG3 isotypes 3-4 fold from vehicle control and propaniltreated animals by day 10 (Figure 6A, 6B, and 6C). The serum titers of mixture and 2,4D-treated groups were not significantly different, indicating that 2,4-D is the chemical
component of the mixture responsible for the decrease in titers. The results also indicate
a correlation between the reduced bone marrow ASC response and the decrease in serum
antibody levels.
Herbicide exposure does not affect the antibody response to PspA.
To determine if exposure to propanil, 2,4-D, or the mixture would affect the
response to a TD antigen, mice were treated with the herbicides and vaccinated with
HKSP. The peak serum antibody response to PspA has been demonstrated to be at 14
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days post-vaccination (Wu et al., 1999). The results demonstrate that the number of
splenic IgM and total IgG PspA-specific ASC was comparable to the vehicle control in
the propanil, 2,4-D and mixture-treated animals 14 days after herbicide exposure and
vaccination with HKSP (Figure 7A – 7D). The PspA-specific serum antibody titers were
also not affected by herbicide exposure and were comparable for all of the treatment
groups (data not shown). The PspA-specific ASC in the bone marrow were below the
limit of detection at day 14.

75

DISCUSSION
Propanil and 2,4-D are immunotoxic herbicides commonly applied together as a
mixture (Crop Protection Handbook, 2003; Farenhorst and Prokopowich, 2003).
Previous findings have demonstrated that the two herbicides exert greater-than-additive
immunotoxic effects on the primary immune organs, the thymus and bone marrow (de la
Rosa et al., 2003; de la Rosa et al., 2005). However, the present study demonstrated that
there was no subsequent effect on the mature lymphocyte populations in the spleen. The
increase in total spleen cell number in the mixture-treated group is probably due to the
presence of immature precursor cell populations as determined by differential analysis
(not shown). Furthermore, increased immunotoxicity due to mixture exposure did not
occur in the humoral response to HKSP examined in the present study. At the 150 mg/kg
1:1 mixture tested, the mixture combination failed to produce a greater-than-additive
effect on ASC or the serum antibody levels. Splenic PC-specific ASC were increased to
the same extent in both propanil and mixture-treated mice, suggesting that propanil was
responsible for the increase in splenic ASC. Reduction in the number of bone marrow
PC-specific ASC and serum antibody titers was dependent on 2,4-D treatment. These
experiments indicate that propanil and 2,4-D modulate the immune response to
vaccination with HKSP independently.
Propanil magnified the splenic PC-specific ASC response without altering the
kinetics of the response or shifting the isotype composition. The earliest observed
increase due to propanil exposure was 5 days post-exposure. Maximal effects were
observed at day 7 and ASC decreased by day 10. Both T helper 1 (Th1) and Th2
cytokines alter the antibody response. IFN-γ, a Th1 cytokine, promotes IgG3 production
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and TGF-β, a Th2 cytokine, promotes a shift to IgG2b production (Stavnezer, 1996). The
retention of the predominant PC-specific isotypes IgG3 and IgG2b suggests that propanil
does not skew the cytokine profile of the immune response. The kinetics of the splenic
antibody response in propanil and vehicle-treated animals were similar, suggesting that
proliferation and activation is not unregulated as would be indicated by a continued
increase in ASC at day 10.
Despite a several fold increase in the number of PC-specific ASC in the spleen,
and an increased ex vivo production of PC-specific antibody by splenocytes from
propanil-treated animals in comparison to the control, the serum antibody titers were
comparable for the two groups. There are several possible explanations for this result.
First, it is possible that the increased amount of antibody produced in propanil-treated
animals remains localized to the spleen. Second, the antibodies produced in the spleen in
propanil-treated mice may be rapidly catabolized if serum antibodies levels are at a
saturated concentration, therefore no increase in serum titers would be detected.
However, the second possibility is unlikely since mixture-treated animals also had
increased splenic ASC but reduced serum titers. Several earlier reports established the
bone marrow as the primary source of serum antibodies (reviewed in Benner et al.,
1981).

Exposure to propanil had no effect on the number of bone marrow PC-specific

ASC. In contrast to propanil, 2,4-D decreased PC-specific ASC in the bone marrow and
the decrease correlated with a decrease in PC-specific titers. Splenic ASC were
comparable to control animals after 2,4-D exposure. Taken together, the results suggest
that 2,4-D decreased serum PC-specific titers by decreasing bone marrow ASC and
demonstrates the importance of bone marrow ASC for PC-specific titers during the
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primary response to HKSP. The ability of a chemical to decrease the number of plasma
cells in the bone marrow could have long-term implications for maintaining circulating
levels of protective antibody after immunizations.
In contrast to the results presented here, propanil exposure has previously been
reported to suppress the number of plaque-forming cells after immunization with the TI-2
antigen DNP-Ficoll, and the TD antigen, SRBC (Barnett and Gandy, 1989; Barnett et al.,
1992). The nature of the antigen may be important for the immunomodulation of the
immune response by propanil. DNP-Ficoll and PC are both model TI-2 antigens.
However, in the present study, PC is presented in the context of whole HKSP, a complex
particulate immunogen. It was previously demonstrated that the requirements for the
humoral response to PC, after immunization with HKSP, is substantially different than
after immunization with purified polysaccharide preparations (Wu et al., 1999).
Although the PC antibody response is classically considered to be T-independent, Wu et
al, (1999) demonstrated that the IgG isotype responses to PC after immunization with
HKSP was decreased in T cell receptor β knock-out mice. In addition, they demonstrated
that CD4+ T cells and CD8+ T cells contributed to an optimal antibody response, and the
PC response was significantly decreased in CD40L knockout mice (Wu et al., 1999).
Further studies demonstrated that noncognate T cell help was required for an optimal PC
response after HKSP immunization (Wu et al., 2002). Therefore, propanil could affect
one of the components necessary for the response to PC after immunization with HKSP
that is not required after immunization with soluble DNP-Ficoll.
The time of exposure to the herbicide may also be important to the subsequent
effects on the immune response. In the previous studies that demonstrated propanil
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suppressed the plaque-forming cell response to SRBC and DNP-Ficoll, the antigens were
administered 3 days after propanil exposure (Barnett and Gandy, 1989; Barnett et al.,
1992). In the present study, propanil was administered at the time of HKSP vaccination.
This may suggest that propanil is acting as an adjuvant to affect innate immune
mechanisms and enhance the immune response to PC.
The antibody response to vaccination with HKSP is influenced by the early innate
immune response. S. pneumoniae has pathogen associated molecular patterns on its
surface that can stimulate signaling pathways through pattern recognition receptors such
as toll-like receptor-2 (TLR2) (Yoshimura et al., 1999). It was recently demonstrated
that the IgG2b and IgG3 antibody response to PC after immunization with heat-killed S.
pneumoniae type 14 is decreased in TLR-2 knockout mice (Khan et al., 2005). The
complement pathways are also important for the innate immune response to S.
pneumoniae that can influence the subsequent adaptive immune response (Brown et al.,
2002). Conjugation of the complement component, C3d, to pneumococcal capsular
polysaccharide, has been demonstrated to enhance the antibody response to the
polysaccharide dependent on the dose of antigen (Test et al., 2001). Similarly,
preliminary studies in our laboratory suggest that the dose of HKSP is important, as mice
vaccinated with suboptimal doses of HKSP did not have an increase in ASC. The effect
of propanil on specific components of the innate immune response has not been
investigated.
Propanil may alter the immune response through interactions with the endocrine
system. Propanil induces thymic atrophy primarily through the induction of
glucocorticoids, however, inhibition of glucocorticoid production does not completely
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abrogate thymic atrophy (Cuff et al., 1996; de la Rosa et al., 2005). In addition,
glucocorticoids are reported to inhibit Th1 responses and enhance Th2 responses
(Ashwell et al., 2000; Miyaura and Iwata, 2002). Propanil did not alter the major isotype
response to PC, which suggests that the T cell response and subsequent production of
cytokines driving B cell switching was not affected. This suggests that additional
mediators may play a role in the immunotoxic effects of propanil. Propanil also
decreases the pre-B cell and IgM+ B cell populations in the bone marrow via an unknown
mechanism (de la Rosa et al., 2003). Similar to propanil, 17β-estradiol exposure has
been shown to induce thymic atrophy and decrease immature B cell populations in the
bone marrow (Erlandsson et al., 2003). Chronic exposure to 17β-estradiol has been
reported to increase ASC to bacterial and autoantigens in C57BL/6 mice (Verthelyi and
Ahmed, 1998). In addition, exposure to 17β-estradiol was demonstrated to increase
activation of the marginal zone B cell population and lead to the production of
autoantibodies by the marginal zone B cells (Grimaldi et al., 2001). Marginal zone B
cells are crucial in the generation of the immune response to TI-2 antigens (reviewed in
Zandvoort and Timens, 2002). Mice deficient in marginal zone B cells have a deficient
antibody response to TI-2 antigens (Guainamard et al., 2000). If propanil induced the
production of 17-β estradiol it could enhance the antibody response to PC through the
effects of 17-β estradiol on the marginal zone B cell population. Preliminary studies in
our laboratory have demonstrated that propanil does not increase the number of PCspecific splenic ASC in ovariectomized mice suggesting an important potential role for
17β-estradiol.
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The mechanism by which 2,4-D decreased the bone marrow PC-specific ASC is
unknown. However, there are several possibilities. Homing of plasma cells from the
spleen to the bone marrow is dependent on the expression of the chemokine receptor,
CXCR4, on splenic plasma cells and its ligand, CXCL12, in the bone marrow (Erickson
et al., 2003). The splenic ASC in 2,4-D-treated mice could be defective in the expression
of CXCR4. It is also possible that production of CXCL12 in the bone marrow could be
defective. Finally, support of plasma cells in the bone marrow could be affected due to
damage to the bone marrow microenvironment.
In contrast to the effect on the TI-2 antigen, PC, exposure to propanil, 2,4-D or
the mixture had no effect on the response to the TD antigen, PspA. The number of PspAspecific ASC in the spleen and the serum titers to PspA were comparable to the controls
for all of the treatment groups. This could suggest that the effects of both propanil and
2,4-D occur early after vaccination when the TI-2 antigen response is being generated. If
propanil has effects on the innate immune system or on marginal zone B cells which are
critical to the response to TI-2 antigens, as discussed above, the effects may not impact
the subsequent response to the TD antigen, PspA. A second possibility is that the time of
exposure to the herbicides during the immune response to each antigen is critical. In the
experiments presented here, herbicide exposure was on the day of HKSP vaccination.
The peak response to PC was determined 7 days post-exposure while the peak response
to PspA is at day 14. If the herbicides mediate their effect during the time antigenspecific B cells are undergoing activation or expansion, and the effect is short-term, then
the later response to PspA may not be affected. Similar to PspA, propanil exposure does
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not increase the number of splenic IgM ASC to SRBC, another TD antigen, when
administered at the time of SRBC immunization (de la Rosa, unpublished results).
As the use of herbicides escalates, it is necessary to have an accurate
understanding of the risks associated with their use. This report illustrates the importance
of studying immunotoxic effects using naturally occurring microbial pathogens and the
diverse effects that different compounds can have. The enhanced antibody response after
exposure to propanil has implications for the potential of this class of compounds to be
environmental factors in autoimmune disease. In contrast, other compounds, such as 2,4D, may impair the ability of the host to mount an appropriate protective immune response
after vaccination.
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Figure 1. Propanil and mixture exposure increases the number of PC-specific ASC
in the spleen.
C57BL/6 mice (5/group) were vaccinated with HKSP (2x108 CFU/mouse) and treated
with vehicle control, 150 mg/kg propanil, 150 mg/kg 2,4-D, or a 150/150 mixture.
Spleens were removed at days 3, 5, 7, and 10. Numbers of PC-specific IgM (A, D),
IgG2b (B, E), and IgG3 (C, F) ASC were determined by ELISPOT assay. All values
represent the mean ± SD of ASC per 1x106 B cells (A, B, and C) or per spleen (D, E, F).
Propanil and mixture treatments are significantly different from vehicle control on days
5, 7, 10 for IgM, IgG2b, and IgG3, p ≤ .05.
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Figure 2. Propanil and mixture exposure increase spleen weight.
C57BL/6 mice (5/group) were vaccinated with HKSP (2x108 CFU/mouse) and treated
with vehicle control, 150 mg/kg propanil, 150 mg/kg 2,4-D, or a 150/150 mixture.
Spleens were removed at days 3, 5, 7, and 10 and the wet weights determined. Results
are expressed as the ratio of spleen weight to body weight. Propanil and mixture
treatments are significantly different from vehicle control on days 5, 7, 10, p ≤ .05.
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Table 1. Spleen cell populations 7 days after herbicide exposure and HKSP
vaccination.
Treatmenta
Vehicle
Propanil
2,4-D
Propanil/2,4-D
a

Total cellsb
80 ± 13.6
108 ± 31.8
76 ± 17.6
143 ± 35.7e

B220+
B cellsc
30 ± 3.6d
34 ± 6.4
33 ± 7.7
40 ± 5.4

Marginal zone
B cells
1.9 ± 0.25
2.1 ± 0.31
1.8 ± 0.42
2.1 ± 0.43

Follicular
B cells
20 ± 3.8
23 ± 4.2
22 ± 4.9
26 ± 2.4

CD4+ T cells

CD8+ T cells

18 ± 5.1
22 ± 5.9
18 ± 5.0
27 ± 3.1

C57BL/6 mice (5/group) were vaccinated with HKSP and treated with vehicle, 150
mg/kg propanil, 150 mg/kg 2,4-D, or a 150/150 mg/kg mixture of propanil and 2,4-D.
Spleens were harvested on day 7.
b
Total number of spleen cells (x 106) ± SD.
c
Individual cell populations were determined by flow cytometric analysis as described in
the Methods.
d
Data represents the total number of cells (x 106) ± SD.
e
p ≤ 0.05 versus vehicle control.
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11 ± 3.7
15 ± 3.5
12 ± 3.5
17 ± 0.9
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Figure 3. Propanil increases the number of splenic ASC in a dose dependent
manner.
C57BL/6 mice (5/group) were vaccinated with HKSP (2x108 CFU/mouse) and treated
with vehicle control (0), 25 mg/kg, 50 mg/kg, and 150 mg/kg propanil. Spleens were
removed at day 7. Numbers of PC-specific IgM (A, D), IgG2b (B, E), and IgG3 (C, F)
ASC were determined by ELISPOT assay. All values represent the mean ± SD of ASC
per 1x106 B cells (A, B, and C) or per spleen (D, E, F). The asterisk (*) represents a
significant difference (p ≤ .05) from vehicle control.
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Figure 4. Propanil and mixture exposure increases ex vivo antibody production by
splenocytes following HKSP vaccination.
C57BL/6 mice (5/group) were vaccinated with HKSP (2x108 CFU/mouse) and treated
with vehicle control, 150 mg/kg propanil, 150 mg/kg 2,4-D, or a 150/150 mixture.
Spleens were harvested on day 7 and cultured in vitro for 5 days. Antibody supernatants
were collected and analyzed by ELISA. De novo PC-specific IgM (A) and IgG (B)
production was determined by subtracting cycloheximide treated samples from the total
antibody produced. Values represent the mean de novo antibody produced ± SD.
Propanil and mixture treatments are significantly different from vehicle control at
dilutions 1:2, 1:4, and 1:8 for IgM and IgG, p ≤ .05.

94

ASC/1x106 bone marrow cells

40

B. IgG

Vehicle
Propanil
2,4-D
Propanil/ 2,4-D

30
20
10
1000
0

ASC/ bone marrow

A. IgM

D. IgG

C. IgM

800
600
400
200
0
3

5

7

10

3

5

7

10

Days post-exposure

Figure 5. 2,4-D and mixture exposure decreases the number of PC-specific bone
marrow ASC.
C57BL/6 mice (5/group) were vaccinated with HKSP (2x108 CFU/mouse) and treated
with vehicle control, 150 mg/kg propanil, 150 mg/kg 2,4-D, or a 150/150 mixture. Bone
marrow was harvested on days 3, 5, 7, 10. Numbers of PC-specific IgM (A, C) and IgG
(B, D) ASC were determined by ELISPOT assay. Values represent the mean ± SD of
ASC per 1x106 bone marrow cells (A, B) or per total bone marrow (D, E). 2,4-D and
mixture treatments are significantly different from vehicle control on days 5, 7, and 10
for IgM and IgG, p ≤ .05.
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Figure 6. 2,4-D and mixture exposure decreases PC-specific titers.
C57BL/6 mice (5/group) were vaccinated with HKSP (2x108 CFU/mouse) and treated
with vehicle control, 150 mg/kg propanil, 150 mg/kg 2,4-D, or a 150/150 mixture.
Serum was collected on days 3, 5, 7, 10. The titers of PC-specific IgM (A), IgG2b (B),
and IgG3 (C) were determined by ELISA. Values represent the mean ± SEM. 2,4-D and
mixture treatments are significantly different from vehicle control at day 10 for IgM and
IgG, p ≤ .05.
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Figure 7. Herbicide exposure has no effect on the number of splenic PspA-specific
ASC.
C57BL/6 mice (5/group) were vaccinated with HKSP (2x108 CFU/mouse) and treated
with vehicle control, 150 mg/kg propanil, 150 mg/kg 2,4-D, or a 150/150 mixture.
Spleens were harvested on day 14. Numbers of PspA-specific IgM (A, C) and IgG (B,
D) ASC were determined by ELISPOT assay. Values represent the mean ± SD of ASC
per 1x106 B cells (A, B) or per spleen (C, D).
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CHAPTER 4: FURTHER CHARACTERIZATION OF THE
EFFECT OF PROPANIL EXPOSURE ON THE HUMORAL
IMMUNE RESPONSE
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INTRODUCTION
Previous studies demonstrated that propanil enhances the antibody response to the
TI-2 antigen PC when presented on the surface of killed whole bacteria (de la Rosa,
2005). However, propanil did not increase the number of ASC to the TD antigen PspA
on day 14 in mice that were vaccinated and treated with herbicides on day 0 (de la Rosa,
2005). In addition, the increased number of PC-specific ASC in propanil-treated animals
did not cause an elevated response in PC-specific serum titers. The following
experiments were performed to answer a number of questions raised from these findings
that are important in determining the immune-based mechanisms involved in enhancing
the humoral response.
The context in which the antigen is presented to the immune system can alter the
response in a number of ways. For example, S. pneumoniae contains a number of
pathogen associated molecular patterns (PAMPS) that are recognized by Toll-like
receptors (Sen et al., 2005). TLR have been shown to be important for enhanced
antibody responses (Sen et al., 2006). Processing and presentation by the APCs differs in
mice immunized with particulate or soluble antigens (Ramachandra et al., 1999). An
example of a soluble antigen that induces a TI-2 PC-specific response independent of
TLR activation is PC-Ficoll. The following experiments utilized PC-Ficoll to evaluate
the importance of soluble versus particulate antigens in the ability of propanil to enhance
the immune response.
The inability of propanil to increase the number of PspA-specific ASC suggests
that propanil may induce changes on a specific subset of B cells responsible for TI-2
responses and the effect is independent of T-cell help. Alternatively, propanil may
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enhance the antibody response only within a limited timeframe following herbicide
exposure. For example, immunization of mice with DNP-Ficoll 3 days following
propanil exposure suppresses the antibody response on day 7 (Barnett et al., 1992).
Given that the PspA response is not measurable until day 6 and peaks around 10-14 days,
it is possible that propanil, which is eliminated from the body within 2 days, may not
remain in the animal long enough to enhance the PspA response (Izmerov, 1984).
Experiments were also performed to determine the effect of exposure to herbicides at
different time points following HKSP immunization on the PspA response.
The inability of propanil to increase serum titers despite a robust enhancement of
the splenic response and increased ex vivo antibody production suggest a number of
explanations. Antibody catabolism has been discussed in Chapter 3. Alternatively, the
increased antibodies may not exit the spleen into the serum due to binding of the
antibodies to HKSP in the spleen. Finally, the serum antibody titers may be increased at
a later time point. Experiments were performed to examine these possibilities.

METHODS
Animals
Six to eight week old C57Bl/6 female mice were purchased from Hill Top Lab
Animals (Scottdale, PA). Mice were housed in microisolator cages in pathogen free
conditions at West Virginia University’s animal facility. Mice were kept on a 12 hr lightdark cycle and allowed to acclimate to the facility for 1 week. These studies were
conducted in accordance with all federal and institutional guidelines for animal use and
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were approved by the West Virginia University Institutional Animal Care and Use
Committee.
Reagents
Propanil (3,4-dichloropropionanilide, 99% pure) was purchased from Chem
Service (West Chester, PA). PC-Ficoll containing 6 PC molecules per molecule of Ficoll
was purchased from Biosearch Technologies (Novato, CA). PC-KLH containing 15 PC
molecules per molecule of Ficoll was purchased from Biosearch Technologies.
Bacterial preparation and immunization with R36A
S. pneumoniae strain R36A, an avirulent, nonencapsulated strain, was grown to
mid-log phase in Todd-Hewitt broth (Becton Dickinson, Sparks, MD) + .05% yeast
extract (Becton Dickinson) and stored at –80°C. For immunization, stock was cultured in
a candle jar for 18 hrs at 37°C on blood agar plates (Becton Dickinson). A few
characteristic colonies were selected and suspended in 200 ml Todd-Hewitt broth + .05%
yeast extract. Bacteria were grown at 37°C to an absorbance reading at 650nm of 0.4 and
heat killed for 4 hours in a 60°C water bath. A final concentration of 109 CFU/ml was
established in PBS based on colony counts. Sterility was confirmed by culture. Heatkilled stock was stored at -20°C in 1 ml aliquots. Mice were immunized ip with either
5x106 or 2x108 CFU.
Animal exposures
Propanil was dissolved in peanut oil for a final concentration of 15 mg/ml for all
experiments. Mice (5/group) were treated ip with either 150 mg of propanil/kg of body
weight (mg/kg) or vehicle on the same day as immunization. For PC-Ficoll, mice were
immunized i.p. with 50µg of PC-Ficoll in 200 µl PBS as in a previous study (Wu et al.,
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1999). For PC-KLH immunizations, mice were immunized i.p. with 100µg of PC-KLH
in 200 µl PBS.
Preparation of splenocytes
Mice were euthanized with 100 µl Nembutal Sodium Solution (50 mg/ml, Abbott
Laboratories, North Chicago, IL) vaccination. Spleen wet weights were recorded.
Spleens were mechanically dissociated through Spectra nylon mesh (Spectrum Labs,
Rancho Dominguez, CA) in complete cell media containing RPMI-1640 (BioWhitaker,
Walkersville, MD), 10% heat inactivated fetal bovine serum (FBS, Hyclone Laboratories,
Inc, Logan, UT), 10 mM HEPES (Sigma), 1 mM L- glutamine (Gibco, Rockville, MD),
5x10-5 M 2-mercaptoethanol (Sigma), 100 U/ml penicillin (Gibco), and 100 µg/ml
streptomycin (Gibco). Red blood cells in the spleen were lysed with Tris-buffered
ammonium chloride. Cell suspensions were washed twice and counted using a
hemacytometer. Viability was determined using Trypan blue dye exclusion.
Measurement of antibody secreting B cells (ASC) in the spleen
Acrowell 96 well filter plates (Pall Life Sciences, Ann Arbor, MI) were coated
with 50 µl PC-BSA (Biosearch Technologies, Novato, CA) (10 µg/ml) or 50 µl PspA (10
µg/ml) (PspA was a generous gift from Clifford Snapper, USUHS) overnight at 4°C. In
all subsequent steps, plates were washed with PBS + .01% Tween-20. Plates were
blocked with 200 µl/well complete medium + 25% FBS for 2 hours at 37°C. Plates were
washed and cells (100 µl/well) were then added at a concentration of 5x106 cells/ml or
1x106 cells/ml. All samples were plated in triplicate. Plates were incubated for 4-6 hours
at 37°C in a 5% CO2 incubator. After washing, goat anti-mouse alkaline phosphatase
(AP) conjugated IgG, IgG1, IgG2a, IgG2b, IgG3, or IgM antibodies (Southern
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Biotechnology Associates, Birmingham, AL), diluted 1/250 in PBS + 1%BSA + .05%
Tween-20, were added to the appropriate wells (100 µl/well). Plates were incubated
overnight at 4°C and washed. SIGMAFAST 5-bromo-4-chloro-3-indolyl phosphate/nitro
blue tetrazolium tablets (Sigma-Aldrich, St. Louis, MO) were dissolved in distilled water
and added at 100 µl/ well. Color development was stopped by washing with distilled
water. The number of spots/well was counted using a dissection microscope (Olympus
Optical Co., Melville, NY). The number of ASC was calculated by using the mean
number of spots from triplicate wells. The number of ASC was normalized to 1x106 B
cells. Comparable fold increases were noted when normalized to whole spleen.
Flow cytometric analysis
Splenic cells were stained with the appropriate combinations of rat anti-mouse
B220-APC (RA3-6B2). All steps were performed in PBS supplemented with 1% FBS
and 0.04% sodium azide (Sigma). Briefly, 1 x 106 cells were stained in a total volume of
25 µl of antibodies at the appropriate concentrations for 25 minutes on ice in the dark.
After incubation, cells were washed twice and fixed in 0.04% paraformaldehyde
overnight at 4°C (Fisher Scientific, Pittsburgh, PA). The following day cells were
washed twice to remove the paraformaldehyde and resuspended in 1 ml of staining
media. For each sample, 10,000 cells were collected for analysis on a Becton-Dickinson
FACScan (Becton Dickinson Immunocytometry Systems, Mansfield, MA). Analysis was
performed using WinMDI software (Joseph Trotter, Scripps Institute, San Diego, CA).
Population percentages, obtained from flow cytometric analysis, were used to calculate
the absolute cell number by multiplying the percentage of cells in a population by the
total number of cells harvested per organ.
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Measurement of PC- and PspA- specific titers
Serum samples were prepared via blood collected from the heart. Immulon 2
plates (for PC) or Immulon 4 plates (for PspA) (ThermoLabsystems, Franklin, MA) were
coated overnight at 4°C with 5 µg/ml PC-BSA or 5 µg/ml PspA (50 µl/well). Plates were
washed, blocked with 3% BSA + PBS at 37°C for 2 hours. Plates were washed and 100
µl/well of twofold dilutions of sera in PBS +1% BSA were added starting at 1/400 for the
IgG and IgM ELISAs and 1/250 for the IgG subclasses. Plates were then incubated for 1
hour at 37°C and washed. AP conjugated antibodies (100 µl/well) were added for 1 hour
at 37°C. Plates were washed and phosphatase substrate tablets (Sigma-Aldrich) were
dissolved in PNPP (p-Nitrophenyl Phosphate, Disodium Salt) substrate buffer. Plates
were developed and absorbance read at 405nm on a µQuant spectrophotometer (Bio-Tek
instruments, Winooski, VT) using KCJunior software (Bio-Tek instruments).
Statistics
ANOVA was performed for all statistical analyses using a Tukey-Kramer t-test to
perform multiple comparisons between all treatment groups. A significance level of p ≤
0.05 was used for all tests. Statistical analysis was performed using JMP software (SAS
Institute Inc., Cary, NC). All experiments were performed 3 or more times with similar
results. The figures are representative data from one experiment.

RESULTS
Propanil increases the number of PC-specific ASC following PC-Ficoll
immunization.
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Previous studies have demonstrated that propanil increases the antibody response
to PC following immunization with the particulate antigen HKSP. To determine if the
propanil-induced antibody enhancement requires immunization with whole bacteria, mice
were vaccinated with the soluble TI-2 antigen PC-Ficoll and treated on the same day with
propanil or vehicle. The number of splenic PC-specific ASC and the PC-specific serum
titers were determined 7 days later by ELISPOT and ELISA, respectively. Propanil
increased the number of PC-specific IgG2b, IgG3 and IgM ASC 3-4 fold in PC-Ficoll
immunized animals (Figure 1). The fold increase in ASC in propanil-treated and PCFicoll immunized mice was similar to propanil-treated HKSP immunized mice.
However, the baseline PC response to PC-Ficoll was 6-10 fold lower than after
vaccination with HKSP (Figure 1). However, PC-specific serum titers in propanil-treated
mice were not significantly increased following either PC-Ficoll or HKSP immunization
compared to the controls (Figure 2). This data suggests that propanil induces a similar
effect on the immune response to a soluble TI-2 antigen.
Propanil does not enhance the antibody response to a suboptimal HKSP
immunization.
These experiments were performed to determine if the propanil-induced
enhancement of the antibody response has a minimum threshold for antigen stimulation.
To determine if propanil exposure can increase the antibody response to a suboptimal
immunization to the same level as an optimal immunization, mice were immunized with
5x106 or 2x108 CFU of HKSP and treated on the same day with propanil or vehicle. The
number of PC-specific ASC was determined at day 7. The number of PC-specific ASC
in vehicle-treated mice immunized with 5x106 CFU HKSP is decreased 4-5-fold from
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mice immunized with 2x108 CFU HKSP (Figure 3). In addition, propanil does not
significantly affect the number of PC-specific ASC in mice immunized with 5x106 CFU
HKSP. This data suggests that propanil enhancement of the antibody response has a
minimum threshold of antigen stimulation to induce the effect.
Propanil increases secondary antibody responses to PC and PspA.
Previous data demonstrated that propanil enhances a primary TI-2 antibody
response but not a primary TD response. These experiments were performed to
determine if propanil enhances a TI-2 or TD secondary antibody response and if multiple
exposures to propanil can produce either greater enhancement or prolonged enhancement
of the antibody response. Mice were immunized with 2x108 HKSP on day 0 and day 14.
Mice were exposed to propanil on either day 0, day 14, or days 0 and 14. PC and PspAspecific antibody responses were measured on day 21. The number of PC-specific ASC
from mice treated with propanil once on day 0 and mice treated with propanil twice on
days 0 and 14 were not significantly different from vehicle controls (Figure 4A).
However, PC-specific ASC from mice exposed to propanil once on day 14 were
increased 2-3 fold compared to controls (Figure 4A). None of the propanil exposure
treatments significantly affected PC-specific serum titers (Figure 5A).
The effect of propanil on the PspA-specific response was similar to the PCspecific response. The number of PspA-specific ASC from mice exposed to propanil
once on day 14 was increased 2-fold compared to vehicle-treated mice (Figure 4B).
Propanil exposure on day 0 or days 0 and 14 did not significantly affect the number of
PspA-specific ASC (Figure 4B). None of the propanil exposure treatments significantly
affected PspA-specific serum titers (Figure 5B). Altogether, these data suggest that
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propanil enhances the antibody response to both protein and polysaccharides. However,
enhanced splenic ASC did not increase serum titers on day 21.
Delayed propanil exposure enhances a primary antibody response to PspA.
The previous findings demonstrating that propanil enhances the secondary
antibody response to PspA when mice are exposed on day 14 suggest that the
enhancement of the antibody response is dependent on the time of propanil exposure
relative to the developing antibody response. To determine if propanil can increase the
number of PspA-specific ASC during a primary response, mice were immunized with
HKSP on day 0 and treated with propanil on day 9. The PspA and PC antibody responses
were measured on day 14. The number of PspA-specific ASC was increased
approximately 2-fold compared to vehicle-treated mice (Figure 6A). In addition, the
number of PC-specific ASC was also increased 4-6-fold in propanil-treated mice
compared to vehicle controls (Figure 6B). This data demonstrates that the enhancement
of the antibody response is dependent on the condition of the antibody response when
mice are exposed to propanil.
Propanil does not enhance the antibody response following PC-KLH immunization.
To determine if propanil requires the TD antigen to be presented in a particulate
form such as HKSP to enhance the antibody response, mice were immunized with PCKLH or HKSP and treated with propanil or vehicle on day 0. The number of PC-specific
ASC was determined on day 7. Both high affinity and low affinity PC-specific ASC
were also determined by using a high and low conjugation ratio of PC-BSA. To detect
high affinity ASC, ELISPOT plates were coated with 2PC-BSA. Low affinity ASC were
detected by 15PC-BSA coated plates. PC-KLH immunization produced a 2-fold greater
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number of ASC in vehicle-treated animals compared to vehicle-treated animals
immunized with HKSP (Figure 7A). Interestingly, propanil did not enhance the PCspecific response following PC-KLH immunization (Figure 7A). Analysis of the affinity
of PC-specific antibodies demonstrates that the number of low affinity ASC is 20%, 65%,
and 220% greater than high affinity IgM, IgG3, and IgG2b ASC, respectively (Figure 7A
vs. Figure 7B). This data indicates that high and low affinity ASC are detectable with
this assay. The number of low affinity PC-specific ASC in propanil-treated animals was
increased approximately 4-fold for IgG2b and 5-fold for IgG3 and IgM (Figure 7A). The
number of high affinity PC-specific ASC in propanil-treated animals were increased
approximately 6-fold, 5-fold, and 4-fold for IgG2b, IgG3, and IgM, respectively (Figure
7B). Altogether, this data suggests that propanil does not preferentially increase either
high or low affinity ASC.

DISCUSSION
This set of experiments addressed a number of questions concerning the effect of
propanil on the antibody response. Effects of propanil on humoral responses to
particulate and soluble antigens also provide important information on any putative
effects on antigen processing. As mentioned previously, the role of T cells in the
amplification of the antibody response can be assessed through TI-2 and TD comparison
studies. Finally, determining when during the time of the response the immune system is
susceptible to the effects of propanil exposure was also addressed. The results from these
initial experiments may help to focus experiments studying the immunological
mechanisms regulating the enhanced antibody response.
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These data suggest that the increased antibody response is not due to a
nonspecific polyclonal increase in ASC. Propanil increased the PC-specific response
following HKSP and PC-Ficoll immunization. However, propanil does not increase the
PC-specific response following PC-KLH immunization, despite a robust antibody
response at day 7. In addition, propanil induction of nonspecific polyclonal activation
would predict a greater increase in low affinity PC-specific B cells. However, the data
indicates that both high and low affinity PC-specific ASC are increased equally.
Previous reports demonstrated that the low affinity PC-specific serum titers are increased
120% compared to high affinity PC-specific serum titers in samples collected on days 6
or 9 (Wu and Ward, 1993). However, the affinity of individual isotypes was not
determined (Wu and Ward, 1993). Our study supports the previous affinity analysis
however precise comparisons are difficult due to the different time points and antigen
employed. Altogether, these data suggest an antigen-specific increase in antibody
production.
Another unresolved finding in the previous chapter was the discrepancy between
increased ASC and increased ex vivo antibody production in propanil-treated animals,
but unchanged serum antibody titers. The results from Chapter 3 indicate that antibody
serum titers are more sensitive to changes in the number of BM ASC. Since the number
of BM ASC are not increased in propanil-treated animals despite an increase in splenic
ASC, propanil treatment may not increase the antibody serum titers since the increased
number of plasma cells do not survive in the BM.
Propanil failed to amplify the antibody response exposure following a suboptimal
HKSP immunization. This data provided an interesting finding that propanil exposure
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increased the antibody response to a weak PC-Ficoll response but not to a weak HKSP
immunization. The low conjugation ratio of the PC-Ficoll used in this experiment (6 PCFicoll) was lower than that used in previous experiments (25 PC-Ficoll) which generated
serum titers comparable to optimal HKSP immunization (Wu et al., 1999). A possible
explanation for the discrepancy between responses is that the low PC-concentration on
PC-Ficoll activates high affinity B cells. Propanil is able to amplify the PC response to
low PC-Ficoll immunization because the concentration of PC-Ficoll molecules is in
excess, allowing for receptor engagement by the increased number of responding PCspecific B cells. In contrast the low dose of HKSP would limit the number of individual
PC expressing bacterium thus fewer BCR are able to bind to HKSP. This hypothesis
would suggest that propanil cannot increase the number of PC-specific ASC in
suboptimally vaccinated mice because the increased number of responding B cells
require antigen stimulation to differentiate to plasma cells. Altogether, these data suggest
that propanil enhancement of the antibody response is not dependent on particulate or
soluble antigen presentation by the APC.
A second question addressed by these set of experiments was whether the
enhancement of the antibody response by propanil was specific for TI-2 responses.
Given the major differences in the processes leading to B cell activation in TD and TI-2
responses as noted in the General Introduction, addressing this issue is important for
determining the mechanisms responsible for the increased numbers of ASC. These data
demonstrate that enhancement of the antibody response is dependent on when the animal
is exposed to propanil during the antibody response. Propanil increased the antibody
response to a TD antigen when it is given 5 days prior the peak antibody response in
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HKSP immunized mice. Although PC-KLH elicits a robust TD PC-specific response at
day 7, previous reports have demonstrated that the T15+ antibody response following PCKLH immunization is maximal on day 13 in Balb/c mice (Wiens et al., 2003). The data
suggests that propanil exposure to PC-KLH on day 8 would amplify the anti-PC
response.
These data indicate that the amplification of the antibody response by propanil is
not a direct effect on the B cells and may require T cell involvement. This hypothesis is
supported by the observation that enhancement of the PC-specific response is not
observed in HKSP immunized animals until day 5, despite actively differentiating and
proliferating B cells by day 3. Similarly, PC-KLH immunization produces a greater
number of PC-specific ASC on day 7 than a HKSP immunization. This also indicates
robust B cell differentiation and proliferation. One of the differences between TD and
TI-2 responses is the nature of T cell help and other costimulation molecules early on
during B cell activation. For instance, T cell help is required for the first 3-4 days of the
PC response and the first 5-6 days for the PspA response (Wu et al., 2002). B7dependent costimulation is required for the first 1-2 days during the PC response in
contrast to the first 5-6 days for the PspA response (Wu et al., 2000). It is possible that
propanil may affect T cell dependent costimulation, which could explain the delayed
enhancement of the PC response until day 5 and the requirement of delayed propanil
exposure to enhance TD responses.
Altogether these data eliminate a number of possible immunological mechanisms
by which propanil amplifies the TI-2 and TD humoral responses. Antibody enhancement
does not require a particulate antigen on a whole killed bacterium. Increased antibody
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responses are antigen specific and not polyclonal. However, more experimentation is
required to resolve the discrepancy between ASC and serum titers and to determine the
importance of T cell help in the amplified response.
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Figure 1. Propanil exposure increases the number of PC-specific ASC following
PC-Ficoll immunization.
Female C57BL/6 mice (5/group) were treated with 150 mg/kg propanil or vehicle control
and vaccinated with 2x108 CFU HKSP or PC(6)-Ficoll. Numbers of PC-specific IgG2b,
IgG3, and IgM ASC were determined by ELISPOT assay on day 7. Values represent the
mean ± SD of ASC/1x106 B cells. # Significantly different from Vehicle + PC-Ficoll, p
≤ .05. * significantly different from Vehicle + HKSP, p ≤ .05.
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immunization.
Female C57BL/6 mice (5/group) were treated with 150 mg/kg propanil or vehicle control
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immunized mice.
Female C57BL/6 mice (5/group) were treated with 150 mg/kg propanil or vehicle control
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and IgM ASC were determined by ELISPOT assay on day 7. Values represent the mean
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Figure 4. Day 14 propanil exposure increases the number of PC-specific and PspAspecific ASC following a HKSP boost on day 14.
Female C57BL/6 mice (5/group) were treated with vehicle control or 150 mg/kg propanil
on day 0, day 14 or day 0 and day 14 and vaccinated on day 0 and day 14 with 2x108
CFU HKSP. (A) Numbers of PC-specific IgG2b, IgG3, and IgM ASC were determined
by ELISPOT assay on day 21. (B) Numbers of PspA-specific IgG and IgM ASC were
determined by ELISPOT assay on day 21. Values represent the mean ± SD of
ASC/1x106 B cells. * Significantly different from vehicle control, p ≤ .05.
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ASC.
Female C57BL/6 mice (5/group) were treated with vehicle control or 150 mg/kg propanil
on day 9 and vaccinated on day 0 with 2x108 CFU HKSP. (A) Numbers of PspA-specific
IgG1, IgG2a, and IgM ASC were determined by ELISPOT assay on day 14. (B)
Numbers of PC-specific IgG2b, IgG3, and IgM ASC were determined by ELISPOT assay
on day 14. Values represent the mean ± SD of ASC/1x106 B cells.
different from vehicle control, p ≤ .05.
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Figure 7. Propanil exposure does not affect the number of PC-specific ASC
following PC-KLH.
Female C57BL/6 mice (5/group) were treated with vehicle control or 150 mg/kg propanil
and vaccinated on day 0 with 2x108 CFU HKSP or PC-KLH. Numbers of PC-specific
IgG2b, IgG3, and IgM ASC were determined by ELISPOT assay on day 7. (A) Low
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were detected using PC(2)-BSA coated plates. Values represent the mean ± SD of
ASC/1x106 B cells. * Significantly different from vehicle HKSP, p ≤ .05.
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ABSTRACT
Steroid hormones are known to affect the humoral immune response to a variety
of antigens. However, the mechanisms regulating these effects are poorly understood.
The immunotoxic chemical, propanil, and estrogen have similar effects on the immune
system including augmentation of humoral immune responses. Propanil enhances the
number of phosphorylcholine (PC)-specific IgG2b, IgG3, and IgM antibody secreting
cells (ASC) in the spleen 4-6-fold 7 days after vaccination of female C57BL/6 mice with
heat-killed Streptococcus pneumoniae (HKSP). Several experiments were performed to
test the hypothesis that propanil increases the response via an estrogenic pathway.
Ovariectomy abrogated the effect of propanil on the PC-specific ASC response. Both in
vitro and in vivo assays indicate that propanil does not bind either ERα or ERβ.
Exogenous estradiol administration in ovariectomized mice failed to restore the effect of
propanil on the PC response. Treatment of female mice with a pure ER antagonist, ICI
182,780, or the progesterone antagonist, RU-486, did not inhibit the increase in ASC.
These data suggest that estrogen and progesterone do not regulate the effect of propanil.
However, complete inhibition of steroid synthesis with the GnRH antagonist, antide,
abrogated the increased response in propanil-treated mice, indicating a necessary role for
steroid synthesis. Experiments in male mice demonstrated that propanil increased the
number of ASC comparable to female mice. However, orchiectomy did not inhibit this
effect, suggesting that androgens do not regulate the amplification of the humoral
response. These data suggest a novel role for the ovarian hormones in the regulation of
the PC-specific antibody response.
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INTRODUCTION
Numerous studies have characterized the immunomodulating effects of the
steroid hormone 17β-estradiol (E2) on developing lymphocyte populations in the thymus
and bone marrow and on the peripheral humoral immune response. Studies have
demonstrated that E2 induces thymic atrophy through a Fas/FasL pathway dependent on
both estrogen receptor (ER) α and β (Do et al., 2002; Erlandsson et al., 2001; Yao and
Hou, 2004). E2 treatment induces thymic atrophy primarily by decreasing the number of
CD4+CD8+ double positive thymocytes (Screpanti et al., 1989). E2 also inhibits B
lymphopoiesis in the bone marrow (Erlandsson et al., 2003; Islander et al., 2003).
Specifically, E2 decreases pro-B cell, pre-B cell, and mature B cells of the bone marrow
in an ERα and ERβ dependent manner (Erlandsson et al., 2003). Studies on the effects
of E2 on specific immune responses have demonstrated that chronic exposure to E2
increases both the number of splenic antibody secreting cells (ASC) and the serum
antibody titers to bacterial and autoantigens (Meyers and Petersen, 1985; Verthelyi and
Ahmed, 1998). Recent data suggest that E2 skews the genetic expression profile of B
cells to enhance survival and to lower tolerance, which may contribute to the enhanced
antibody response after E2 exposure (Frasor et al., 2003; Grimaldi et al., 2002). It has
been proposed that naturally occurring and synthetic compounds capable of acting
through an estrogenic pathway may be able to induce the same immunomodulating
effects as the endogenous hormone.
Reports on endocrine disrupting chemicals (EDC) that are known estrogen
mimics demonstrate that these compounds induce similar immune enhancement as E2
(Sobel et al. 2005; Yurino et al., 2004). One study demonstrated that in vitro exposure to
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bisphenol A (BPA) and diethylstilbesterol (DES) increased IgM secretion from B1 cells
(Yurino et al., 2004). In addition, chronic DES exposure accelerated the onset of
systemic lupus erythematosus (SLE) in BWF1 mice (Yurino et al., 2004). In another
study illustrating the ability of EDC to enhance an autoimmune disease, the
organochlorine pesticides chlordecone, methoxychlor, and DDT accelerated the
progression of SLE in (NZB x NZW)F1 mice (Sobel et al., 2005). Additionally, the antiDNA titers were also increased in chlordecone treated animals (Sobel et al., 2005).
These reports suggest that EDC have the potential to impact the immune system and
accelerate the progression of autoimmune diseases.
The amide class herbicide 3,4-dichloropropionanilide (propanil) is predominantly
used for the control of grassy weeds in rice crops. Exposure to propanil causes a diverse
array of immunotoxic effects that are similar to those seen in animals treated with E2.
Specifically, in vivo exposure to propanil induces thymic atrophy, with reduced double
positive and single positive thymocyte populations (Cuff et al., 1996; de la Rosa et al.,
2005). The thymic atrophy is associated with an increase in glucocorticoid production
(Cuff et al., 1996; de la Rosa et al., 2005). However, administration of the glucocorticoid
receptor antagonist RU486 did not completely abrogate the atrophy suggesting that
glucocorticoids are only partially responsible for inducing thymic atrophy (de la Rosa et
al., 2005). Propanil also decreases the number of immature IgM+ B cells and pre-B cells
in the bone marrow 7 days post-exposure, however the mechanism is unknown (de la
Rosa et al., 2003).
Recently, propanil has been demonstrated to enhance the humoral immune
response to a bacterial vaccine (Salazar et al., 2005). Heat-killed Streptococcus
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pneumoniae (HKSP) was used as the model for measuring the antibody response. HKSP
elicits a robust IgG2b, IgG3, and IgM response to the immunodominant T-independent
type 2 (TI-2) polysaccharide phosphorylcholine (PC) (Wu et al., 1999). When propanil is
administered to mice simultaneously with a HKSP vaccine, the number of splenic ASC
specific for PC is increased 4-6 fold over control animals (Salazar et al., 2005). The
current studies were designed to investigate the mechanism for the increase in PC
antibody production following exposure to propanil.
Only limited studies have reported the endocrine disrupting effects of propanil.
Using an in vitro luciferase reporter assay, propanil was found to be weakly antiandrogenic and lacked estrogenic receptor α- and β-binding activity (Kojima et al.,
2004). Another report found that the major metabolite of propanil, 3,4-dichloroaniline
(3,4-DCA), binds the androgen receptor in vitro (Bauer et al., 1998). Given the paucity
of information describing the potential endocrine disrupting effects of propanil in vivo,
one of the goals of this study was to better characterize propanil as an EDC, using both in
vivo and in vitro models.
As described above, propanil induces a number of immunotoxic effects also
caused by E2. The hypothesis for the present studies was that propanil increased the
antibody response to HKSP vaccination through an estrogenic mechanism. The results
demonstrate that propanil requires the ovaries and steroid synthesis to induce an increase
in the antibody response in female mice. However, the experiments demonstrate that the
enhanced antibody response following exposure to propanil occurs independently of the
estrogen pathway. These studies suggest that the ovaries may regulate the systemic
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humoral immune response through a novel, estrogen-independent mechanism and that
propanil modulates this pathway.
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MATERIALS AND METHODS
Mice
Six to eight week old C57Bl/6 female and male mice were purchased from Hill
Top Lab Animals (Scottdale, PA). Ovariectomized (OVX), castrated (CAS), and shamoperated mice were surgically gonadectomized at Hill Top Lab Animals. Mice were
housed in microisolator cages in pathogen free conditions at West Virginia University’s
animal facility. Mice were kept on a 12 hr light-dark cycle and allowed to acclimate to
the facility for 1 week. Gonadectomized mice were housed at least 2 weeks following
surgery to allow endogenous hormones to decline. Food and water were provided ad
libidum. These studies were conducted in accordance with all federal and institutional
guidelines for animal use and were approved by the West Virginia University
Institutional Animal Care and Use Committee.
Chemicals
Propanil (3,4-dichloropropionanilide, 99% pure) was purchased from Chem
Service (West Chester, PA). 17β-estradiol (E2) was purchased from Sigma Chemical
Co. (St. Louis, MO) and diluted in 99% peanut oil (p.o.) and 1% EtOH. ICI 182,780
(ICI) was purchased from Tocris Bioscience (Ellisville, MO). ICI was diluted in 95%
p.o. and 5% EtOH. The GnRH antagonist, antide, was purchased from Bachem
(Torrance, CA) and dissolved in 20% propylene glycol and 0.85% saline. The
progesterone antagonist, RU486, was purchased from Sigma Chemical Co. and dissolved
in propylene glycol.
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Bacterial preparation and immunization
S. pneumoniae strain R36A, an avirulent, nonencapsulated strain, was grown to
mid-log phase in Todd-Hewitt broth (Becton Dickinson, Sparks, MD) + .05% yeast
extract (Becton Dickinson) and stored at –80°C. For immunization, stock was cultured in
a candle jar for 18 hrs at 37°C on blood agar plates (Becton Dickinson). A few
characteristic colonies were selected and suspended in 200 ml Todd-Hewitt broth + .05%
yeast extract. Bacteria were grown at 37°C to an absorbance reading at 650nm of 0.4 and
heat killed for 4 hours in a 60°C water bath. A final concentration of 109 CFU/ml was
established in PBS based on colony counts. Sterility was confirmed by culture. Heatkilled stock was stored at -20°C in 1 ml aliquots. Mice were immunized ip with 2x108
CFU. This dose of vaccine has previously been demonstrated to elicit an optimal PCspecific antibody response that peaks at day 7 post-vaccination (Wu et al., 1999; Wu et
al., 2000).
Animal exposures
Propanil was dissolved in p.o. for a final concentration of 15 mg/ml or 20 mg/ml
for all experiments. For the experiments measuring antibody responses, mice (5/group)
were treated ip with either 150 mg of propanil/kg of body weight (mg/kg) or vehicle on
the same day as vaccination with heat-killed S. pneumoniae (HKSP). The dose of
propanil was chosen based on previous studies that demonstrate an increase in the
antibody response to PC in vaccinated mice at 150 mg/kg (Salazar et al., 2005).
In experiments using E2, ovariectomized mice were injected sc with a daily dose
of E2 (10 µg/kg). Animals received the first dose of E2 1 hr prior to herbicide or vehicle
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treatment and vaccination. Subsequent E2 treatments were given at the same time daily.
Animals were sacrificed 24 hrs following the final E2 exposure.
In experiments using the ER antagonist, ICI 182,780 (10 mg/kg/day), was injected
sc into female mice. Animals were treated with the first dose of ICI 1 hr prior to
herbicide or vehicle exposure and vaccination. Subsequent ICI exposures were given at
the same time daily throughout the course of the experiment.
In experiments using the GnRH antagonist, antide (60 µg/mouse), female mice
were injected sc every 48 hours 14 days prior to propanil or vehicle exposure and
vaccination (Couse et al., 2003). Subsequent antide treatments were given at the same
time every 48 hours throughout the course of the experiment.
For the uterotrophic assays, OVX mice were treated with either a single ip
injection of the vehicle or propanil (150 mg/kg), or 3 daily sc injections of E2 (10
µg/kg/day). Mice were euthanized 24 hours after the last E2 exposure, and the wet
weights of the uteri were recorded.
In experiments using the progesterone receptor antagonist, RU486 (12.5 mg/kg),
female mice were injected sc 2 hours prior to propanil treatment, 12 hours following
propanil treatment, followed by injections every 24 hours throughout the duration of the
experiment. For thymic atrophy experiments, mice were injected with 200 mg/kg of
propanil or vehicle control. The dose of propanil was based on previous studies on
propanil-induced thymic atrophy (de la Rosa et al., 2005). Thymic weights were
recorded on day 3. For HKSP experiments, mice were treated with 150 mg/kg of
propanil or vehicle control and vaccinated. Splenic antibody responses were measured
on day 7.
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Serum estradiol levels
Serum estradiol levels were determined for mice treated with antide for 14 days
using the Estradiol EIA kit (Diagnostic Automation Inc., Calabasas, CA), according to
the kit instructions. Briefly, serum samples collected from the saphenous vein or E2
standards were added to the provided 96-well microtiter plates coated with anti-E2
antibody. Anti-E2 antibody conjugated to peroxidase was added, and the wells were
incubated for 90 min at room temperature. The wells were washed and substrate was
added to each well for 20 min. The reaction was stopped and read at 450 nm with a
µQuant spectrophotometer (Bio-Tek Instruments, Winooski, VT). The level of detection
for the assay was 1 pg/ml.
Preparation of splenocytes
Mice were euthanized with 100 µl Nembutal Sodium Solution (50 mg/ml, Abbott
Laboratories, North Chicago, IL) on days 5 or 7 following herbicide exposure and
vaccination. Spleen wet weights were recorded. Spleens were mechanically dissociated
through Spectra nylon mesh (Spectrum Labs, Rancho Dominguez, CA) in complete cell
media containing RPMI-1640 (BioWhitaker, Walkersville, MD), 10% heat inactivated
fetal bovine serum (FBS, Hyclone Laboratories, Inc, Logan, UT), 10 mM HEPES
(Sigma), 1 mM L- glutamine (Gibco, Rockville, MD), 5x10-5 M 2-mercaptoethanol
(Sigma), 100 U/ml penicillin (Gibco), and 100 µg/ml streptomycin (Gibco). Red blood
cells in the spleen were lysed with Tris-buffered ammonium chloride. Cell suspensions
were washed twice and counted using a hemacytometer. Viability was determined using
Trypan blue dye exclusion.
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Measurement of antibody secreting B cells (ASC) in the spleen
Acrowell 96 well filter plates (Pall Life Sciences, Ann Arbor, MI) were coated
with 50 µl PC-BSA (Biosearch Technologies, Novato, CA) (10 µg/ml) overnight at 4°C.
In all subsequent steps, plates were washed with PBS + .01% Tween-20. Plates were
blocked with 200 µl/well complete medium + 25% FBS for 2 hours at 37°C. Plates were
washed and cells (100 µl/well) were then added at a concentration of 5x106 cells/ml or
1x106 cells/ml. All samples were plated in triplicate. Plates were incubated for 4-6 hours
at 37°C in a 5% CO2 incubator. After washing, goat anti-mouse alkaline phosphatase
(AP) conjugated IgG, IgG2b, IgG3, or IgM antibodies (Southern Biotechnology
Associates, Birmingham, AL), diluted 1/250 in PBS + 1%BSA + .05% Tween-20, were
added to the appropriate wells (100 µl/well). Plates were incubated overnight at 4°C and
washed. SIGMAFAST 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium
tablets (Sigma-Aldrich, St. Louis, MO) were dissolved in distilled water and added at 100
µl/ well. Color development was stopped by washing with distilled water. The number
of spots/well was counted using a dissection microscope (Olympus Optical Co., Melville,
NY). The number of ASC was calculated by using the mean number of spots from
triplicate wells. The number of ASC was normalized to 1x106 B cells. Comparable fold
increases were noted when normalized to whole spleen (Salazar et al., 2005).
Flow cytometric analysis
Splenic cells were stained with the appropriate combinations of rat anti-mouse
B220-APC (RA3-6B2), rat anti-mouse CD4-FITC (GK1.5), or rat anti-mouse CD8α-PE
(53-6.7) (BD PharMingen, San Diego, CA). All steps were performed in PBS
supplemented with 1% FBS and 0.04% sodium azide (Sigma). Briefly, 1 x 106 cells were
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stained in a total volume of 25 µl of antibodies at the appropriate concentrations for 25
minutes on ice in the dark. After incubation, cells were washed twice and fixed in 0.04%
paraformaldehyde overnight at 4°C (Fisher Scientific, Pittsburgh, PA). The following
day cells were washed twice to remove the paraformaldehyde and resuspended in 1 ml of
staining media. For each sample, 10,000 cells were collected for analysis on a BectonDickinson FACScan (Becton Dickinson Immunocytometry Systems, Mansfield, MA).
Analysis was performed using WinMDI software (Joseph Trotter, Scripps Institute, San
Diego, CA). Population percentages, obtained from flow cytometric analysis, were used
to calculate the absolute cell number by multiplying the percentage of cells in a
population by the total number of cells harvested per organ. Previous experiments have
determined that the number of CD4+ T cells, CD8+ T cells, and B cells is not changed
after propanil exposure (Salazar et al., 2005).
ER binding assay
ER competitive binding assays were performed using purified recombinant ERα
and ERβ (Panvera, Madison, WI). Reactions were performed in 10 mM Tris, 1.5 mM
EDTA, 1.0 mM dithiothreitol, and 10% glycerol at pH 7.4. Reactions containing 1 nmol
ER, 10 nmol [3H]-E2, and the indicated concentrations of competing unlabeled E2 or
propanil were performed in reaction buffer at 4°C for 18 to 20 h. [3H]-E2 bound to ER
was separated from free [3H]-E2 by adding a 60% hydroxylapatite solution followed by
repeated centrifugation and washing. The amount of [3H]-E2 bound to E2 was
determined by liquid scintillation.
Ishikawa cells and alkaline phosphatase activity

132

Ishikawa cells (a generous gift from Richard B. Hochberg, Yale University
Medical School, New Haven, Connecticut) were maintained in MEM medium (Sigma),
10% fetal bovine serum, as described (Littlefield et al., 1990). Ishikawa cells were
treated as described to assess the effect of propanil on estrogen-inducible alkaline
phosphatase (Littlefield et al., 1990). Briefly, cultures were rinsed twice with estrogenfree basal medium and maintained in this medium for 24 hours. Cells were then
trypsinized and plated into 96 well plates (1x104 cells/well) in the presence or absence
(negative control) of indicated concentrations of estrogen (positive control) or propanil.
All cell treatments were performed in quadruplicate. After 72 hr, cultures were treated as
described in detail, and alkaline phosphatase activity was determined by measuring the
conversion of p-nitrophenyl phosphate to p-nitrophenol. MTT Cell Proliferation Kit
(Roche Applied Science, Indianapolis, IN) was used as specified by the manufacturer to
assess effects on cell numbers. Propanil had no effect on the proliferation of Ishikawa
cells (data not shown).
Statistics
One-way analysis of variance (ANOVA) was performed for all statistical analyses
using a Tukey-Kramer t-test to perform multiple comparisons between all treatment
groups. A significance level of p ≤ 0.05 was used for all tests. Statistical analysis was
performed using JMP software (SAS Institute Inc., Cary, NC). All experiments were
performed 3 or more times with similar results. The figures are representative data from
one experiment.
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RESULTS
Ovariectomization abrogates the antibody increase induced by propanil.
To test the hypothesis that propanil increases the antibody response after
vaccination with HKSP through an estrogenic mechanism, OVX or sham-operated mice
were vaccinated with HKSP and treated with propanil or the vehicle. All sham-operated
mice exposed to propanil had a significantly increased number of PC-specific ASC
compared to sham-operated vehicle-treated mice (Figure 1). PC-specific IgM and the
dominant PC isotypes, IgG2b and IgG3, were significantly increased in propanil-treated
animals (Figure 1). Spleen cells from these mice were also cultured in vitro for 5 days
and the production of antibody measured by specific ELISA. There was an increase in
antibody production that corresponded with the increase in ASC (data not shown).
Ovariectomy abrogated the ability of propanil to increase the number of PC-specific ASC
in the spleen (Figure 1). Comparable results were obtained when the data were
normalized to 1 x 106 splenic B cells (Figure 1) or to the total spleen (data not shown).
The number and percentage of B cells, CD4+ T cells and CD8+ T cells in the spleen was
similar for all groups as determined by flow cytometry (data not shown). These data
indicate that the ovaries are required for propanil to induce increases in the PC antibody
response.
Propanil does not bind to estrogen receptors in vivo or in vitro.
To determine if propanil increased the PC antibody response by binding directly
or indirectly with ERα, in vivo uterotrophic assays were performed. OVX mice were
treated once with 150 mg/kg of propanil. Positive control animals were treated daily with
E2 (He et al., 2003). Uterine weights were recorded 3 days following the first exposure.
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As expected, E2 treatment significantly increased uterine weight (Figure 2). Propanil,
however, did not increase the uterine weights compared to vehicle treated animals
(Figure 2). This data suggests that propanil does not directly or indirectly activate ERα,
which is primarily responsible for the E2-induced uterine proliferation (Weihua et al.,
2000).
To establish if propanil interacts directly with the ERα or ERβ, an in vitro
competitive ER binding assay was performed. Propanil did not bind either ERα or ERβ
over a wide range of concentrations (Figure 3), confirming a previous report (Kojima et
al., 2004). In addition, propanil was administered to Ishikawa cells, which express both
ERα and ERβ. Propanil did not increase estrogen-inducible alkaline phosphatase activity
compared to controls, further supporting that propanil does not bind ERα or ERβ (Figure
4).
Administration of exogenous E2 does not restore the enhanced antibody response in
propanil-treated OVX mice.
To determine if propanil requires E2 to enhance the antibody response to HKSP,
OVX mice were exposed once to either propanil or vehicle control. In addition, half of
the propanil-treated and vehicle-treated OVX mice received daily sc E2 for 7 days. All
groups were vaccinated with HKSP on day 0. The PC-specific responses from the OVX
mice were compared with sham-operated mice. Uterine weights and PC-specific splenic
ASC were measured on day 7. Uterine weights of OVX mice were significantly lower
than sham-operated vehicle mice (Figure 5A). Exogenous E2 administration restored
uterine weights of OVX mice comparable to uterine weights of sham-operated mice
(Figure 5A, OVX Vehicle + E2 vs. Vehicle, OVX Propanil + E2 vs. Vehicle). The
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addition of exogenous E2 to propanil-treated OVX mice failed to restore the increase in
PC-specific ASC (Figure 5B, OVX Propanil + E2 vs. Propanil). All ovariectomized mice
had a similar number of PC-specific ASC as vehicle control animals (Figure 5B). These
results suggest that the inability of propanil to enhance the antibody response in OVX
mice was not due to the absence of E2.
An ER antagonist does not inhibit the ability of propanil to enhance the antibody
response.
The previous experiment demonstrated that the addition of exogenous E2 did not
restore the ability of propanil to enhance the antibody response in OVX mice. However,
it is possible that the dose of exogenous E2 given does not accurately mimic the level of
E2 in mice with intact ovaries. To determine if signaling through the estrogen receptor is
required for the increased immune response, mice were treated with the ERα and ERβ
antagonist ICI 182,780. Normal female mice were vaccinated and treated with propanil
or vehicle on day 0, and given daily treatments with ICI 182,780. Uterine weights were
measured to confirm the efficacy of the ICI treatment and the PC-specific antibody
response was determined. The uterine weights of all animals receiving the ER antagonist
were significantly reduced compared to control animals (Figure 6A). Treatment with the
ER antagonist did not affect the basal PC-specific ASC response in vehicle-treated mice
(Vehicle vs. Vehicle + ICI, Figure 6B). Propanil-exposed mice treated with ICI had an
increased ASC response comparable to propanil alone (Propanil vs. Propanil + ICI,
Figure 6B). These results demonstrate that the ER antagonist did not inhibit the increase
in PC-specific ASC in propanil-treated animals, which suggests that signaling through the
estrogen receptor pathway is not required for propanil to enhance the antibody response.
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Inhibition of steroid synthesis in propanil-treated mice abrogates the increase in
ASC.
Chemical inhibition of steroid synthesis was conducted to determine if a gonadal
steroid other than estradiol regulates the propanil amplification of the humoral immune
response. Animals were treated with the GnRH antagonist antide for 14 days prior to
propanil exposure and HKSP vaccination to ensure complete suppression of ovarian
steroid synthesis (Couse et al., 2003). Serum estradiol levels were determined prior to
propanil treatment on day 14. All mice had non-detectable levels of estradiol, which is
indicative of the efficacy of the antide treatments (data not shown). Uterine weights and
the immune response to PC were determined 7 days post-vaccination. Antide-treated
animals had significantly decreased uterine weights (Figure 7A). Treatment with antide
did not affect the basal PC-specific ASC response (Vehicle vs. Vehicle Antide, Figure
7B). The number of PC-specific ASC in mice treated with antide and exposed to
propanil were not significantly different from the vehicle controls (Vehicle vs. Propanil
Antide, Figure 7B), but were significantly different from the propanil-treated control
animals that had an increased ASC response (Propanil vs. Propanil Antide, Figure 7B).
These results demonstrate that steroid synthesis is necessary for the enhanced immune
response in the spleens of mice exposed to propanil.
A progesterone receptor antagonist does not inhibit antibody enhancement by
propanil.
Progesterone is another steroid hormone that has been shown to affect antibody
production. The progesterone antagonist, RU486, was utilized to determine if
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progesterone signaling is required for the increased antibody response. As previously
stated, propanil induces thymic atrophy which is partially inhibited by RU486 (de la Rosa
et al., 2005). To determine the efficacy of the RU486 treatments, mice were treated with
RU486 2 hours prior to propanil or vehicle treatment, and at 12 and 24 hours postexposure. RU486 partially abrogated thymic atrophy as determined by measurement of
the thymic weights and by quantification of the CD4+CD8+ thymocyte population (Figure
8A and 8B), demonstrating that RU486 is efficacious via the sc route.
To determine if blockade of the progesterone receptor inhibits the increased
antibody response, mice were injected with RU486 2 hours prior to propanil exposure
and vaccination. Mice were subsequently injected with RU486 12 hours post-exposure
and every 24 hours following propanil treatment. Treatment with the progesterone
antagonist did not affect the basal PC-specific ASC response in vehicle-treated mice
(Vehicle vs. Vehicle + RU486, Figure 8C). Propanil-exposed mice treated with RU486
had an increased ASC response comparable to propanil alone (Propanil vs. Propanil +
RU486, Figure 8C). These results demonstrate that the progesterone antagonist did not
inhibit the increase in PC-specific ASC in propanil-treated animals, which suggests that
progesterone is not required for propanil to enhance the antibody response.
Propanil enhances the antibody response in both normal and orchiectomized males.
To determine if propanil increased the antibody response in a gender specific
manner, male mice were vaccinated and treated with propanil or vehicle (Figure 9). The
PC-specific splenic ASC were measured after 7 days. Propanil increased the IgG2b,
IgG3 and IgM PC-specific splenic ASC approximately 3-fold (Vehicle vs. Propanil,
Figure 9). Castration did not significantly affect the propanil-induced increase in PC-
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specific ASC. Castrated males treated with propanil produced approximately the same
fold increase in PC-specific ASC as normal propanil-treated male mice (Propanil vs.
Propanil Castrated, Figure 9). These results suggest that androgens are not involved in
the amplification of the immune response after propanil exposure.
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DISCUSSION
Gonadal steroid regulation of the immune system is poorly understood. The
majority of the research into the effects of sex steroids on the humoral immune response
involves the hormones estradiol, progesterone, and testosterone. Estradiol has been
demonstrated to increase the number of antigen-specific splenic ASC several fold
(Verthelyi and Ahmed, 1998). The other major gonadal hormones progesterone and
testosterone are generally considered to be immunosuppressive. The data presented here
suggest a novel role for the amplification of the TI-2 humoral immune response by the
ovary that is independent of estrogen or progesterone. This report also demonstrates the
novel use of propanil exposure to study the mechanism for gonadal steroid regulation of
antibody responses.
Previous reports demonstrated that propanil induces a number of immunotoxic
effects that suggest a manipulation of the estrogenic pathway (de la Rosa et al., 2003; de
la Rosa et al., 2005; Salazar et al., 2005). Propanil has been classified by two studies as
non-estrogenic and weakly anti-androgenic, as determined by receptor binding assays
(Bauer et al, 1998; Kojima et al., 2004). However, given the heavy usage of propanil and
the importance of studying endocrine disruption, extensive characterization of propanil as
a potential EDC is warranted. Synthetic chemicals can manipulate the estrogenic
pathway in a number of ways including 1) direct binding of ERs, 2) indirect ER
activation by stimulating ER phosphorylation, 3) altered expression of the ER, 4)
changing the levels of hormone expression, or 5) modifying the intracellular estrogenic
signaling pathway (Borgest et al., 2002).
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The uterotrophic assay is the classic method to determine the in vivo estrogenic
activity of a chemical. Measuring uterine weights after 3 days of chemical exposure is a
sensitive assay for detecting weak ER agonists (O'Connor et al., 1996). In vivo exposure
to propanil did not induce an increase in uterine weight. Disadvantages of the
uterotrophic assay include the inability to decipher antagonistic or agonistic activity in
different organs, a lack of specificity, and the inability to measure ERβ binding activity
(O'Connor et al., 1996; Weihua et al., 2000). For instance, chemicals such as tamoxifen
act either as ER antagonists or agonists within different organs or at different
concentrations (Watanabe et al., 1997). Therefore, the ERα and ERβ binding activity of
propanil were determined using in vitro assays. Propanil did not compete for E2 binding
to either ERα or ERβ nor did it increase estrogen-inducible alkaline phosphatase activity
in ER-responsive cells. The results of the uterotrophic assay, ER binding studies, and the
ER-inducible alkaline phosphatase assay establish that propanil is not a classic EDC.
Increasing ER expression levels might also affect antibody activity since the ER is
found on many immune cells including B cells (Grimaldi et al., 2002). Removal of E2
from circulation would eliminate the ability of ER expressing cells to respond. However,
subcutaneous administration of E2 to OVX mice failed to restore the stimulatory effect of
propanil on the antibody response to HKSP, which indicates that propanil does not
require the presence of E2 to exert its effect on the splenic antibody response. This also
suggests that propanil exposure does not induce antibody stimulation by increasing the
ability of cells to bind E2. In addition, the data shows that high concentrations of E2 for
a short period of time (7 days) do not affect the TI-2 antibody response.
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Chronic low E2 exposure increases splenic ASC (Myers and Petersen, 1985;
Verthelyi and Ahmed, 1998). However, high levels of E2, such as during the third
trimester of pregnancy, is immunosuppressive (Confavreux et al., 1998). Measuring E2
serum levels is compounded by a number of factors including estrous cycling and the
selection of several time points for hormone analysis. An alternative approach to directly
measuring estradiol serum levels is to inhibit the effects of E2 by blocking the ER. The
ER antagonist ICI 182,780 has been demonstrated to completely attenuate the ability of
ERα and ERβ to regulate transcription by 1) impairing receptor dimerization, 2)
increasing receptor degradation, thereby lowering ER expression, and 3) disrupting
nuclear localization of the ER/ligand complex (Wakeling, 2000). Several reports have
shown that administration of ICI 182,780 1 hr prior to EDC exposure is sufficient to
inhibit the effect of an EDC (Ciana et al., 2001; Jung et al., 2005; Papaconstantinou et al,
2001). Propanil does not appear to trigger antibody stimulation by acting on the
estrogenic signaling pathway, as indicated by the failure of ICI 182,780 to inhibit the
increased ASC response following propanil treatment. These data strongly suggest that
propanil does not affect the TI-2 antibody response via an estrogenic mechanism.
The GnRH antagonist antide was utilized to determine if gonadal steroids regulate
the ovarian-dependent stimulation of the antibody response. Antide treatment abrogated
the effect of propanil similar to ovariectomy, suggesting that propanil stimulates the
antibody response via a gonadal dependent mechanism in females. Antide treatment not
only blocks the effects of GnRH, but also decreases the production of LH and FSH from
the pituitary and eliminates the secretion of gonadal hormones (Couse et al, 2003; Fallest
et al., 1995). The hypothalamic hormone, GnRH, and the pituitary hormones, LH and
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FSH, have all been demonstrated to regulate the antibody response (Athreya et al., 1993;
Jacobson and Ansari, 2004). Since ovariectomized animals have elevated levels of LH
and FSH compared to antide-treated animals, but have similar antibody responses
following propanil exposure, it can be inferred that LH and FSH do not participate in the
increase in the number of PC-specific ASC (Wakeling et al., 1991; Couse et al., 2003).
Other non-estrogenic hormones in the steroid synthesis pathway can regulate the
antibody response. Androgens can induce immunosuppression (Brick et al., 1985). As
mentioned previously, propanil has some anti-androgenic activity. However, antibody
studies evaluating the effects of anti-androgens indicate that they are not
immunostimulatory (O'Connor et al., 2002). In addition, removal of the primary source
of testosterone in males via castration did not affect the ability of propanil to enhance the
antibody response. Altogether, this data does not support an androgenic mechanism.
Progesterone has been demonstrated to be primarily immunosuppressive in
pregnant women (Beagley and Gockel, 2003). Observations in pregnant women with
autoimmune diseases such as multiple sclerosis have demonstrated that progesterone and
estradiol levels are at the highest during the third trimester when the severity of disease
decreases (Confavreux et al., 1998). However, some studies have demonstrated that the
number of antigen-specific ASC in the vaginal tissue is increased following mucosal
immunization and progesterone treatment Johansson et al., 1998). Blockade of the
progesterone receptor with RU486 did not have any effect on the stimulation of the
antibody response in propanil-treated mice. This suggests that antibody enhancement
does not require a progesterone-dependent mechanism.
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Loss of the increased PC response following ovariectomy or inhibition of steroid
synthesis may be the result of an indirect effect caused by the loss in homeostatic steroid
hormone levels. Immunomodulatory hormones, such as GnRH and E2, are produced
locally in lymphoid organs. Studies have shown that the gonads regulate these locally
produced lymphoid hormones, suggesting another potential mechanism for ovarian
regulation of the humoral immune response. For instance, GnRH has been demonstrated
to have immunomodulating effects independent of other hormones. Reports have shown
that GnRH receptor mRNA and GnRH mRNA are expressed in murine spleen cells and
human B lymphocytes (Jacobson et al., 1998; Khan et al., 2003; Silveira et al, 2002). In
addition, the spleen has been demonstrated to have a higher affinity for GnRH peptide
compared to other endocrine and nonendocrine organs including the testes and liver
(Khan et al., 2003). Three weeks of exogenous GnRH treatment increases both the total
IgG serum levels in female ovariectomized mice and the proliferation of B and T
lymphocytes in response to LPS and ConA stimulation, respectively (Jacobson and
Ansari, 2004).
The classically studied source of GnRH is the hypothalamus, although it is
unlikely that hypothalamic produced GnRH can directly affect spleen function since the
concentration of GnRH in the portal blood is low and rapidly metabolized (Eskay et al.,
1975). Evidence suggests that the ligand for GnRH receptors on splenic lymphocytes is
likely to be derived from another endogenous source and may act in an autocrine or
paracrine fashion in non-pituitary organs (Chen et al., 1999). Both GnRH mRNA and
GnRH receptor mRNA are altered in splenocytes throughout the estrous cycle, however,
the exact mechanism of this regulation is unknown (Jacobson et al., 1998).
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It is possible that the ovaries are involved in regulating the local GnRH
production in the spleen, which contributes to the increased antibody response in
propanil-treated animals. This hypothesis might also explain the contrasting results
between castrated and ovariectomized animals. There is data which indicates that male
and female discrepancies in immune function exist in response to GnRH treatment
following gonadectomy (Jacobson et al., 1999). These data suggest that the sexual
disparities exist due to a residual effect caused by hormonal differences experienced early
in development.
Additional evidence exists suggesting gonad-mediated hormone regulation in
lymphocytes and the spleen. A recent report demonstrated that removal of the ovaries
alters the activity of the steroid hormones aromatase and 17β-hydroxysteroid
dehydrogenase locally in the spleens and T cells of mice (Samy et al., 2001). In addition,
castration had the opposite effect on the activity of these enzymes (Samy et al., 2001).
The role of these steroidogenic pathways in the spleen and T cells on the humoral
immune response has not been evaluated. Propanil may act by disrupting the ovarian
control of the steroidogenic enzymes in the spleen leading to altered B cell activation.
Analyzing the local spleen-specific and ovary-specific hormone receptor mRNA,
hormone mRNA, and the activity of steroid enzymes would yield valuable clues to the
mechanism regulating this effect.
In contrast to the results presented here, previous studies have demonstrated that
exposure to propanil can decrease the response to a T dependent and a T-independent
antigen (Barnett et. al., 1992; Barnett and Gandy, 1989). In the previous studies,
C57Bl/6 female mice were exposed i.p. to propanil on day 0, immunized i.v. on day 3
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with the TI-2 antigen DNP-Ficoll, or the T dependent antigen, SRBC, and the plaqueforming cell response in the spleen determined on day 7. In the present studies, propanil
was administered i.p. on day 0 and the mice immunized i.p. with HKSP on day 0. The
PC-specific ASC response was determined on day 7. It is possible that the different
results between the studies in the PC antibody response is due to the nature of the
antigen, purified antigen versus whole heat-killed bacteria. However, preliminary studies
in the laboratory have demonstrated a similar enhancement of the ASC response to the
TI-2 antigen PC-Ficoll when propanil is administered at the time of PC-Ficoll
immunization. Therefore, the timing of propanil exposure and immunization may be the
critical factor in the ultimate effect that propanil has on the humoral immune response.
Preliminary studies demonstrate that propanil can be given 3 days after HKSP
immunization and still enhance the PC immune response. In addition, preliminary
experiments demonstrate that propanil can also enhance the ASC response in the spleen
to a T dependent antigen on HKSP, PspA. The PspA-specific serum antibody titers peak
approximately 14 days post-immunization. Propanil must be given on day 9 after
immunization to enhance the PspA response. If the animals are exposed to propanil at
the time of immunization on day 0 there is no effect on the immune response to PspA on
day 14. Taken together, these studies suggest that propanil exposure must occur near the
time of the peak antibody response to increase the response. It is not yet known if the
ovaries are required for the enhancement of the immune response to PC-Ficoll or PspA.
Altogether, these data support two novel findings. First, propanil enhances the
antigen-specific antibody response in females in an ovary-dependent, estrogenindependent manner unlike other EDC reported to date. Second, the data suggests a
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novel role for antibody stimulation by the ovaries following chemical exposure. Future
studies will utilize propanil as a unique tool to examine interactions between the immune
and endocrine systems with an emphasis on how the ovaries contribute to regulation of
humoral immune responses.
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Figure 1. Ovariectomy abrogates the propanil-induced increase in PC-specific
splenic ASC.
OVX and sham-operated female C57BL/6 mice (5/group) were treated with 150 mg/kg
propanil or vehicle control and vaccinated with 2x108 CFU HKSP. Numbers of PCspecific IgG2b, IgG3, and IgM ASC were determined by ELISPOT assay on day 7.
Values represent the mean ± SD of ASC/1x106 B cells. * Significantly different from all
other groups, p ≤ .05.
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Figure 2. Propanil does not increase uterine weights in OVX mice.
C57BL/6 mice (5/group) were ovariectomized and treated with vehicle control (open
bar), 150 mg/kg propanil (hatched bar), or 10µg/kg/day of E2 (black bar). Uterine
weights were recorded after 3 days. Values represent the mean ± SD. * Significantly
different from vehicle, p ≤ .05.
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Figure 3. Propanil does not bind to ERα or ERβ.
Competitive binding assays determined the binding of propanil to ERα or ERβ in the
presence of [3H]-E2. Values represent the percent of [3H]-E2 bound to ER in the
presence of either propanil (open circles) or unlabeled E2 (closed circles).
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Ishikawa cells were treated with propanil (1 µm, 3µM, 10 µM, or 100 µM) or E2 (10 pM
or 100 pM). Alkaline phosphatase activity was measured after 72 hours. Values
represent the mean absorbance recorded in the propanil or E2 treated cells. *
Significantly different from vehicle, p ≤ .05.
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Figure 5. Addition of exogenous E2 does not restore the increase in PC-specific
ASC of propanil-treated animals.
OVX and sham-operated female C57BL/6 mice (5/group) were treated with 150 mg/kg
propanil or vehicle control and vaccinated with 2x108 CFU HKSP. OVX mice were
treated with 10µg/kg/day of E2 or the vehicle. Spleens and uteri were removed after 7
days. (A) Uterine weight. * Significantly different from vehicle control, p ≤ .05. (B)
Numbers of PC-specific IgG2b, IgG3, and IgM ASC. Values represent the mean ± SD of
ASC/1x106 B cells. * Significantly different from vehicle control, p ≤ .05.
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Figure 6. Addition of the ER antagonist ICI 182,780 does not block the increase in
ASC in propanil-treated animals.
C57BL/6 mice (5/group) were vaccinated with 2x108 CFU HKSP, and treated with 150
mg/kg propanil or vehicle control, with or without ICI 182,780 (10 mg/kg/day) or
vehicle. Spleens and uteri were removed after 5 days. (A) Uterine weight. *
Significantly different from vehicle control, p ≤ .05. (B) Numbers of PC-specific IgG2b,
IgG3, and IgM ASC. Values represent the mean ± SD of ASC/1x106 B cells. *
Significantly different from the respective vehicle control, p ≤ .05.
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Figure 7. Antide treatment abrogates the propanil-induced increase in PC-specific
ASC.
C57BL/6 female mice were treated with antide (60µg/mouse) or vehicle for 14 days as
described in Methods. Mice were vaccinated on day 14 with 2x108 CFU HKSP and
treated with 150 mg/kg propanil or vehicle. Spleens and uteri were removed 7 days postvaccination. (A) Uterine weight. * Significantly different from vehicle control, p ≤ .05.
(B) Numbers of PC-specific IgG2b, IgG3, and IgM ASC. Values represent the mean ±
SD of ASC/1x106 B cells. * Significantly different from vehicle control, p ≤ .05.
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Figure 8. Treatment with the progesterone antagonist RU486 does not inhibit the
increase in ASC in propanil-treated animals.
C57BL/6 female mice were treated with RU486 as described in the Methods. Thymic
wet weights and thymocyte populations were determined on day 3. (A) Thymus to body
weight ratio. * Significantly different from the vehicle control and vehicle + RU486, p ≤
.05. (B) CD4+CD8+ cells. * Significantly different from the vehicle control and vehicle
+ RU486, p ≤ .05. # Significantly different from vehicle, propanil, and vehicle + RU486,
p ≤ .05. (C) Numbers of PC-specific IgG2b, IgG3, and IgM ASC were determined by
ELISPOT assay on day 7 post-vaccination. Values represent the mean ± SD of
ASC/1x106 B cells or per spleen. * Significantly different from the respective vehicle
control, p ≤ .05.
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Figure 9. Propanil enhances the antibody response in both normal and
orchiectomized males.
Sham-operated and castrated C57BL/6 male mice were vaccinated with 2x108 CFU
HKSP and treated with 150 mg/kg propanil or vehicle control. Spleens were removed
after 7 days. Numbers of PC-specific IgG2b, IgG3, and IgM ASC were determined by
ELISPOT assay. Values represent the mean ± SD of ASC/1x106 B cells or per spleen. *
Significantly different from the respective vehicle control, p ≤ .05.

165

CHAPTER 6: PROPANIL EXPOSURE DOES NOT
ENHANCE SURVIVAL TO A VIRULENT S. PNEUMONIAE
CHALLENGE FOLLOWING A SUBOPTIMAL
IMMUNIZATION
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INTRODUCTION
The previous experiments demonstrated that propanil enhances the number of PCspecific ASC in the spleen, but does not affect serum antibody titers. Previous reports
have shown that PC-specific antibody is protective against a lethal challenge with S.
pneumoniae (Briles et al., 1992; Wallick et al., 1983). However, protection is correlated
with circulating antibodies in the serum (Fischer et al., 1995). These experiments were
conducted to determine if propanil enhances the survival of HKSP immunized animals
lethally challenged with S. pneumoniae.
Previous studies evaluating the survival of mice following HKSP immunizations
have been performed using an immunization schedule of one ip injection on day 0 and a
second immunization on day 14 followed by lethal challenge on day 21 (Wallick et al.,
1983; Briles et al., 1992; Fischer et al., 1995). However, PC-specific titers peak by day 7
and subsequent immunizations do not significantly increase the PC antibody titers (Wu et
al., 2002; Wu et al., 1999). Analysis of the idiotypes produced in response to HKSP
immunization demonstrates that the high affinity T15+ is increased as much as 20-fold (2
µg/ml to 40 µg/ml) following the second immunization in C57BL/6 mice (Ruppert et al.,
1980). These studies suggest that the second immunization enhances survival by
increasing the percent of high affinity PC-specific antibody produced in C57BL/6 mice
rather than increasing the total amount of PC-specific antibodies in the serum.
Previous experiments primarily concentrated on the effect of a single exposure of
propanil on a primary antibody response. Therefore, the following experiments utilized a
lethal challenge exposure model following a primary immunization. A single primary
immunization with HKSP was found to induce a suboptimal level of protection against a
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lethal challenge. Addition of propanil to the primary immunization did not affect
mortality outcomes.

METHODS
Animals
Six to eight week old C57Bl/6 female mice were purchased from Hill Top Lab
Animals. Mice were housed in microisolator cages in pathogen free conditions at West
Virginia University’s animal facility. Mice were kept on a 12 hr light-dark cycle and
allowed to acclimate to the facility for 1 week. These studies were conducted in
accordance with all federal and institutional guidelines for animal use and were approved
by the West Virginia University Institutional Animal Care and Use Committee.
Reagents
Propanil (3,4-dichloropropionanilide, 99% pure) was purchased from Chem
Service.
Bacterial preparation
S. pneumoniae strain R36A, an avirulent, nonencapsulated strain, was grown to
mid-log phase in Todd-Hewitt broth + .05% yeast extract and stored at –80°C. For
immunization, stock was cultured in a candle jar for 18 hrs at 37°C on blood agar plates.
A few characteristic colonies were selected and suspended in 200 ml Todd-Hewitt broth
+ .05% yeast extract. Bacteria were grown at 37°C to an absorbance reading at 650nm of
0.4 and heat killed for 4 hours in a 60°C water bath. A final concentration of 109 CFU/ml
was established in PBS based on colony counts. Sterility was confirmed by culture.
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Heat-killed stock was stored at -20°C in 1 ml aliquots. Mice were immunized ip with
2x108 CFU.
S. pneumoniae strain D39, an encapsulated virulent strain from which R36a was
derived, was grown on blood agar plates for 18 hr at 37°C. A few colonies were added to
Todd-Hewitt broth + 10% FBS and grown to mid-log phase (approximately 1x108
CFU/ml). Bacterial concentration was confirmed by plating. Bacteria was stored in 10%
glycerol at -80°C. For lethal challenge, bacteria was thawed, washed in PBS, and
resuspended at the appropriate concentration (approximately 2x107 CFU/ml).
Animal exposures
Propanil was dissolved in peanut oil for a final concentration of 15 mg/ml for all
experiments. Mice (4-8/group) were treated ip with either 150 mg of propanil/kg of body
weight (mg/kg) or vehicle on the same day as immunization. On day 7, mice were
challenged either ip or iv with D39. Survival was monitored for 7 days, at which time the
experiment was terminated. An LD50 dose of S. pneumoniae was experimentally
determined prior to these studies.

RESULTS
IP injected oil enhances survival to a lethal challenge to D39.
To determine if ip injection of the vehicle affects survival against a lethal
challenge of S. pneumoniae, 3 groups of mice were vaccinated ip with HKSP and treated
with saline, vehicle or propanil. Immunized mice treated with either vehicle or propanil
had an increased survival rate (60%) compared to immunized alone animals only
immunized with HKSP (0%) (Figure 1). It is possible that oil may increase survival by
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inducing a general inflammatory reaction. Previous research demonstrated that ip oil
exposure increases the number of inflammatory cells in the spleen (data not shown).
These data suggest that interpretations from studies using an ip challenge model is
complicated by the effects of the vehicle.
IP injected oil does not affect survival to an iv D39 challenge.
The previous experiment demonstrated that evaluation of the effects of propanil
on survival to a lethal challenge requires altering the route of exposure to the virulent
bacteria. Previous studies have shown that ip and iv routes of challenge have
approximately the same degree of virulence (Briles et al., 1992). Mice were treated with
or without the vehicle, immunized ip with HKSP and challenged iv with virulent S.
pneumoniae. Survival of immunized animals was not affected by ip vehicle treatment
(Figure 2). Therefore, the iv route of challenge was chosen for future experimentation.
Propanil treatment does not increase survival in suboptimally immunized mice.
To determine if the increased number of PC-specific ASC induced by propanil
affects survival, vaccinated mice were treated with propanil or vehicle and challenged
with 2x106 CFU of D39 on day 7. Results were compared to naïve animals treated with
propanil or vehicle. The CFU of D39 used was determined to be a LD50 in HKSP
vaccinated mice. Immunization with HKSP did not consistently increase survival
compared to naïve animals (Figures 3A and 3B). In addition, propanil exposure in naïve
animals did not affect survival compared to vehicle treated naïve animals (Figure 3A).
Finally, propanil-treatment did not increase survival in immunized mice compared to
either naïve mice or vehicle-treated immunized mice (Figures 3A and 3B).
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DISCUSSION
These experiments begin to address the significance of the increased number of
PC-specific ASC in the spleen. The experiments also address the question of whether
antibody serum titers or ASC in the spleen are more important for virulent bacterial
challenges. These results demonstrate that one vaccination of HKSP is not sufficient to
increase survival to a lethal challenge. Furthermore, propanil was not able to enhance
survival following a suboptimal immunization.
As previously mentioned, a second immunization with HKSP increases the
percent of T15+ antibodies in the serum. The inability to protect mice following one
HKSP injection is likely due to the relatively low concentration of T15+ antibodies.
Previous reports have shown that T15+ idiotype antibodies are more effective at
protecting against a lethal challenge than other idiotypes produced to PC (Nicoletti et al.,
1993; Briles et al., 1982a; Briles et al., 1984). Experiments have shown that passive
immunization with T15+ antibodies increases protection from a lethal ip S. pneumoniae
challenge in a dose dependent fashion (Briles et al., 1982a). Given the importance of
T15+ antibodies for protection, future experiments should evaluate the effect of propanil
on PC-specific idiotypes in both the spleen and serum.
Alternative strategies to examine the effect of propanil on mortality include
studying the effect of propanil on a secondary immunization. Our previous results
demonstrate that propanil treatment at the time of the second immunization results in an
increased PC-specific ASC response in the spleen. Challenging propanil and vehicletreated mice that have been immunized twice would determine if propanil increases
survival following an optimal immunization.
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Altogether, this data begins to address relevance of an increased local antibody
response in resolving a virulent challenge. Immunization with an alternative antigen that
may increase serum titers such as PC-Ficoll or PC-KLH would be valuable in exploring
the necessity of a corresponding increase in serum titers. In addition, passive
immunization with pooled antibody collected from ex vivo splenic cultures from
propanil-treated animals would determine the efficacy of the antibodies produced from
the amplified response. Altogether, these studies support previous reports demonstrating
the importance of serum titers to protect against a lethal challenge.
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Figure 1. IP oil injection increases survival to a lethal ip S. pneumoniae challenge.
Female C57BL/6 mice (5-7/group) were immunized ip with 2x108 CFU HKSP and
treated ip with saline, 150 mg/kg propanil or vehicle. Mice were challenged ip with a
2x106 CFU D39 S. pneumoniae on day 7. Values represent the percent of surviving mice.
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Figure 2. IP oil injection does not affect survival to a lethal iv S. pneumoniae
challenge.
Female C57BL/6 mice (5/group) were immunized ip with 2x108 CFU HKSP and treated
ip with saline or vehicle. Mice were challenged iv with a 2x106 CFU D39 S. pneumoniae
on day 7. Values represent the number of surviving mice.
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following a suboptimal immunization.
(A) Female C57BL/6 mice (4-8/group) were immunized ip with 2x108 CFU HKSP or
saline and treated ip with 150 mg/kg propanil or vehicle. Mice were challenged iv with a
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CHAPTER 7: GENERAL DISCUSSION
Objective
These studies were designed to 1) examine the effect of an exposure to a mixture
of herbicides on the humoral response utilizing the HKSP immunization model, 2)
determine the mechanism regulating the propanil-induced enhancement of the PCspecific response induced by propanil, and 3) determine if propanil acts as an adjuvant
that enhances the efficacy of an immunization.
Endocrine regulation of the humoral response
Propanil was found to require ovarian steroid synthesis to enhance the PC-specific
response following HKSP immunization. However, the data demonstrates that propanil
enhances the humoral response independent of an estrogenic mechanism. In addition,
evidence was presented suggesting that progesterone is not involved in the increased
response. Castration of male mice did not affect the propanil-induced response in male
mice, suggesting an androgenic independent mechanism. This data eliminates the vast
majority of published mechanisms by which the gonads directly regulate the antibody
response.
A valid hypothesis must account for the two primary observations: 1) the ovaries
are required for enhancement, and 2) the testes are not required. These observations
suggest that the unknown factor produced by the ovaries required for antibody
enhancement is also produced outside of the male gonads, assuming a similar mechanism
for antibody enhancement in male and females. There are two hypotheses that may
explain the data. 1) Propanil exposure induces the ovaries to produce or suppress
protein(s) with a novel function that stimulates the antibody response. The site of protein
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synthesis in males is outside of the gonads. 2) Alternatively, when mice are
ovariectomized or steroid synthesis is inhibited, this disrupts local splenic hormone
regulation. Propanil may act directly on the splenic hormones. However, disruption of
ovarian regulation interferes with the ability of the spleen to respond to propanil. Both
hypotheses represent novel roles for the ovarian regulation of the humoral immune
response.
The first hypothesis suggests that propanil exposure alters ovarian function either
directly or indirectly. There are several difficulties with this hypothesis. Presently, the
existing literature has not characterized a protein or hormone associated with ovarian
regulation of the antibody response that induces a similar response as observed in the
propanil exposure model. Identification of the responsible protein(s) will be difficult
since there is not a small group of likely candidates and detection would require a large
screen of proteins and mRNA via such techniques such as proteomics and RNA
microarrays. Additionally, the data indicates that the protein(s) would be synthesized
independent of the testes in males. Locating the responsible protein in males would be
more difficult since a target site has not been identified.
The second hypothesis proposes that propanil affects the local endocrineregulated genes in the spleen. As mentioned in Chapter 5, the spleen contains a number
of sex hormone mRNAs as well as sex hormone receptor mRNAs and steroidogenic
enzymes. The ovaries and testes contribute to regulation of these hormones, receptors,
and enzymes (Samy et al., 2001; Jacobson et al., 1998; Jacobson et al., 1999). Notably,
the ovaries and testes differentially regulate these local endocrine systems. The
significance of global hormones on the immune response is well established. However,
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the impact of local production of endocrine mediators in the spleen and lymphocytes is
poorly understood. It is possible that propanil does not affect ovarian function, but
instead exerts its effects on the spleen. Removal of the ovaries may disrupt local splenic
hormone production, thereby preventing “normal” enhancement of the antibody response
by propanil. Addition of the ovarian hormones such as E2 and progesterone to OVX
mice prior to propanil exposure would address whether the ovarian hormones act in a
supplementary fashion. Although E2 treatments in OVX mice did not restore the
enhanced response following propanil exposure, studies suggest that both progesterone
and E2 are required for accurate mimicry of ovarian hormone production. For example,
complete GNRH and LH feedback regulation in OVX mice requires both progesterone
and E2 (Dalkin et al., 1990). Failure of E2 and progesterone supplements in OVX mice
to restore the propanil enhancement of the antibody response would suggest that propanil
is exerting its effect on the ovaries and not the spleen.
The results gathered by testing either one of these hypotheses would yield novel
findings. Since the discovery of endocrine-related hormones and receptors in lymphoid
organs, their function is largely unknown. Propanil could be used as a model reagent to
study these locally produced hormones and their contribution to immune regulation.
Alternatively, discovery of a novel protein or a novel function of an ovarian protein could
lead to a number of studies elaborating the role of this protein in normal immune function
and disease.
Immune mediators of the enhanced humoral response
Although it is known that the ovaries are required for the enhanced humoral
response, the role of lymphocytes and costimulating molecules is unknown. As
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mentioned in the General Introduction, there are a number of ways the PC-specific
antibody response is enhanced. Both the innate and the adaptive immune system regulate
the antibody response. Complement receptors enhance the antibody response by
lowering the activation requirements of the B cell. APC such as FDC also enhance the
antibody response via a CR2 dependent mechanism. As discussed in Chapter 4, propanil
is not able to enhance the antibody response to a suboptimal immunization. In addition,
affinity analysis suggests that lower affinity PC-specific B cells are not increased. This
data suggests that a complement-mediated mechanism does not contribute to the
enhanced response.
Other innate immune mechanisms such as MZ macrophages, cytokines and TLR
regulate the TI-2 response via different mechanisms. MZ macrophages negatively
regulate the PC-specific response. The data indicates that propanil did not affect the
number of splenic macrophages. However, measurements of the MZ subpopulation was
not performed, therefore this mechanism cannot be eliminated. Cytokines are important
for early isotype switching. Since both the IgG isotypes and IgM are increased equally
following propanil exposure, enhanced isotype switching is not likely to be responsible
for the enhanced response. The available literature has shown that TLR stimulation
increases the PC-specific response in a dissimilar manner compared to propanil exposure.
However, TLR9 stimulation enhances polysaccharide specific antibody titers (Sen et al.,
2006). As previously shown, propanil does not enhance antibody titers. Furthermore,
propanil enhancement of the number of splenic ASC is not further increased at later time
points. Altogether, the data does not strongly indicate a specific innate immune
mechanism for enhanced TI-2 responses following propanil exposure.
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T cells possess a number of costimulating molecules that enhance the TI-2
antibody response. The inability of propanil to enhance the PC-KLH response on day 7
and the inability of a day 0 propanil-treatment to enhance the PC-specific response on
day 3 suggests a role for T cells in the enhanced response. A direct method for
evaluating the role of T cells is T cell deletion studies. As mentioned previously in the
Discussion of Chapter 4, T cells are not required for normal PC-specific responses after 4
days. It has also been shown that delayed propanil exposure enhances the PC-specific
response similarly to simultaneous vaccination and propanil treatment. Conflicting
reports present evidence for a necessity of either CD4+or CD8+ T cells in PC antibody
responses (Wu et al., 2002; Kobrynski et al., 2005). An initial study could employ an
anti-CD8, anti-CD4, or an anti-CD3 antibody on day 4 following HKSP immunization.
Mice could then be exposed to propanil to determine the necessity of the different
subpopulations of T cells in the amplified PC-response.
A possible mechanism for T cell mediated enhancement of the antibody response
in propanil-treated mice is via a CD40 dependent pathway. As mentioned in the General
Introduction, anti-CD40 treatment enhances the TI-2 antibody response with similar
kinetics (Garcia et al., 1999a). In addition, CD40 ligation is also important for TD
responses. The number of TI-2 antigen-specific ASC is not increased until day 6
following anti-CD40 treatment (Garcia et al., 1999a). Immunohistochemistry analysis
suggests that the increase is the result of extended rounds of proliferation rather than an
increase in recruitment of low affinity B cells to the response (Garcia et al., 1999a). In
addition, splenomegaly is observed in anti-CD40 treated animals with similar kinetics
seen in propanil treated mice (Garcia et al., 1999a). The splenomegaly observed in the
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anti-CD40 treated animals are the result of an increase in white pulp and IgD+ cells
(Garcia et al., 1999a). Propanil treatment is hypothesized to increase splenomegaly via
an influx in undifferentiated cells (de la Rosa, dissertation). Another discrepancy
between the two treatments is the predominant IgG1 and IgG3 increase in anti-CD40
treated mice (Garcia et al., 1999a). However, IgM was not measured in this report,
making conclusions about the effects on isotype switching difficult. Altogether, these
similarities in responses suggest a plausible T cell dependent mechanism to enhance the
TI-2 response. However, a CD40 mechanism could still be plausible if T cells are not
involved in the enhanced response. Some studies have shown a T cell independent
source for CD40L ligation (Grammer et al., 1999).
Studies exploring the immunological regulation of the antibody response may also
aid in determining the mechanism for ovarian regulation by narrowing the search for
enzyme or hormone mRNA. Identification of the affected immune cells important for the
antibody enhancement will aid in a more precise analysis of the kinetics of activation of
individual cells. Understanding the exact time of activation will further narrow the range
of time for the mechanism of endocrine mechanism. Using both endocrine directed and
immunological approaches will be necessary for efficient identification of the
mechanisms involved.
Proliferation vs. polyclonal activation of B cells
Three primary methods for amplifying the number of ASC is by increasing the
proliferation of activated B cells, by increasing the number of B cells recruited activated
in the response, or increased differentiation. The evidence presented in Chapters 3 and 4
suggest that polyclonal activation is not the mechanism by which propanil enhances the

181

number of ASC. Polyclonal activation is characterized by increased lower affinity B
cells, increased number of nonspecific antibodies, and increased recruitment of B cells
into the follicles and red pulp of the spleen. An increase in proliferation is characterized
by extended rounds of division, which leads to more B cells derived from the same
progenitor cell. This results in an increased number of ASC with identical affinity and
isotype. The third method for increasing the number of ASC is increased differentiation.
This mechanism would suggest an increase in switching. Since all the predominant IgG
isotypes are enhanced equally and IgM is also enhanced similarly to the IgG isotypes,
this indicates that increased switching is not responsible for the increase in ASC.
Although our data suggests an increase in proliferation rather than polyclonal
activation or increased differentiation, more specific experiments are necessary for a
more definitive conclusion. More precise affinity analysis could be conducted using
idiotype analysis since the affinities of the various idiotypes are known. Identifying the
number of T15 and M167 idiotypes in propanil and vehicle-treated animals is another
way of conducting affinity analysis. Determining if propanil increases the number of
T15+ B cells similarly as other idiotypes will provide information on the polyclonal
activation. In addition, T15 and M167 analysis provides information on the contribution
of B1 B cells and MZ B cells since T15 plasma cells are predominantly derived from B1
cells and M167 are predominantly MZ B cells (Martin et al., 2001). Finally,
incorporating immunohistochemistry data and BrdU assays would provide information
on the proliferation and recruitment of B cells into the antibody response. These studies
would provide a more definitive assessment of polyclonal and proliferative activity
following propanil exposure. In addition, determining the method of enhancement would
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aid future experiments studying the immunological and endocrine mechanisms regulating
the response.
Correlating serum antibody titers with ASC responses
An important question remaining from Chapters 3 and 4 is the lack of increased
titers despite a several fold increase in the number of splenic ASC. Addressing this issue
is important for future studies examining the effect of propanil exposure on a virulent
challenge. The ex vivo antibody production from spleens of propanil-treated animals
suggests that the increased number of splenic ASC produce antibodies normally. In
addition, BM ASC were also demonstrated to contribute to the serum titers. However,
splenic ASC in propanil-treated animals do not migrate to the BM in greater numbers.
One explanation for the lack of increased titers could be that plasma cells from the spleen
must migrate and survive in the BM in greater numbers to produce an increase in serum
titers.
There are several possibilities for a lack of increased BM ASC in propanil-treated
animals. The plasma cells may fail to migrate from the spleen to the BM. Alternatively,
the BM may be unable to support the increased number of ASC. In order to address the
issue of migration in propanil-treated animals, analysis of apoptosis could be performed.
Previous studies indicate that splenic ASC that do not migrate to the BM will undergo
apoptosis (Smith et al., 1996). To determine if the increased number of splenic ASC are
migrating to the BM or undergoing apoptosis, annexin V staining could be performed in
splenic plasma cells and measured by flow cytometry. Increased levels of annexin
expression from propanil-treated ASC compared to vehicle-treated animals would
provide evidence suggesting that the increased ASC do not migrate in greater numbers
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because the plasma cells undergo apoptosis. To address the impact of splenic plasma cell
migration to the BM on antibody titers, ex vivo production of antibodies could be
measured from the BM, spleen and peripheral blood. Comparing the quantity of antibody
produced from ASC from each site would address the importance of successful migration
of plasma cells from the spleen to the BM to could be measured. Splenic, BM and
peripheral blood ASC could be cultured ex vivo and the amount of antibody produced
into the supernatant could be quantitated. Directly comparing the amount of antibody
produced by these three sources would provide evidence for or against the hypothesis that
increased splenic ASC must migrate to the BM to increase serum titers. Altogether, these
experiments would provide experimental evidence to address the correlation between
serum titers and BM and splenic ASC.
The effect of propanil on a survival to a virulent S. pneumoniae challenge
Determining the effect of propanil exposure on the host’s mortality following
virulent challenge is important for assessing the relevance of the antibody enhancement
model. Several additional experiments would provide more conclusive results
concerning propanil’s efficacy as an adjuvant. As mentioned in Chapter 6 Introduction,
the T15 response is strongly linked to effective clearance of virulent S. pneumoniae. Two
immunizations with HKSP are necessary for an optimal immunization. In addition, the
T15 response following one injection of HKSP in Balb/c mice is approximately the same
as double immunization in C57BL/6 mice (Ruppert et al., 1980).
From this data, two experiments can be derived to evaluate the effect of propanil
on an optimal immunization. As demonstrated in Chapter 4, propanil enhances a
secondary PC response to HKSP. However, the effect of propanil on the T15 idiotype
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has not been determined in C57BL/6 mice. C57BL/6 mice could be immunized twice
with HKSP to elicit an optimum response. Challenging mice treated with propanil during
a secondary response would determine if propanil enhances the optimal response.
Alternatively, Balb/c mice could be substituted for C57BL/6 mice in the protection
experiments since propanil enhances the response in Balb/c mice similarly to C57BL/6
mice (Schafer, personal communication). From these experiments, the protective effect
of a propanil exposure on the optimal antibody response can be determined. Combined
with the suboptimal data and serum antibody analysis, these studies would provide the
requisite information to draw conclusions about the relevance of the enhanced splenic
ASC response.
2,4-D as a model to study plasma cell homing and survival
The experiments in Chapter 3 demonstrated that 2,4-D reduces both the number
of ASC in the BM and serum antibody titers. Although the mechanism is unknown as
well as the antigen specificity of the effect, this discovery yielded a novel finding
concerning the early importance of BM ASC to the primary TI-2 serum titers. Future
studies could use 2,4-D as a model reagent to study BM plasma cells.
The mechanism regulating the 2,4-D induced decrease in BM ASC should be
determined prior to employing 2,4-D as a model. Possible mechanisms include 1)
defective migration out of the spleen, 2) failure to home properly to the BM, or 3)
inability to support plasma cells upon homing to the BM due to disruption of the BM
microenvironment. Upon establishing the mechanism of action, 2,4-D could then be used
as a specific disruptor of long-lived BM plasma cells.
Summary
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This dissertation presented findings that have implications for both the emerging
studies of endocrine-mediated immune interactions and the field of endocrine disruption.
As we begin to understand the purpose of the expression of endocrine-related genes in
lymphocytes and lymphoid organs as well as the impact of these genes on basic immune
function, new tools and models will be needed to address these basic questions. The
novel effect of enhancing the number of splenic ASC in conjunction with ovarian steroid
synthesis may yield valuable insight into this emerging field. Determining the
mechanism by which propanil interacts with both the endocrine and immune system may
not only yield new information into how these systems interact, but also, these
experiments may reveal that propanil will serve as a useful tool for studying other
endocrine-immune interactions.
Secondly, endocrine disruption is of recent concern in the field of toxicology. A
large number of ubiquitously occurring compounds have the potential for endocrine
disruption. The impact of these newly discovered endocrine disruptors on human health
is currently being addressed. However, given the promiscuous binding nature of the ER
and the need for rapid, large-scale screening, most studies have focused exclusively on
evaluating the affinity of a chemical or compound to the ER. Rapid, comprehensive
examinations of other potential nonestrogenic effects of compounds on the endocrine
system are absent in the field of toxicology. Although propanil interacts with the
endocrine system at high doses in our model, these experiments may be useful in
discovering alternative nonestrogenic mechanisms for chemicals to interact with the
endocrine system. Once the molecular targets are identified in this propanil exposure
model, other chemicals could be rapidly screened for similar effects. As demonstrated in
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our model as well as others, endocrine disruption can affect a number of other biological
systems in the host organism. Given the impact of the endocrine system on the overall
health of the organism as well as the dependence of the modern economy on the chemical
industry, thorough evaluation of these compounds is necessary for sustained human and
environmental health.
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